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The Exon Junction Complex (EJC) is a protein complex formed by a core of three proteins, 
eIF4AIII, MAGO, Y14, which is cotranscriptionally deposited on spliced mRNAs in 
mammalian cells, typically 24 nucleotides before the exon-exon boundaries. EJC deposition is 
believed to occur in evolutionarily divergent organisms, possibly all those that express the 
three core proteins. However, recent observations suggest that EJC factors are also associated 
with mRNAs derived from intron-less genes.  
My PhD project aimed to clarify whether the EJC components are recruited on mRNAs 
independently of splicing in Schizosaccharomyces pombe. The data I have gathered indicate 
that Fal1, the ortholog of eIF4AIII in S. pombe, is associated with Pol II transcribed genes 
independently of the presence of an intron. To investigate whether Fal1 has a direct role in 
transcription or pre-mRNA processing, I engineered an Auxin-Inducible Degron (AID) 
system to rapidly deplete Fal1. However, I found that the application of the system causes a 
decrease in the Fal1 protein levels even in the absence of auxin, accompanied by severe 
growth defects. Therefore, I have discussed the limiting factors which might prevent the use 
of the AID system in S. pombe.  
I have also investigated whether an EJC is formed in fission yeast. My data suggest that a 
mammalian-like EJC might not be formed in S. pombe, and that Fal1 can exist independently 
of MAGO and Y14, even though these two proteins are likely to form a heterodimer also in 
this organism, which in mammalian cells is sufficient to stabilize the association of eIF4AIII 
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AA     Anchor-Away 
AID     Auxin-Inducible degron 
BPS     Branch-point sequence 
BSA     Bovine serum albumin 
CBC     Cap-binding complex 
CBP     Cap-binding protein 
CDS     Coding sequence 
CTD     C-terminal domain 
ChIP     Chromatin Immunoprecipitation 
DEPC     Diethylpyrocarbonate 
DSE     Downstream sequence element 
DSR     Determinant of selective removal 
EDTA     Ethylenediaminetetraacetic acid 
eIF     Eukaryotic translation initiation factor 
EJC     Exon Junction Complex 
GFP     Green Fluorescent Protein 
KO     Knock-Out 
mRNP     Messenger ribonucleoprotein particle 
NMD     Nonsense-mediated mRNA decay 
NPC     Nuclear pore complex 
ORF     Open reading frame 
PABP     Poly(A) binding protein  
 IV 
PBS     Phosphate buffered saline 
PEG     Polyethylene glycol 
PTC     Premature termination codon 
PMSF     Phenylmethaneshulfonyl fluoride 
RNA Pol (I, II, III)   RNA polymerases (I, II, III) 
Rpb     DNA-directed RNA polymerase II subunit 
SDS     Sodium dodecyl sulphate 
SS     Splice site 
Tris     Tris (hydroxymethyl) aminomethane 
TSS     Transcription start site 
UPF     Up-frameshift 
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Chapter 1: Introduction 
1.1 - The process of gene expression in eukaryotes 
Gene expression is a fundamental biological mechanism that converts the genetic information 
deposited in the DNA sequence of protein-coding genes into messenger RNAs (mRNAs), 
which are then translated into the several thousands of proteins that make and operate a living 
organism. In eukaryotes, protein-coding genes are transcribed by RNA Polymerase II (RNA 
Pol II) into transcripts that are extensively modified, mostly co-transcriptionally, by capping, 
splicing and polyadenylation (Bentley, 2014, Moore and Proudfoot, 2009). Contrary to 
prokaryotes, where the mRNA is immediately available to the ribosome for its translation, in 
eukaryotic cells the mRNA has to be transported from the nucleus to the cytoplasm, passing 
through nuclear pore complexes (NPCs), where it will be translated by the ribosome, into a 
protein (Figure 1.0). Due to its complexity, regulation of gene expression can occur at 
different stages, such as chromatin remodeling, transcription, mRNA processing, nuclear 






Figure 1.0 - The process of gene expression in eukaryotes. Protein-coding genes are 
transcribed by RNA Polymerase II (RNA Pol II) in the nucleus where the pre-mRNA is co-
transcriptionally processed via capping, splicing and polyadenylation. RNA Polymerase I 
(RNA Pol I) transcribes the ribosomal DNA (rDNA) in the nucleolus, producing the rRNAs, 
which together with ribosomal proteins form the ribosome. The mRNA, exported to 






1.2 - Transcription 
Transcription is the first step of gene expression, through which the information stored in the 
DNA is copied into RNA by RNA polymerases. Protein-coding genes are transcribed by RNA 
Pol II, which is a multiprotein complex, composed of several subunits varying from 8 to 12 
according to the organism. RNA Pol II from Saccharomyces cerevisiae is formed by 12 
subunits, denoted from Rpb1 to Rpb12, in order of decreasing molecular weight. The subunits 
Rpb1, -2, -3, -6 and 11 are the counterpart of the bacterial subunits β’, β, αI, αII, ω, 
respectively (Ebright, 2000). Additionally, the subunits Rpb5, -6, -8, -10 and 12 are also 
present in RNA Pol I and III, confirming the high level of homology between the three 
enzymes. The subunits Rpb4 and Rpb7 form instead a heterodimer, which associates 
reversibly with RNA Pol II; in S. cerevisiae, these two subunits are present in the complex 
during the early stationary phase, while in exponential growth, they are present in 
substoichiometric quantity, suggesting that their recruitment occurs under poor growth 
conditions  (Choder, 2004, Craighead et al., 2002).  
The largest subunit of RNA Pol II, Rbp1, is characterized by a unique C-terminal domain 
(CTD), formed by repeats of the heptad Y1S2P3T4S5P6S7; the number of these repeats can vary 
in different organisms, according to their complexity; for example, the CTD in human 
consists of 52 repeats, in D. melanogaster of 45, in S. pombe of 29 and in S. cerevisiae of 27. 
The CTD can be phosphorylated on the heptad residues during different stages of 
transcription and, as I will explain in the next paragraphs, its phosphorylation changes 





1.3 - Pre-mRNA processing is coupled to transcription 
The maturation of the pre-mRNA typically involves three major covalent modifications: 5’-
end capping, splicing and 3’-end cleavage and polyadenylation (Bentley, 2014, Proudfoot, 
2000). Intriguingly each of these modifications is followed by the deposition of specific 
factors on the transcript, which determine downstream later processes of gene expression. As 
a consequence, transcripts are never in the form of naked RNA and are always associated with 
several proteins, forming messenger ribonucleoprotein complexes (mRNP) (Singh et al., 
2015).  
The CTD of the Rpb1 subunit plays a pivotal role in the transition through different stages of 
transcription and pre-mRNA processing. In vivo, RNA Pol II is present in two different 
forms: RNAPIIA, with a non-phosphorylated CTD, and RNAPII0, which is highly 
phosphorylated (Weeks et al., 1993). Using polytene chromosome of D. melanogaster, it was 
initially observed that RNAPIIA associated with inactive genes and promoters, whereas, the 
RNAPII0 was found at the sites of active transcription (O'Brien et al., 1994, Weeks et al., 
1993). The phosphorylation status of RNA Pol II and its biological meaning have become 
clear thanks to Chromatin Immunoprecipitation (ChIP) technique which allows identifying 
protein-DNA interactions in vivo (Collas, 2010, Gilmour and Lis, 1984, Gilmour and Lis, 
1985) 
At different stages of transcription, RNA Pol II shows a distinctive pattern of 
phosphorylation, which permits recruiting factors involved in the histone modifications, in the 
transition from initiation to terminations and pre-mRNA processing (Buratowski, 2009). 
Phosphorylation occurs on the heptad repeats of the CTD of Rpb1. Ser5 and Ser2 represent 
the most studied phosphorylation sites. In mammals Ser5 is phosphorylated by the cyclin-
dependent kinase 7, CDK7, a subunit of the transcription factor IIH (TF2H); this residue is 
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highly phosphorylated in RNA Pol II loaded within the first few hundred nucleotides of the 
gene (Komarnitsky et al., 2000). This phosphorylation appears to play a critical role  in 
transcription initiation and the recruitment of enzymes needed for the pre-mRNA capping 
(Hsin and Manley, 2012). Conversely, Ser5 is dephosphorylated in downstream regions 
(Phatnani and Greenleaf, 2006). Instead, the phosphorylation on Ser2 by p-TEFb (which is 
composed by CDK9 and cyclin T) in mammals, is fundamental to stimulate the transcription 
elongation and for the recruitment of the splicing and poly(A) machinery (Ahn et al., 2004). 
As a consequence, the phosphorylation levels of Ser2 increases progressively as RNA Pol II 
moves along the coding sequence of the gene (Buratowski, 2009).  
In the next paragraphs of this section, I will explain more in detail the mechanism of pre-
mRNA processing and how this is connected with transcription. 
 
1.3.1 - 5’ pre-mRNA capping 
When the 5’-end of the transcript emerges through the RNA Pol II exit channel, typically as 
its length reaches 20-30 nucleotides, it is promptly modified by the addition of a 7-
methylguanosine (m7G), a guanine nucleotide attached to the 5’-end of the nascent transcript 
by an unconventional 5’ to 5’ triphosphate bridge, which is also modified by methylation of 
the base at position-7 (Moore, 2005, Noe Gonzalez et al., 2018). These chemical 
modifications require three enzymatic activities: an RNA triphosphatase, which cleaves the 5’ 
triphosphate of the pre-mRNA to a diphosphate, a guanylyl-transferase which adds the 
guanosine monophosphate (GMP) to the 5’, and the methyltransferase which methylates the 
guanine (Furuichi et al., 1976, Shatkin, 1976). The capping enzymes are recruited to the 5’ 
end of the nascent mRNAs through interactions with the CTD of the Rbp1 subunit 
(Buratowski, 2003). The association of the capping enzymes to the CTD is stimulated by the 
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phosphorylation of Ser5 (Martinez-Rucobo et al., 2015). The CTD appears essential for the 
mechanism of capping; for the mRNAs derived by chimeric gene constructs in which a gene 
normally transcribed by RNA Pol II is under the control of an RNA Pol I or Pol III promoter, 
capping is prevented or partially repressed (Smale and Tjian, 1985). The enzymatic activities 
required for the capping are evolutionarily conserved (Yue et al., 1997). However, the 
organization of the different subunits and the modalities by which they bind the 
phosphorylated CTD can vary according to the species (Pei and Shuman, 2002). For example, 
in S. cerevisiae, the three enzymatic activities are on different polypeptides; the 
methyltransferase and the guanylyl-transferase components bind the CTD of RNA Pol II 
independently of each other, while the RNA triphosphatase does not bind the CTD directly 
but is associated to the guanylyl-transferase. In metazoans, the capping enzymes are formed 
by a bifunctional RNA triphosphatase/guanylyl-transferase and a methyltransferase. The 
guanylyl-transferase domain, located at the C-terminal, binds the CTD of RNA Pol II, but the 
triphosphatase does not (Pei and Shuman, 2002). The cap is then recognized by a nuclear cap-
binding complex (nCBC), consisting of a cap-binding subunit 20 (CBP20), which exploits its 
ribonucleoprotein (RNP) domain to bind the cap, and an auxiliary cap-binding protein 80 
(CBP80), whose function is to stabilize the interaction between CBP20 on the cap 
(Topisirovic et al., 2011). Besides, CBP80 appears to interacts with REF (RNA and export 
factor binding protein), and with the CTD of RNA Pol II (Topisirovic et al., 2011) 
The nCBC not only stabilizes the transcript, but it appears to play a pivotal role in numerous 
aspects of gene expression, stimulating pre-mRNA splicing and nuclear export (Topisirovic et 
al., 2011). In the cytoplasm the heterodimer CBP80 and CBP20 is believed to persist on the 
mRNA until the first round of translation; then it is replaced by the eukaryotic Translation 
 7 
Initiation Factor 4E (eIF4E), which remains associated to the transcript for the remaining 
rounds of translation (Maquat et al., 2010). 
 
1.3.2 - pre-mRNA splicing 
 
Before being exported to the cytosol, introns are removed from the mRNA via splicing. In S. 
cerevisiae splicing appears to occur on the nascent-mRNAs, before RNA Pol II has completed 
the transcription of the gene. This notion derives from single-molecule RNA-sequencing 
(SMIT) experiments, which indicate that splicing happens when Pol II is only a few hundred 
nucleotides downstream the intron, indicating that as soon introns emerge from RNA Pol II 
they are rapidly excised (Oesterreich et al., 2016). However, this conclusion contrasts with 
previous observations that reported that splicing can happen co-transcriptionally in yeast only 
for those genes which have a long second exon, while for the majority of the genes introns are 
removed predominantly post-transcriptionally (Tardiff et al., 2006). The SMIT experiments in 
S. pombe confirm that also in fission yeast, splicing might occur early in transcription when 
RNA Pol II is just downstream of the 3’ splice site (Oesterreich et al., 2016). 
In mammalian cells, the sequencing of the newly synthesized transcripts from human B-cells, 
via 4-thio-uridine (4sU) labeling, has shown that the frequency of co-transcriptional splicing 
events is approximately 75% (Windhager et al., 2012). A similar result was obtained through 
sequencing of total RNA from human brain (Ameur et al., 2011). That said, some human 
long-non coding RNAs (lncRNAs) or alternative exons, are spliced post-transcriptionally or 
not spliced at all (Tilgner et al., 2012).  
The CTD of the Rpb1 subunit also plays a crucial role in splicing; during transcription, the 
phosphorylated form of Ser2 allows the recruitment of splicing factors involved in the 
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definition of the splice sites and in the assembly of the spliceosomal machinery (Corden and 
Patturajan, 1997, Hsin and Manley, 2012). 
Splicing requires regulatory cis-acting RNA elements for its functioning (Xiao et al., 2007). 
Each intron is characterized by a set of distinctive sequences which are: the 5’ splice site also 
known as donor site, generally defined by a dinucleotide GU, the 3’ splice site, characterized 
by a dinucleotide AG, and a branch point adenosine, typically found 20-25 bases upstream of 
the 3’ splice site (Wahl et al., 2009)   
Exploiting these consensus motifs, splicing proceeds through two consecutive reactions of 
transesterification: in the first, the ribose 2’OH group of an adenosine located at the branch 
point, attacks the 5’phosphate of the G located in the 5’splice site, causing the formation of a 
lariat intermediate and a free 5’ exon. In the second reaction of transesterification, the 3’-OH 
of the last residue of the free exon attacks with the 5’ phosphate of the first residue of the 











            
 
     Figure 1.1 - Splicing occurs through two transesterification reactions. In the first 
reaction of transesterification, the 2’OH group of an adenosine’s ribose located at the 
branch point attacks the 5’phosphate of the G located in the 5’SS causing the formation of 
a lariat intermediate and a free 5’ exon. In the second reaction of transesterification, the 3’ 
OH of the last residue of the free exon attacks the 5’ phosphate of the first residue of the 







To allow intron removal and ligation of the two flanking exons, splicing requires five small 
nuclear uridine-rich RNAs (U1, U2, U4, U5, U6 snRNAs), which are associated with a 
number of additional proteins, varying from 6 to 10 for each snRNA, forming the small 
nuclear ribonucleoprotein particles (snRNP). The snRNPs together with additional non-
snRNPs factors, which assist in the splicing reactions, form the spliceosome machinery 
(Kramer, 1996). The two reactions of transesterification require the formation of several 
splicing complexes, formed through the association and dissociation of the snRNPs during the 
different stages of splicing (Figure 1.2). The first spliceosome component to bind the 
transcript is the U1 snRNP; U1 associates at the 5’splice site of the intron, via base pairing, 
and at the same time some auxiliary factors, mark the BPS and the 3’ splice site, to form the 
inactive E complex. The recruitment of the U2 snRNP, at the BPS through base pairing, 
marks the transition from the E complex to the A-complex, or pre-spliceosome. With the 
recruitment of a pre-assembled trimeric complex formed by U4/U6 and U5 snRNPs, the pre-
spliceosomal complex, is converted in the pre-catalytical spliceosome, or complex B. The 
further dissociation of U1 and U4 is required to form an active splicesome or complex B*; 
during the first reaction of transesterification, the complex B* is converted in complex C, 




            
     Figure 1.2 - Assembly of spliceosome complexes. snRNA U1 and U2 are recruited on the 
5’ splice site and BPS respectively, where they form a stable bond via base pairing (A 
Complex). A trimeric complex, formed by U4/U6 and U5, is then recruited on the Complex 
A, to generate the B Complex, which is still in an inactive form until the release of U1 and 
U4 (active spliceosome or B* Complex). With the formation of an active spliceosome, the 
first transesterification is performed, followed by a second reaction driven by the assembly 
of a C complex.  
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1.3.3 - 3’ end processing 
Cleavage and polyadenylation of the 3’-end of the nascent transcript is an essential step in the 
maturation of the pre-mRNA.  Specific sequences on the transcript dictate the site of cleavage 
and polyadenylation. In humans, the core upstream element, also known as poly(A) signal, is 
characterized by an AAUAAA or AUUAAA sequence, and it is found in almost 80% of the 
polyadenylated transcripts (Proudfoot, 1991). The remaining 20% are characterized by a non-
canonical hexamer sequence, occurring mainly in those transcripts modified by alternative 
cleavage and polyadenylation (Nunes et al., 2010, Tian et al., 2005). 
Downstream of the poly(A) signal, two other sequences can be detected; a cleavage site, 
consisting of a CA dinucleotide, where the endonucleolytic cleavage occurs, and a U-rich or 
GU-rich motif, also known as downstream sequence element (DSE). These cis-elements are 
recognized by trans-acting factors; the cleavage and polyadenylation specificity factor 
(CPSF), contacts the poly(A) signal through its 160 kDa subunit (CPSF-160), whose binding 
specificity seems to be guaranteed also by CPSF-100, CPSF-73 and CPSF-30 (Proudfoot et 
al., 2002). The binding of CPSF to the poly(A) signal is strengthened by the Cleavage 
Stimulation Factor (CstF), which consists of CstF-77, CstF-64 and CstF-50. While CstF-64 
contacts the DSE, CstF-77 makes a bridge between CPSF-160 and Cstf-64 and Cstf-50 (Fong 
and Bentley, 2001). The binding of the two complexes on their respective elements is 
cooperative since when CstF is bound to the DSE, it enhances the affinity of CPSF for the 
poly(A) signal and vice-versa (Proudfoot et al., 2002). 
The 3’-end of the transcript is defined by the cleavage reaction, which is perfomed by the 
CPSF-73 endonuclease (Hill et al., 2019, Mandel et al., 2006). In vitro experiments 
demonstrated that Ysh1, the yeast homolog of CPSF-73, is incorporated into an CPF core 
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complex of eight subunits, which increases the formation of an active catalytic complex, 
required for the cleavage reaction (Hill et al., 2019). 
After the cleavage, the Poly(A)-polymerase (PAP) catalyses the polyadenylation of the 
transcript (Bienroth et al., 1993, Wahle, 1995, Wahle et al., 1991). 
Following cleavage, polyadenylation and release of the mature mRNA from the transcription 
site, RNA Pol II remains engaged to the DNA and continues transcribing the downstream 
region for up to several kb before it is released. How RNA Pol II is removed from the DNA 
template after cleavage and polyadenylation, is still not completely understood. One 
possibility represented by the “allosteric model”, is that RNA Pol II dissociates as a result of a 
conformational change when it reaches the poly(A) signal, or by loss of elongation factors 
and subsequent decrease in the processivity (Loya and Reines, 2016). Another model, known 
as “torpedo” proposes instead that the endonucleolytic cleavage at the poly-(A) site generates 
an entry site for a 5’-3’ exonuclease, XRN2 in Human or Rat1 in S. cerevisiae, which reaches 
the uncapped transcript behind RNA Pol II, degrading the RNA and dislodging the 
polymerase (Eaton and West, 2018, West et al., 2004). However, new recent observations 
suggest that the two models could be not mutually exclusive. Cortazar and colleagues 
reported that downstream the poly-(A) site, RNA Pol II decelerates because of  
dephosphorylation of the Transcription Elongation Factor 5 (Spt5), which is promoted by a 
protein phosphatase (PNUTS-PP1) (Cortazar et al., 2019). Through this change in speed, 
XRN2 can reach RNA Pol II and terminate the process. The model has been defined as 
“sitting duck torpedo” (Cortazar et al., 2019). Similarly, Eaton and colleagues proposed that 
allosteric changes,  occurring beyond the poly-(A) site and responsible for an RNA Pol II 
slowing down, allow XRN2 to reach the uncapped transcript to promote termination (Eaton et 
al., 2020). 
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1.4 - The Exon Junction Complex (EJC) 
1.4.1 - Splicing alters the composition of the mRNPs by deposition of the 
Exon Junction Complex 
 
Pre-mRNA splicing is thought to alter the composition of the newly synthesized mRNP, by 
the deposition of a specific set of proteins which form the Exon Junction Complex (EJC) 
(Le Hir et al., 2001b, Le Hir et al., 2000). This deposition is thought to act as a signature for 
those transcripts that have been processed by the splicing machinery and it is believed to 
regulate several downstream biological mechanisms such as nuclear export, mRNA 
localisation and mRNA decay (Le Hir et al., 2016). In light of this, the EJC seems to explain 
how an intron, which is removed upon splicing, can still affect translation and  nonsense- 
mediated RNA decay (NMD) in the cytoplasm (Brogna et al., 2016, Le Hir et al., 2003, 
Shaul, 2017). 
The EJC was discovered in 2000 by Le Hir and colleagues who reported that following in 
vitro splicing in HeLa nuclear extracts, the spliced mRNAs were resistant to RNase H 
digestion at a specific position, typically 20-24 nucleotides upstream of the exon-exon 
junction. The same observation was also confirmed in vivo, by injecting intron-containing 
gene reporters into the oocyte nuclei of Xenopus: following dissection, isolation and RNase H 
treatment of the nuclei, the same pattern of protection was observed, suggesting that the 
phenomenon was evolutionarily conserved (Le Hir et al., 2000). The authors concluded that 
the protection was caused by the presence of a specific set of proteins bound to the transcripts 
at this position. 
This initial observation led to further understanding of the factors associated in this particular 
position. Since the binding was in close vicinity of the exon-exon junctions, the complex 
which they were forming was named EJC.  
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Subsequent studies revealed that the EJC is a highly stable hetero-tetramer composed of four 
pivotal factors, eIF4AIII (DDX48), Y14 (RRM8A), MAGO and Barentz (BTZ or MNL51, or 
CASC3), and it is surrounded by numerous peripheral components, which affect the destiny 
of the mRNA during the different stages of gene expression (Bono et al., 2004, Chan et al., 
2004, Le Hir et al., 2001b). MAGO and its partner Y14, were initially shown to be crucial 
factors for the localisation of the oskar mRNA to the posterior pole of D. melanogaster during 
oogenesis, thus providing a link between splicing and mRNA localisation (Hachet and 
Ephrussi, 2001, Hachet and Ephrussi, 2004, Le Hir et al., 2001a). Further discoveries 
demonstrated that EJC factors were involved in nonsense-mediated mRNA decay (NMD) a 
surveillance pathway which degrades defective mRNAs harboring premature termination 
codons (PTC) (Conti and Izaurralde, 2005, Lejeune and Maquat, 2005, Maquat, 2005, 
Palacios et al., 2004). Two other peripheral factors, Aly/REF and UAP56, enhanced the 
export of the spliced mRNAs from the nucleus to the cytoplasm (Le Hir et al., 2016).  
 
1.4.2 - eIF4AIII is the core component of the EJC 
The anchor point of all the EJC factors is represented by eIF4AIII, which directly contacts the 
spliced mRNAs, 24 nucleotides before each exon-exon junction in a sequence-independent 
fashion,  and associates with MAGO, Y14, and BTZ (Chan et al., 2004, Zhang and Krainer, 
2007). eIF4AIII belongs to the Eukaryotic Translation Initiation Factor family 4A, a group of 
ATP dependent RNA helicases comprising also eIF4AI and eIF4AII (Cordin et al., 2006). 
Structurally, eIF4AIII is an Asp-Glu-Ala-Asp DEAD-box helicase: members of this family 
use ATP hydrolysis to rearrange secondary structures of RNA, in order to facilitate translation 
initiation, pre-rRNA processing, or to clear away factors bound to nucleic acids (Bono et al., 
2006, Le Hir and Andersen, 2008). Like other members of the DEAD-box family, eIF4AIII 
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has a standard modular structure, characterized by two domains, RecA1 (located at N-
terminal) and RecA2 (located at C-terminal), separated by a short linker of 11 amino acids 
(Figure 1.3A). Biochemically, each RecA contains a parallel β sheet formed by a variable 
number of β strands, with loops on both the amino and carboxyl-terminal (Caruthers et al., 
2000, Cordin et al., 2006). Within the two RecA domains, numerous short and highly 
conserved motifs, involved in RNA and ATP binding, can be identified (Figure 1.3B). Motif 
I, also known as Walker A, is characterized by a typical GKT (glycine-lysine-threonine) 
sequence, and it is involved in ATP binding and hydrolysis. The presence of the lysine allows 
it to establish interactions with the γ-phosphate of the ATP; if it is substituted with an 
Arginine the ATP binding, but not its hydrolysis, can occur, while when substituted with an 
Alanine the ATP binding is compromised (Sharma et al., 2013). The threonine instead 
coordinates the interaction with Mg2+ ions. Motif II, also known as Walker B, contains the 
DEAD-box sequence and it is involved in the ATP binding and hydrolysis (Walker et al., 
1982). In this domain, the glutamate regulates the catalytic activity and the aspartate binds the 
Mg2+ ions. Motif III or serine acetyltransferase (SAT) domain, coordinates with Motif V the 
interactions between the ATP and the RNA binding motifs. Motif IV contains a conserved 
residue of phenylalanine, followed by a cysteine, and it is involved in the interaction with 
RNA.  Motif VI is involved in ATP binding and hydrolysis, whose function is explicated by 
two evolutionary conserved residues of arginine. The Motif QxxR, where glutamine is 
separated by non-conserved amino acids from an arginine, is a typical signature of DEAD-
box helicases and plays a crucial role in RNA binding; the conserved Q and R residues help to 
orientate the helicase to the RNA surface. Motif Ia and Ib, contribute to RNA binding, 
interacting with the sugar-phosphate backbone of the RNA (Linder and Jankowsky, 2011, 
Rocak and Linder, 2004).  
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The binding of the ATP and RNA to eIF4AIII causes a conformational change of the protein; 
whereas in absence of ATP, the RecA1 and RecA2 domains do not show a clear orientation 
and the structure is characterized by an “open” conformation, when ATP and RNA are bound, 
the two ReC domains move in close vicinity (closed conformation), thus forming a stable 
anchor point on the mRNA (Bono et al., 2006).  Despite eIF4AIII contains all the domains of 
a typical DEAD box-RNA helicase, it does not function as a canonical translocating helicase, 
but it is generally recognized as a clamp or a “place holder” for the recruitment of other RNA 
binding proteins (Bono et al., 2006, Le Hir et al., 2016). Supporting this view, eIF4AIII 
appears to be functionally distinct from the other two members of the same family, eIF4AI 
and eIF4AII, both of which are required to melt secondary structures in the 5’-UTRs, 
facilitating the correct attachment and positioning of the 40S ribosomal subunit. Moreover, in 
light of the functional difference with eIF4AI and eIF4AII, eIF4AIII primarily localises in the 
nucleus differently to the others two isoforms of the same family, which accumulate in the 













     Figure 1.3 - Crystal structure of the human eIF4AIII associated with CWC22.  (A) 
The amino-terminal of eIF4AIII corresponds to the RecA1 domain and the carboxyl-
terminal to the RecA2 domain (both are represented in cyan); CWC22, a partner of 
eIF4AIII in mammalian cells, establishing contacts with RecA2 is in green (Images 
elaborated using Chimera, PDB: 4C9B ((Buchwald et al., 2013)). (B) Conserved sequence 




1.4.3 - MAGO and Y14 form a stable heterodimer 
MAGO and Y14, which are also known as MAGO NASHI and Tsunagi/RBM8 respectively, 
are evolutionarily conserved proteins across eukaryotes and they form an obligatory 
heterodimer in all the organisms in which their association has been biochemically 
investigated (Gong et al., 2014). Heterodimerisation is required for their biological function 
(Fribourg et al., 2003, Lau et al., 2003). To keep the structural interactions throughout 
evolution, two kinds of strategies were evolved: conservation of the same amino-acid residues 
involved in the heterodimerisation, or coordinated sequence variations in both the proteins 
(Gong et al., 2014). Supporting this idea, a stable heterodimer of MAGO and Y14 has been 
confirmed in at least 11 different species, from Human to the plant Physalis floridiana (Gong 
et al., 2014). Y14 does not contact directly the RNA; using an electrophoretic mobility shift 
assay, neither MAGO or Y14 bind the RNA (Shi and Xu, 2003). This observation is 
consistent with the crystal structure of the EJC, where eIF4AIII is anchored on the mRNA, 
and MAGO and Y14 are perpendicular to eIF4A3 (Bono et al., 2006) (Figure 1.4). Whilst 
eIF4AIII has been identified in all the eukaryotic groups, MAGO and Y14 are absent in 
organisms with low intron-density such as S. cerevisiae or the alga Cyanidioschyzon merolae 
(Bannerman et al., 2018). However, both proteins are present in the fission yeast S. pombe, 
and in the budding yeast Y. lipolytica, where the percentage of genes containing introns is 
approximately 45% and 37% respectively (Boisramé et al., 2019, Kuhn and Käufer, 2003). 
Y14 and MAGO are involved in NMD in mammalian cells (Gehring et al., 2003). However, 
in D. melanoagaster, where the heterodimer is essential for cell viability, MAGO and Y14 are 
required for mRNA localisation, but not for NMD  (Gatfield et al., 2003, Hachet and 
Ephrussi, 2001, Hachet and Ephrussi, 2004). MAGO and Y14 are also not required for NMD 
in S. pombe (Wen and Brogna, 2010). 
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 Figure 1.4 - Crystal structure of the EJC at 2.2 Å resolution. The EJC forms an L-shaped 
structure with MAGO (green) and Y14 (orange) almost perpendicular to eIF4AIII (cyan) and 
BTZ (magenta), located instead at the base of the structure. In the presence of ATP, eIF4AIII 
binds the RNA by using both the RecA1 and RecA2 domains. BTZ does not assume a 
globular conformation, but it is extended along with the two RecA domains of eIF4AIII and 
also contacts MAGO. The MAGO and Y14 heterodimer interact mainly with the RecA2 




1.4.4 - Mechanisms of the EJC deposition and assembly 
EJC deposition depends on splicing in vivo, and the complex can be assembled in vitro in the 
presence of RNA and the other core EJC components (Ballut et al., 2005). In mammalian 
cells, the assembly and positioning of the EJC require an eIF4G-like protein known as 
CWC22. CWC22 is a spliceosome associated protein, which associates in vivo with eIF4AIII, 
but not with MAGO and Y14 (Steckelberg et al., 2012). The association between eIF4AIII 
and CWC22 is mediated by its MIF4G domain (Middle domain of Eukaryotic Initiation 
Factor 4G) (Steckelberg et al., 2012). 
The biological function of CWC22 in the deposition of the EJC is to escort eIF4AIII to the 
proximity of the splicing machinery and to prevent premature binding with the pre-mRNA; 
this model derives from an in vitro experiment by Barbosa and colleagues, which showed that 
in absence of CWC22, eIF4AIII does not immunoprecipitate with spliced mRNA (Barbosa et 
al., 2012). However, contrary to mammalian cells, in D. melanogaster, CWC22 is not 
required for association of eIF4AIII on the nascent mRNA; in fact, the conditional depletion 
of CWC22 does not interfere with the association of eIF4AIII and Y14 on the nascent 
transcripts (Choudhury et al., 2016).  
EJC assembly and deposition on the spliced mRNAs follows a precise hierarchical pathway in 
mammalian cells; when an intron-containing transcript is incubated in a splicing nuclear 
extract, the EJC components precipitate with fully spliced mRNAs, but a portion of eIF4AIII, 
MAGO and Y14 associates with pre-mRNA, thus suggesting that the deposition occurs in the 
early stage of the splicing reaction (Gehring et al., 2009a). This observation seems to be 
supported by the fact that the EJC components have been purified within an active 
spliceosomal C-complex (Bessonov et al., 2008). Additionally, when the 3’-splice site is 
mutated, thus preventing the exon-exon ligation, eIF4AIII, MAGO and Y14, but not BTZ, can 
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still precipitate on splicing intermediates, suggesting not only that three major components of 
the EJC are recruited before the exon ligation, but also that BTZ associates with the EJC after 
dissociation of the spliceosome (Gehring et al., 2009a).  
The binding of the EJC to exon-exon junctions also requires a “closed” conformation of 
eIF4AIII; the factor can oscillate from an open to a closed conformation, according to 
whether the helicase is bound with ATP (closed) or not bound (open). Introducing point 
mutations in the pocket of eIF4AIII required for ATP binding, MAGO and Y14, but not BTZ, 
do not  precipitate with eIF4AIII, suggesting that the recruitment of the heterodimer can occur 
only when eIF4AIII is stably associated with the RNA; conversely, BTZ can be loaded on the 
EJC regardless of the conformation state of eIF4AIII (Bono et al., 2006, Gehring et al., 
2009a). Additionally, the closed conformation of eIF4AIII on the mRNA is kept by the 
interaction with MAGO and Y14, which are believed to inhibit the hydrolysis of the ATP, 
thus permitting the formation of a stable grip on the transcript, with the remarkable ability to 
translocate from the nucleus to the cytoplasm, clamping on the same position (Ballut et al., 
2005). 
 
1.4.5 - Mechanism of EJC disassembly  
EJC disassembly occurs during translation of the mRNA in the cytoplasm (Gehring et al., 
2009b). Despite it being initially hypothesized that the helicase activity of the ribosome was 
sufficient to displace the EJC from the transcript, later studies identified Partner of Y14 and 
MAGO (PYM), as a pivotal protein for EJC disassembly (Gehring et al., 2009b, Park and 
Muench, 2007). The interaction of PYM with the 40S ribosomal subunit and the heterodimer 
MAGO-Y14, via its N-terminal and C-terminal domains respectively, is believed to trigger 
the disassembly of the EJC and the recycling of the factors from the cytoplasm to the nucleus 
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(Bono et al., 2004, Bono and Gehring, 2011).  Moreover, the interaction between PYM and 
the EJC factors, is probably restricted to the first round of translation, when the first ribosome 
scans the mRNA; a crucial observation supporting this hypothesis is that on sucrose gradient 
fractionation, Y14 sediments in monosomal but not polysomal fractions (Dostie and Dreyfuss, 
2002, Gehring et al., 2009b). 
1.4.6 - Canonical and non-canonical deposition of the EJC  
As previously stated, the EJCs are deposited 20-24 nucleotides upstream of each exon-exon 
junction (Le Hir et al., 2000). Initial studies about the function, the assembly and the 
deposition of the EJCs were performed in vitro, using protein expressed exogenously or gene 
reporters transfected into the cells. However, in vivo approaches have revealed a greater level 
of complexity in the EJC deposition. 
Using the RNA:protein immunoprecipitation in tandem sequencing (RIPiT-seq), a high-
throughput approach to map the sites of interaction of a specific protein on the mRNP, Singh 
and colleagues confirmed that in mammalian cells the majority of the EJC factors were 
positioned at the canonical positions (cEJC), 24 nucleotides before each exon-exon junction 
(Singh et al., 2012). However, it was also observed that almost 20% of spliced mRNAs were 
not associated with any EJCs, and more interestingly that EJCs were also positioned in non-
canonical positions (nEJC), typically localised in the exon regions of spliced mRNAs (Singh 
et al., 2012, Singh et al., 2014). Another study based on the use of the ultraviolet Cross-
linking and Immunoprecipitation sequencing (CLIP-seq), has shown that eIF4AIII is 
associated both at canonical and not canonical positions, in variable quantities and at purine-
rich motifs: however, eIF4III is not detected on mRNAs derived from intron-less genes 
 24 
(Saulière et al., 2012). Interestingly in the CLIP-seq analysis from Sauliere and colleagues, 
not all the exon-exon junctions contained an EJC. 
Contrary to the general notion that the EJC is recruited only on spliced mRNAs, in D. 
melanogaster, the recruitment of EJC components can occur on the nascent transcripts 
independently of splicing (Choudhury et al., 2016). Moreover, it was also reported that the 
association of MAGO and Y14 on the nascent-RNA occurred independently of eIF4AIII, and 
the depletion of neither MAGO or Y14 altered the loading of eIF4AIII, suggesting that in D. 
melanogaster it is not likely that the three components form a stable complex (Choudhury et 
al., 2016). 
Another observation arguing against the loading of the EJC occurring only on spliced mRNAs 
comes from a recent study from Akhtar and colleagues; using ChIP-seq analysis they reported 
that the EJC factors accumulated at the transcription start site (TSS) of any gene, regardless 
the presence of an intron, both in mammalian cells and in S2 cells of D. melanogaster (Akhtar 
et al., 2019). The ChIP signal of the three components was sensitive to an RNase treatment, 
suggesting that their recruitment was occurring on the RNA co-transcriptionally (Akhtar et 
al., 2019).  
Consistent with these studies, Viphakone and colleagues, have recently shown in their CLIP-
seq analysis that, in mammalian cells, eIF4AIII and BTZ, associate also with intronless-
transcripts (Viphakone et al., 2019). 
Additionally, eIF4AIII has been found associated at the 5’-end of CBC-bound mRNAs in 




1.5 - Functions of the EJC  
1.5.1 - Role of the EJC in mRNA surveillance  
Typical error-containing mRNAs are those that harbour Premature Translational Termination 
Codons (PTCs) (Brogna and Wen, 2009, Hentze and Kulozik, 1999, Maquat, 2004). PTCs 
can arise for a variety of reasons; for instance a  single nucleotide substitution can change a 
sense codon into a termination one (TAA, TAG, TGA), or a deletion or insertion can alter the 
original sequence of the CDS, leading to the formation of a termination codon (Chang et al., 
2007). Another source of PTCs derives from chromosomal rearrangements: an example is the 
V(D)J recombination mechanism in mammalian cells, adopted by B and T-cells to increment 
the repertoire of T-cell receptors (TCRs) and immune-globulin (IgG); two times out of three it 
leads to an unfruitful rearrangement, with subsequent generation of transcripts harboring a 
PTC (Chang et al., 2007, Nicholson et al., 2010).  
PTC-containing transcripts are considered the natural target of nonsense-mediated mRNA 
decay (NMD), whose function is to eliminate defective transcripts, preventing their 
translation and the subsequent production of deleterious truncated peptides (Maquat, 1995, 
Zhang and Maquat, 1997). The first evidence of NMD dates back to 1979 when two different 
groups simultaneously observed that genes harboring PTCs, associated with unexpectedly low 
levels of mRNA both in yeast and in human cells (Chang and Kan, 1979, Losson and 
Lacroute, 1979).  
Although NMD is recognized as an evolutionarily conserved surveillance pathway across 
eukaryotes, it remains still nebulous how the cell discriminates between a normal stop codon 
and a PTC (Brogna et al., 2016, Karousis and Mühlemann, 2019).  
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The up-frameshift (UPF) protein UPF1, originally described in S. cerevisiae, is the core 
component of the NMD machinery (Culbertson et al., 1980). UPF1 is an ATP-dependent 
RNA helicase, and in vitro can translocate through single and double-stranded nucleic acids to 
remodel the mRNPs (Fiorini et al., 2015). The protein appears involved in several biological 
mechanisms according to its localization. In the nucleus, there are evidences of its 
involvement in DNA replication and genome stability, release of the nascent RNA from 
chromosomal active sites and viral RNA nuclear export (Ajamian et al., 2015, Azzalin and 
Lingner, 2006, Singh et al., 2019). 
In the cytoplasm, UPF1 plays an active role in the degradation of the PTC-containing 
transcripts via NMD. Depletion of UPF1 via RNA interference in higher eukaryotes, or knock 
out in yeast, rescues aberrant mRNAs from degradation, suggesting that UPF1 is essential for 
NMD (Brogna et al., 2016, Brogna and Wen, 2009, Karousis and Mühlemann, 2019). Two 
up-frameshift proteins, UPF2 and UPF3, also play a role in NMD, and their depletion results 
in the stabilization of the PTC-containing transcripts (Conti and Izaurralde, 2005).  
Despite a huge effort to identify the mechanisms and the factors involved in NMD, a central 
question about this process remains still open: how a PTC is recognized and discriminated 
from a normal stop codon remains unsatisfactorily understood (Brogna et al., 2016)  
A first hypothesis regarding the mechanism of NMD was proposed by Losson and Lacroute, 
who observed that when nonsense mutations were introduced in the URA3 gene of S. 
cerevisiae, the levels of the URA3 mRNA were lower when the PTCs were close to the 5’ end 
of the gene (Losson and Lacroute, 1979). To explain this phenomenon, they conjectured the 
existence of a discriminatory signal, the Downstream Sequence Element (DSE), located 
downstream of the PTC and occurring more likely in the CDS (Brogna et al., 2016, Brogna 
and Wen, 2009) Therefore, if the PTC associated earlier within a transcript, higher was the 
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probability for a DSE to occur downstream. The model was also explored mechanistically: in 
the presence of a PTC-containing transcript, the ribosome stalled on the PTC, allowing the 
recruitment of a surveillance complex, formed by UPF1, UPF2, and UPF3, which scanned the 
transcript looking for the DSE. The interaction between UPF1 and a specific factor located on 
the DSEs, known as HRP1, triggered the mRNA decay (González et al., 2000, Brogna et al., 
2016). Despite these interesting considerations, the DSE model has been largely abandoned 
since the putative DSE is not characterized by a specific consensus sequence (Maquat and Li, 
2001). 
However, the idea that a signal located downstream of the PTC can still influence the 
discrimination from a normal stop codon, is still largely accepted. In particular, in mammalian 
cells, it was observed that a PTC induced NMD only when was located upstream of an intron, 
suggesting that the discrimination of a PTC from a normal stop codon was driven by a splice 
junction or some factors associated in their proximity (Zhang et al., 1998, Carter et al., 1996). 
 Since the splice junctions are highly degenerate sequences, it has been hypothesized that the 
EJC, which are normally deposited 24 nucleotides upstream of the exon-exon boundaries, 
could play a pivotal role in the recognition of a PTC (Le Hir et al., 2001b). 
 According to the model, the ribosome displaces the EJC, during the first round of translation, 
and the encounter with a stop codon, it causes the translation termination. However, in the 
presence of a PTC, the interaction between factors associated on the ribosome, such as UPF1, 
eRF1 and eRF3, and the downstream EJC components, is responsible for the NMD activation. 
More specifically, UPF1 interacts with UPF2, which acts as a bridge, bringing together UPF1 
and UPF3, which was previously loaded into the EJC in the nucleus. The interaction triggers, 
by a still vague and unclear mechanism, the phosphorylation of UPF1 by SMG-1, and the 
 28 
degradation of the transcript by exo-and endonuclease landed on the complex (Figure 1.5) 



















     Figure 1.5 - NMD pathway triggered by EJC.  During translation, the ribosome scans 
the transcript displacing the EJC. However, if the mRNA contains a PTC, the ribosome 
stalls in its proximity and a surveillance complex, known as SURF, formed by UPF1, 
SMG1 and the release factors 1 and 3 (eRF1 and eRF3), is recruited. The SURF complex 
interacts with the downstream EJC via UPF2, which acts as a bridge between UPF1 and 
UPF3. The interaction triggers the activation of the UPF1 helicase activity and the mRNA 
degradation (Figure taken from (Brogna et al., 2016)). 
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However, despite these observations supporting a link between EJC and the NMD, the EJC 
model has been argued by Wen and Brogna, which observed that an intron enhances NMD 
regardless of whether it is positioned downstream or upstream of a PTC (Wen and Brogna, 
2010). In fact, when fission yeast is transformed with an endogenous PTC containing intron-
less gene, the reduction in the mRNA level is less prominent compared to the effect observed 
from the same reporter in which an intron is artificially inserted, suggesting that an intron 
strongly enhances the NMD activity; however, this occurs regardless of whether the intron 
being located before or after the PTC. This finding appears in stark contrast to the EJC model 
since in the case the intron is located upstream of a PTC, the EJC would be removed by the 
translating ribosome before the PTC recognition, and NMD would not be triggered (Wen and 
Brogna, 2010).   
With regard to eIF4AIII, its role in NMD has been investigated in mammalian cells in 
particular, in which its depletion leads to stabilization of PTC containing transcripts (Shibuya 
et al., 2004). A similar effect was also observed when cells are depleted of Y14 (Singh and 
Lykke-Andersen, 2003). 
 In mammalian cells the role of eIF4AIII in NMD has also been recently evaluated by the use 
of specific inhibitors; for example Pateamine A (Pat A), a natural drug derived from the sea 
sponge Mycale, appears to bind specifically members of the eukaryotic translation initiation 
factor 4A, such as eIF4AI, eIF4AII, and eIF4AIII stabilizing their conformation in an “off-
state” and leading to the suppression of their biological function; when Pat A is used on HeLa 
or HEK293T cells,  the PTC-containing mRNAs are stabilized (Dang et al., 2009). The same 
effect was also reported for a new compound, known as 1,4- diacylpiperazine, which is also 
considered a selective inhibitor of eIF4AIII (Ito et al., 2018, Ito et al., 2017, Iwatani-
Yoshihara et al., 2017, Mazloomian et al., 2019, Mizojiri et al., 2018). 
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1.5.2 - Role of EJC in splicing 
Further investigations relative to the function of the EJC factors have demonstrated that the 
EJC is required for the splicing of specific transcripts, both in D. melanogaster and in yeast 
(Ashton-Beaucage et al., 2010, Marayati et al., 2016). For example, in eukaryotes, the 
RAS/MAPK signaling pathway is a fundamental cascade, linked to several biological 
processes, such as cell division, differentiation, and survival;  in flies  the conditional 
depletion of eIF4AIII and MAGO, correlates with a reduction in the MAPK mRNA levels 
and with the formation of new mRNA isoforms derived from the same gene, suggesting that 
the depletion of EJC factors could trigger alternative splicing events (Ashton-Beaucage et al., 
2010).  
In S. pombe, it has been reported that Fal1, the homolog of eIF4AIII, interacts with Red5, a 
key component of the MTREC, a multiprotein complex involved in the targeting and 
degradation of the meiotic transcripts during vegetative growth. Deletion of Fal1 in fission 
yeast, associates with an accumulation of different splicing isoforms of meiotic mRNAs 
(Marayati et al., 2016). 
How splicing itself is affected upon depletion of EJC components remains unclear. Ashton-
Becauge and colleagues have proposed that when splicing occurs, the EJCs are firstly loaded 
on the exon-exon junctions separated by long introns, which are typically spliced more 
efficiently; their presence seems to facilitate the splicing of the small surrounded exons, thus 
permitting that the process occurs in a specific direction and impeding alternative splicing 
events. Instead, when the EJC components are depleted, the hierarchy of the splicing events is 
compromised and the exons are randomly juxtaposed  (Ashton-Beaucage and Therrien, 2011). 
Another possibility is that EJC affects splicing indirectly, primarily as a consequence of 
regulating RNA Pol II elongation rate (Wang et al., 2014). It has been reported that RNA Pol 
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II elongation rate has a strong effect on alternative splicing; for example a faster RNA Pol II 
correlates with an increase in intron-retaining, probably due to less time for the recognition of 
the 5’SS and 3’SS (de la Mata et al., 2003, Wang et al., 2014). Wang and colleagues observed 
that when mammalian cells are depleted of eIF4AIII, the expression of some target genes 
increase faster compared to the WT, upon block and release of transcription with the 
elongation inhibitor 5,6-dichoro-1-β-D-ribofuranosylbenzimidazole (DRB); according to their 
interpretation, the deletion of eIF4AIII correlates with variation in RNA Pol II progression, 
which triggers the inclusion or the skipping of alternative exons (Wang et al., 2014). 
 
1.5.3 - Role of EJC in mRNA export  
After synthesis and processing in the nucleus, the mRNPs are exported to the cytoplasm 
through nuclear pore complexes (NPCs). The most important mRNA export factor is the Tap-
p15 heterodimer, which is conserved from yeast to human (Reed, 2003). The Tap (NXF1) 
protein contains four domains; a non-canonical RNP-type RNA binding domain (RRM) at the 
N-terminus, a domain needed for the heterodimerisation with p15/NXT1, four leucine-rich 
repeats (LRR) and a ubiquitin-associated domain (UBA) that allows interaction with the 
nucleoporins, the constituents of the NPCs which coordinate the flow of macromolecules 
through the NPCs (Erkmann and Kutay, 2004). The Tap-p15 heterodimer interacts with a 
member of the Transcription/Export complex (TREX), such as Aly-REF, which is recruited 
on the nascent mRNA during its synthesis and pre-mRNA processing, and functions as an 
adaptor to facilitate the interaction between the nuclear export receptor Tap-p15 and the 
mRNA. Once the Tap-p15 gains access to the mRNP, it facilitates the translocation through 
the NPCs (Katahira, 2012). 
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Since the EJC dynamically changes its composition as the mRNA move from the nucleus to 
the cytoplasm, it has been reported that the EJC provides a binding platform also for those 
factors involved in mRNA nuclear export (Gatfield and Izaurralde, 2002, Le Hir et al., 2001b, 
Reed, 2003, Viphakone et al., 2019). In particular, several studies report that eIF4AIII 
interacts with Tap and Aly-REF, suggesting a role of the EJC factor in enhancing the export 
efficiency of the spliced-mRNAs. In agreement with this hypothesis, knock-down of eIF4AIII 
leads to moderate retention of poly(A) transcripts in the nucleus, probably due to its function 
in facilitating the deposition of the Aly-REF factors on the spliced mRNAs, and interestingly 
also on intron-less gene transcripts (Viphakone et al., 2019). 
 
1.6 - Functions of eIF4AIII outside the EJC 
Fal1, the ortholog of eIF4AIII in S. cerevisiae, is predominantly localised in the nucleolus and 
its depletion leads to a reduction in 18S rRNA levels (Kressler et al., 1997). Specifically, 
Kressler and colleagues observed that depletion of Fal1 is associated with defects in specific 
endonucleolytic cleavage reactions needed for the biogenesis of 18S rRNA. It has been 
proposed that the RNA helicase activity of eIF4AIII is required to unwind secondary 
structures of the rRNA, thus facilitating its maturation (Kressler et al., 1997). Despite the role 
of eIF4AIII in ribosomal biogenesis being overlooked for several years, recently, the role it 
plays in ribosomal RNA biogenesis has been confirmed in numerous studies also in 
mammalian cells (Alexandrov et al., 2011, Badertscher et al., 2015, Mao, 2016, Mao et al., 
2016, Tafforeau et al., 2013, Wild et al., 2010, Zhang et al., 2011).  Therefore, the function 
appears evolutionarily conserved across eukaryotes, since the D. melanogaster eIF4AIII can 
complement the phenotype of the Fal1 deletion in S. cerevisiae  (Alexandrov et al., 2011).  
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A second function attributed to eIF4AIII, which appears independent of the EJC, is the ability 
to melt secondary structures located at the 5’-UTR of spliced and unspliced transcripts, thus 
providing a role for eIF4AIII in translation initiation (Choe et al., 2014). In fact, Choe and 
colleagues have reported that eIF4AIIII associates at the 5’-UTR of any transcript via a direct 
interaction with CTIF (CBC- dependent translation initiation factor), an MIF4G domain-
containing protein which directly interacts with CBP80, and whose depletion blocks 
translation in vitro (Kim et al., 2009); the presence of eIF4AIII at the 5’-UTR appears crucial 
to remove secondary structures artificially inserted into a reporter plasmid, which might 
prevent the attachment and the movement of the small ribosomal subunit to the translation 
initiation codon (Choe et al., 2014). 
However, this notion seems in contrast to what Li and colleagues reported more than one 
decade ago; they demonstrated that eIF4AIII, as eIF4AI and II, has an ATP-dependent RNA 
helicase activity in vitro, but it fails to substitute eIF4AI in an in vitro ribosome binding 
assay, and differently from the other two members of the same family it does not stimulate 
translation, proposing that eIF4AIII is not involved in translation initiation. (Li et al., 1999). 
Generally, most of the evidence available in the literature, are in agreement with this finding 







1.7 - S. pombe as a model organism 
The fission yeast Schizosaccharomyces pombe is an ascomycete unicellular fungus, used as a 
model organism in molecular and cell biology. Wild type cells have a rod shape, with a 
diameter varying from 3-4 μm and a length of 12-15 μm (Forsburg, 2003). Due to a short 
generation time, ranging from 2 to 5 hours, depending on the strain, the temperature and the 
media, S. pombe is relatively easy to grow and maintain. The small genome size (13.8 Mb), 
which consists of only 3 chromosomes and contains approximately 4950 protein-coding genes 
and 450 non-protein coding RNAs, have made S. pombe a popular model system, to study 
gene expression and cell cycle regulation (Wood et al., 2002, Yanagida, 2002). For example, 
Paul Nurse, who won the Nobel prize in Physiology and Medicine in 2001, has used fission 
yeast to identify genes and mechanisms involved in cell cycle progression (Nurse, 1990). 
Moreover, almost 50 genes involved in human diseases, are highly conserved in S. pombe, 
thus making this organism suitable for the understanding of the molecular basis of human 
pathologies (Wood et al., 2002).  
S. pombe has two forms of propagation, sporulation and binary fission and it can be found 
either in haploid or diploid state (Forsburg, 2003). To evaluate whether the EJC factors have a 
direct role in transcription and pre-mRNA processing, we have decided to use S. pombe as 
model organism, for its ability to preferentially grow in haploid condition (each chromosome 
present in a single copy); therefore any change in the EJC loci or protein levels, will be 
associated with a unique cellular or molecular phenotype and not covered or masked by other 
genetic backups. Because EJCs are highly conserved across eukaryotes, we expect that any 
consideration coming from our study can be reasonably extended to multicellular organisms.  
Another important aspect that makes S. pombe particularly convenient for gene expression 
studies, is the fact 43% of its genes contain introns, while most S. cerevisiae genes have no 
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introns. This wider complexity is therefore particularly important when biological 
mechanisms connected to splicing are investigated. For example, most of the EJC factors are 
retained in fission yeast, but not in S. cerevisiae where only eIF4AIII/Fal1 has been identified 
(Kressler et al., 1997, Wen and Brogna, 2010).  
Lastly, S. pombe is a powerful model organism for studying eukaryotic gene expression, for 
the ability to easily manipulate its genome and generate deletion mutants and tagged proteins: 
due to a powerful homologous recombination machinery, a fragment of exogenous DNA can 
be transformed and integrated into the desired locus. 
Furthermore, the repertoire of genetic tools available in fission yeast is vast and continually 
expanded; for example, CRISPR-Cas9, Auxin-Inducible degron (AID) system and Anchor 
Away (AA)  have been developed and applied for this organism (Ding et al., 2014, Kanke et 
al., 2011, Rodríguez-López et al., 2016).  
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1.8 - Aim of this study  
My work aims to increase our understanding of the function of eIF4AIII in S. pombe, by using 
a new experimental approach to rapidly deplete eIF4AIII and investigate its function. 
The RNA-helicase eIF4AIII is a highly conserved protein across eukaryotes. Previous studies 
reported that eIF4AIII might regulate transcription and pre-mRNA processing (Akhtar et al., 
2019, Ashton-Beaucage and Therrien, 2011, Ashton-Beaucage et al., 2010, Marayati et al., 
2016, Wang et al., 2014). However, a clear limitation coming from these conclusions is that to 
study the function of eIF4AIII, its depletion has been accomplished using siRNA mediated 
knock-down, which normally requires several hours or days; during this time frame cells may 
adapt, thus preventing discrimination between direct and indirect effects. (Akhtar et al., 2019, 
Ashton-Beaucage and Therrien, 2011, Ashton-Beaucage et al., 2010, Wang et al., 2014). 
Furthermore, other studies have based their conclusions from molecular phenotypes deriving 
from the deletion of eIF4AIII, which causes severe growth defects (Marayati et al., 2016). 
In this project three research lines have been explored: 
1) Development and optimisation of a cutting-edge technology known as Auxin-Inducible 
Degron (AID) system, to induce rapid depletion of Fal1/eIF4AIII and then assess the effects 
that this has on transcription and pre-mRNA processing. The results of these experiments are 
discussed in Chapter 3. 
2) Investigating the binding of eIF4AIII and other putative EJC components at specific 
transcription active loci using ChIP. The results are described in Chapter 4.  
3) Investigation whether eIF4AIII might form a stable complex with MAGO and Y14 in S. 
pombe. The results are described in Chapter 5. 
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Chapter 2: Materials and Methods  
2.1 - S. pombe  
2.1.1 - S. pombe strains  
A list of the S. pombe strains used in this study is reported in Appendix II 
 
 
2.1.2 - S. pombe long term storage 
The S. pombe strains were stored at the temperature of -80°C. To prepare the yeast stock, cells 
were plated on YES (Yeast Extract with Supplements) or EMM (Edinburgh Minimal Media), 
(see Appendix I for details), according to the yeast genotype, and incubated overnight at 
30°C. Then, cells were scraped from the plate using a sterile tip, and resuspended in 1mL of 
YES or EMM liquid media, containing 667 μL of 80% glycerol, and stored at the temperature 
of -80°C. 
 
2.1.3 - S. pombe cell culturing 
Two kinds of media were used for cell culturing: YES and EMM, according to the genotype 
of the yeast strain. For most of the experiments, a fresh single colony of S. pombe was 
inoculated in 5 mL of YES or EMM and grown overnight at the temperature of 30°C in a 
shaking incubator; the pre-culture was subsequently scaled up, to achieve the desired final 
volume, according to the experiment. For cell selection, G418 disulfate (Melford), 
hygromycin B (Melford) and Nourseothricin-dihydrogen sulfate (Melford) were added to 
YES or EMM plates at a final concentration of 200 µg/ml, 200 µg/ml and 100 µg/ml 
respectively. For experiments based on the rapid degradation induced by the AID, the plant 
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auxin 1-Naphthaleneacetic acid (NAA) (Sigma) powder was dissolved in 70% ethanol and 
diluted to the required concentration (1 mM). For experiment based on promoter shut-off, 
Thiamine powder (Sigma) was dissolved in sterile distilled water and diluted to the required 
concentration (20 μM). 
 
2.1.4 - Counting S. pombe cells: method 1 
The number of cells was determined using a hemocytometer. In brief, a coverslip was 
positioned over the counting chamber. 10 μL of cell suspension was firstly diluted in 90 μL of 
sterile H2O; then 10 μL of the diluted cell suspension was gently pipetted into the space 
generated between the coverslip and the counting chamber. The chamber was placed under an 
optical microscope and cells in the red squares of the grid were counted (Figure 2.0). In case 
the cells touched the sides of the square, only cells located on two arbitrary borders were 
counted. To determine the total number of cells for mL, the following formula was applied:  
𝒏𝒖𝒎𝒃𝒆𝒓	𝒐𝒇
𝒄𝒆𝒍𝒍𝒔
𝒎𝒍 = 𝒏𝒖𝒎𝒃𝒆𝒓	𝒐𝒇	𝒄𝒆𝒍𝒍𝒔	𝒄𝒐𝒖𝒏𝒕𝒆𝒅	 ×
𝟏
𝟐	× 	𝒅𝒊𝒍𝒖𝒕𝒊𝒐𝒏	𝒇𝒂𝒄𝒕𝒐𝒓 × 	𝟏𝟎𝟎𝟎𝟎 
 
 
Figure 2.0 - Grid of the hemocytometer.  
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2.1.5 - Counting S. pombe cells: method 2 
The cell density was determined using a spectrophotometer (Amersham Pharmacia’s 
GeneQuant pro). 100 μL of cell culture was diluted in 900 μL of sterile H2O in a cuvette 
(Sarstedt), and the absorbance at 600 was measured. The OD600 read by the instrument was 
multiplied by the dilution factor (x10). For all the experiments performed in this study, 
cultures were maintained in mid-exponential growth with an OD600=0.4/05, which 
corresponds to approximately 1x107 cell/mL. 
 
2.1.6 - Spot growth assay 
The functionality and the viability of the S. pombe yeast strains were estimated using the spot 
growth assay. A fresh single colony of S. pombe was inoculated in 5 mL of YES or EMM 
liquid media (according to the yeast genotype) and grown until OD600=0.5. Then, ten-fold 
serial dilutions of the cell culture were prepared in sterile H2O. 10 μL of the diluted samples, 
containing approximately 105, 104, 103, 102 and 10 cells, were spotted on YES and EMM agar 
plates and incubated for 72 hours at 30°C. For some experiments, the EMM plates were 
supplemented with 1-Naphthaleneacetic acid (final concentration of 1mM) and Thiamine 
(final concentration of 20 μM). 
2.1.7 - Growth assay in liquid media 
The growth rate of S. pombe was estimated by growth assay in liquid media. A fresh single 
colony of S. pombe was inoculated in 5 mL of EMM or YES liquid media (according to the 
yeast genotype) and grown overnight until OD600=0.5. The cell culture was diluted in 20 mL 
of liquid media and synchronized at OD600=0.03. Using a hemocytometer, the number of cells 
per mL was determined every two hours. To avoid the saturation of the cell culture, the media 
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was refreshed every 8 hours, removing 10 mL of cell culture and adding 10 mL of fresh 
media.  
2.1.8 - S. pombe microscopy 
Images of S. pombe were acquired using confocal microscopy (Nikon A1R of the 
Birmingham Advanced Light Microscopy (BALM) facility) or a 2D array scanning laser 
confocal miscroscope (Infinity 3, VisiTech) (University of Leicester).  
Cells were analyzed in the vegetative growth phase for all the experiments.  
To prepare the sample, a single fresh colony of S. pombe strain was inoculated in 5 mL of 
YES or EMM liquid media and grown overnight until OD=0.5. Next day, 1 mL of cell culture 
was transferred into a 1.5 mL tube and centrifuged at 15700 g for 1 minute at RT. The 
supernatant was removed and cells were washed twice in 1mL of sterile H2O. Then cells were 
resuspended in 200 μL of sterile H2O, of which 10 μL were gently pipetted onto a glass 
microscope slide (Thermo Scientific), covered with a coverslip.  
 
2.2 - S. pombe DNA techniques 
For S. pombe DNA extraction, method 1 (2.2.1) has been used. Alternatively, method 2 
(2.2.2), was adopeted when GeneJet Genomic DNA purification kit was not available.  
2.2.1 - Genomic DNA extraction: method 1  
The genomic DNA from S. pombe was extracted using the GeneJet Genomic DNA 
purification kit (Thermo Fisher Scientific). A fresh single colony of S. pombe was grown in 5 
mL of YES or EMM (according to the yeast genotype) until OD600=0.5. Cells were harvested 
in a microfuge at 800 x g for 5 minutes. The supernatant was discarded and the pellet was 
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resuspended in 1 mL of Yeast Lysis Buffer (not provided with the kit) consisting of 5 mg/mL 
Zymolyase 20T (AMS Biotechnology), 0.1 M EDTA pH 8.0, and 1 M sorbitol. The cell 
suspension was incubated for 1 hour at 37°C. Cells were harvested at 2700 x g for 10 minutes, 
and the pellet was resuspended in 180 μL of digestion solution (provided with the kit), 
containing 20 μL of Proteinase K (20 mg/mL). The suspension was incubated for 1 hour at 
56°C.  To degrade the RNA, the lysate was treated with 20 μL of RNase A (10 mg/mL), and 
incubated for 30 minutes at room temperature. After incubation, 200 μL of Lysis Solution 
(provided with the kit) was added to the mixture, which was vortexed for a few seconds to 
obtain a homogeneous solution. To precipitate the DNA, 400 μL of 50% of ethanol was added 
to the lysate, which was then transferred into a GeneJET Genomic DNA Purification column 
(provided with the kit).  The column previously inserted into a collection tube, was 
centrifuged at 5900 x g for 1 minute and the flow-through was discarded. The column was 
firstly washed with 500 μL of Wash buffer I and then with 500 μL of Wash buffer II. After 
the final washing, the column was transferred into a sterile 1.5 mL Eppendorf tube. To elute 
the DNA 50 μL of Elution buffer was pipetted in the middle of the column; the sample was 
firstly incubated for 1 minute at room temperature and then centrifuged at maximum speed for 
2 minutes. The DNA concentration was evaluated by nanodrop (ND-1000 spectrometer) and 
the quality was checked by running a 1% agarose gel. 
 
2.2.2 - Genomic DNA extraction: method 2  
To extract the genomic DNA from S. pombe (only to use as a template in a PCR reaction), an 
alternative method to the kit protocol previously described has been also adopted (Murray et 
al., 2016). Cells were grown in 10 mL of YES or EMM (according to the yeast genotype) 
until OD600=0.5. The cell culture was harvested at maximum speed for 1 minute, washed with 
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1 mL of sterile H2O, and resuspended in 1 mL of CSE buffer (1.2 M Sorbitol, 40mM EDTA 
pH 8.0, 1mg/mL of Zymolase 20T). The mixture was incubated at 37°C for 15 minutes. After 
incubation, the cell suspension was harvested at maximum speed for 1 minute and 
resuspended in 450 μL of 5x TE buffer. To the lysate 50 μL of 10% SDS was added, mixed 
by inversion and incubated for 5 minutes at room temperature. Upon addition of 150 μL of 
5M CH3COOK, the sample was incubated on ice for 10 minutes. The suspension was pelleted 
at maximum speed for 10 minutes and the supernatant was transferred in a sterile 1.5 mL 
Eppendorf tube, to which 1 volume of isopropanol was added. The DNA was recovered by 
centrifugation at maximum speed for 10 minutes, washed twice with 75% ethanol and air-
dried at room temperature for 5-10 minutes. The pellet was resuspended in 50 μL of 1xTE 
buffer, containing 1 μL of 10mg/mL RNase A, and incubated for 15 minutes at 37°C. 
Typically, 1 μL of genomic DNA was used as a template in the PCR reaction. 
 
2.2.3 - Agarose gel electrophoresis and gel extraction  
Plasmids and PCR products were mixed with 6X Gel Loading Dye (NEB) and resolved on a 
1% agarose gel and run in 1X TAE buffer (40 mM Tris base, 20 mM acetic acid and 1 mM 
EDTA), containing 0.5 μg/mL of ethidium bromide, at a constant voltage of 90 V. The size of 
the band of interest was identified by referring to the 100 bp or 1kb DNA ladders (NEB). In 
presence of multiple bands, the fragment of interest was extracted using the Monarch DNA 
extraction Kit (NEB) or the QIAquick Gel extraction kit (QIAGEN). Briefly, the desired 
DNA band was cut under the UV light; according to its weight, three volumes of Dissolving 
Buffer (provided with the kit) were added into a 1.5 mL Eppendorf tube containing the band 
of interest, which was melted at 55°C for approximately 5-7 minutes. The suspension was 
loaded into the column (provided with the kit), and centrifuged at maximum speed for 1 
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minute. The flow-through was discarded and the DNA was washed twice with 700 μL of 
Wash buffer (provided with the kit). The column was positioned into a sterile 1.5 Eppendorf 
tube, to which 50 μL of Elution buffer was applied for the elution. The DNA was eluted by 
centrifugation at 15700 x g for 1 minute at room temperature. 
 In the presence of a single band, the DNA was purified using a QIAquick PCR purification 
kit; briefly, the PCR reaction solution (approximately 50 μL), was mixed with 5 volumes of 
Binding Buffer (provided with the kit). The mixture was transferred into a QIAquick Spin 
column, and centrifuged for 1 minute at maximum speed. The flow-through was discarded 
and the column was firstly washed with 750 μL of Wash Buffer I and then with the same 
volume of Wash Buffer II. Lastly, the DNA was eluted by applying 50 μL of Elution Buffer 
and centrifuging at maximum speed for 1 minute at room temperature.  
 
2.2.4 - Standard PCR 
Standard PCR was performed in a reaction volume of 50 μL (1X Q5 Reaction Buffer, 200 μM 
dNTPs, 0.5 μM Forward Primer, 0.5 μM Reverse Primer, 0.02 U/μL Q5 high fidelity DNA 
polymerase, nuclease-free water and template DNA). The sequences of the primers used in 
this study are reported in Appendix III. Primers were designed using Primer3 
(http://bioinfo.ut.ee/primer3-0.4.0/) and bought from Integrated DNA Technologies (ITD) or 
Sigma. PCR was executed in a thermocycler (Biorad, MycyclerTM) and samples were resolved 
on 1% agarose gel.  
2.2.5 - Single Colony PCR 
Confirmation of endogenous gene tag or gene knock-out in S. pombe was also performed by 
single colony PCR. For the colony PCR, the DNA was amplified using the GoTaq DNA 
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Table 1 - Colony PCR reaction set up 
 
PCR was executed in a thermocycler (Biorad, MyclerTM), using the following setting: pre-
denaturation (to break the cell wall and release the nucleic acids) at 95°C for 10 minutes; 30 
cycles of denaturation at 95°C for 30 seconds;  annealing at 52°C for 30 seconds; extension 
at72°C for 90 seconds; final extension at 72°C for 5 minutes. The annealing temperature was 
calculated using the New England BioLabs TM Calculator (http://tmcalculator.neb.com/#!/). 
Amplified fragments were resolved on 1% agarose gel. 
Reagent Volume 
GoTaq polymerase 0.125 μL 
5x Go Taq buffer 5 μL 
FW Primer (10 μM) 1 μL 
RV Primer (10 μM) 1 μL 
dNTP (100 mM) 0.2 μL 
MgCL (25 mM) 1.5 μL 




2.2.6 - DNA sequencing  
DNA fragments were sequenced by either GATC biotech (Konstanz, Germany) or Source 
Bioscience (Nottingham, UK). 
2.2.7 - S. pombe transformation  
To transform plasmids and DNA fragments in S. pombe, a fast transformation protocol was 
adopted (Gietz and Woods, 2002). A fresh single colony was inoculated into 5 mL of YES or 
EMM liquid media (according to the yeast genotype), and grown overnight until OD600=0.5. 
Cells were harvested at 1000 x g for 1 minute at room temperature, and the pellet was washed 
with 1 mL of 0.1 M Lithium Acetate. After a centrifugation at 1000 x g for 1 minute, the 
pellet was resuspended in a solution consisting of:  120 μL of PEG (50% w/v), 18 μL of 1M 
Lithium Acetate, 10 μL of 10 mg/mL salmon sperm DNA, the DNA fragment/plasmid to 
transform (typically 1 μg of DNA) and sterile H2O until a final volume of 180 μL. Cells were 
incubated for 1 hour at room temperature followed by a heat shock at 42°C for 15 minutes. 
After the heat shock, cells were harvested at 800 x g for 30 seconds at room temperature, 
resuspended in 150 μL of sterile H2O and plated on a YES or EMM agar plate (according to 
the yeast genotype). The plate was incubated at 30°C for 24 hours, after which it was replica 
plated on a fresh plate containing the desired antibiotic. The selective plate was incubated for 
2-3 days at 30°C until colony formation. 
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2.2.8 - Endogenous gene tagging- Two-step PCR approach 
To create strains in which epitopes are added endogenously at the C-terminal or N-terminal of 
a target protein, we have adopted a two-step PRC approach/PCR sewing (Krawchuk and 
Wahls, 1999). This method is characterized by the use of pFA6a plasmid, and its derivates, 
which can contain different kinds of epitopes, along with an antibiotic resistance gene. 
Initially, two PCR reactions are set up to produce two DNA fragments of approximately 500 
bp (Figure 2.1). In the first PCR reaction, a FW primer (FW1) anneals to the coding sequence 
of the target gene, approximately 500 bp before the stop codon; the reverse primer (RV1) is a 
hybrid, which anneals at the end of the target gene (excluding the stop codon), and contains a 
short sequence of homology with pFA6a plasmid (approximately 25-30 bp). In the second 
PCR reaction, another fragment of 500 bp is amplified; in this case the FW primer (FW2) is a 
hybrid, containing a sequence of homology with pFA6a plasmid (approximately 25-30 bp) 
and it begins after the stop codon of the target gene, while the RV primer (RV2) is positioned 
500 bp after the stop codon (Figure 2.1). The two PCR products are then purified using the 
QIAquick PCR Purification Kit (Qiagen) or the PCR and DNA Cleanup Kit (Monarch), as 
previously described. After the purification, the two PCR products are used in a third PCR 
reaction with pFA6a plasmid as a template. The previous PCR products will anneal with 
pFA6a plasmid through the short sequences of homology, and the two external primers F1 
and RV2, will amplify a DNA fragment formed by a portion of the gene of interest in frame 
with the tag, a terminator sequence and a selection marker (Figure 2.1). The fragment is 






Figure 2.1 – Two-step PCR approach/PCR sewing. Two DNA fragments of 
approximately 500 bp, having a sequence of homology with pFA6a plasmid, are amplified 
in the first step of the two step-PCR approach. The two PCR products are then purified and 
used in a second PCR reaction with pFA6a plasmid as a template. By using external 
primers FW1 and RV2, a PCR product containing part of the gene of interest in frame with 
the epitope, a terminator and a selectable marker is amplified and subsequently 
transformed in S. pombe where it will be integrated into the desired locus via homologous 
recombination.   
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2.2.9 - Chromatin Immunoprecipitation (ChIP) 
2.2.9.1 - Crosslinking and Sonication  
A fresh single colony of S. pombe was inoculated in 10 mL of YES liquid media and grown 
overnight at 30°C in a shaking incubator. The next day, the cell culture was transferred in 90 
mL of YES, diluted until OD600=0.1 and grown until OD600=0.5 (1x 107 cells/mL). Cells were 
fixed for 5 minutes at room temperature by adding 2.7 mL of 37% formaldehyde (Sigma) so 
that the final concentration was 1%. To stop the reaction, 20 mL of 2.5 M glycine was added 
to the cell culture and incubated for 10 minutes at room temperature on a shaker. The cell 
culture was transferred in two 50 mL Falcon tubes and centrifuged at 2700 x g for 3 minutes 
at 4°C. The pellet was resuspended in 40 mL of cold 1X PBS, and combined into a single 50 
mL Falcon tube. Cells were harvested at 2700 x g for 3 minutes at 4°C, and two more 
washing in cold 1X PBS were made at the same condition. Pellet was resuspended in 750 μL 
of cold FA Lysis Buffer (100 mM HEPES-KOH, pH.7.5, 300 mM NaCl, 2mM EDTA, 2% 
Triton X-100, 0.2% Na Deoxycholate) containing an EDTA-free protease inhibitors cocktail 
tablet (Roche, 1 tablet for 10 ml of FA Lysis Buffer).  The cell suspension was transferred 
into a 2 mL screw-cap tube and pelleted at 3300 x g for 2 minutes at 4°C. The supernatant 
was removed and the pellet was resuspended in 750 μL FA lysis Buffer with EDTA-free 
protease inhibitor cocktail tablet, to which 400 μL of Zirconia beads (0.7mm of diameter, 
Biospec) was added. Cells were broken using a cell homogenizer (Bertin Technologies, 
Precellys 24); to break almost 90% of the cells, 10 cycles of 30 seconds each at 2700 x g were 
applied, alternate with 2 minutes in ice. The bottom of the screw cup tube was pierced twice 
with a hot 25 G needle and each tube was immediately transferred in the barrel of a syringe 
previously inserted into a 15 mL falcon tube. The lysate was collected at 110 x g for 1 minute 
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at 4°C; the residual lysate was collected by adding 500 μL of FA lysis Buffer, and 
centrifuging at the same conditions. The cell lysate was transferred in a 1.5 mL microfuge 
tube and pelleted at 15700 x g for 25 minutes at 4°C. Pellet was resuspended in 600 μL of FA 
lysis Buffer containing a mini EDTA-free protease inhibitor cocktail tablet. Then cell lysate 
(approximately 750 μL) was transferred in a 15 mL tube (Sumitomo): 250 μL of FA lysis 
Buffer with mini EDTA-free protease inhibitor cocktail tablet was added to reach the final 
volume of 1 mL. To increase sonication efficiency 20 μL of 10% SDS and 20 μL of 100 mM 
PMSF was added to the mixture and gently resuspended, avoiding bubbles. Samples were 
sonicated for 15 cycles at 4°C using the Bioruptor (Diagenode). 
2.2.9.2 - Sonication efficiency checking  
After sonication, the sample was transferred to a 1.5 mL microfuge tube, centrifuged at 15700 
x g for 25 minutes at 4°C. The supernatant was collected and transferred to a fresh 1.5 mL 
Eppendorf tube: to check the sonication efficiency, 50 μL of sonicated chromatin were mixed 
with 150 μL of TES buffer (10 mM Tris, pH 7.5; 10 mM EDTA, pH 8; 0.5% SDS), and 
incubated overnight at 65° C. The next day, 200 μL of TE buffer (10 mM Tris, pH 7.5; 10 
mM EDTA, pH 8) were added to reach the final volume of 400 μL. To digest RNA, 1 μL of 
RNase A (10 mg/mL) was added and incubated at 37°C for 1 hour. To digest proteins, the 
mixture was incubated with 10 μL of Proteinase K (20 mg/mL), for 2 hours at 55°C. The 
chromatin was extracted using the QIAquick PCR purification kit, as previously described. 
The eluted DNA (20 μL) was mixed with 4 μL of DNA gel loading Dye (6x) and resolved on 




2.2.9.3 - Immunoprecipitation (IP) 
A 50 μL aliquot of Dynabeads Protein G (Thermofisher) was transferred in a 1.5 mL DNA 
low binding tube (Eppendorf) and washed three times with 1 mL of cold 1xPBS containing 
5% BSA. Between each washing, the tube containing the beads was rotated on a magnetic 
rack 5 times. After the final washing, the beads were resuspended in 500 μL 1x PBS/ 5% 
BSA and transferred into a fresh 1.5 mL DNA low binding tube. Depending on the target, 3-
10 μg of antibody were added to the beads, and gently resuspended. The mixture was 
incubated on a rotor for 1 hour at room temperature. To remove the unbound antibody, the 
beads were washed 3 times with 1 mL of 1xPBS /5% BSA. After the final washing, the 
supernatant was removed and the beads were resuspended in the appropriate amount of 
sonicated chromatin and transferred in a fresh 1.5 mL DNA low binding tube. The coated 
beads and the chromatin were incubated overnight at 4 °C on a rotor.  
 
2.2.9.4 - Beads Washing and ChIP DNA elution 
The next day, each tube containing an IP reaction was positioned into a magnetic rack. The 
supernatant was removed and the beads were washed for 5 minutes at room temperature on a 
rotor using the following buffer: 
- 2 times with Wash Buffer I (50mM HEPES-KOH pH 7.5, 150 mM NaCl, 1mM 
EDTA pH 8.0, 1% Triton X-100, 0.1% Sodium deoxycholate, 0.1% SDS) 
- 2 times with Wash Buffer II (50mM HEPES-KOH pH 7.5, 500 mM NaCl, 1mM 
EDTA pH 8.0, 1% Triton X-100, 0.1% Sodium deoxycholate, 0.1% SDS) 
- 2 times with Wash Buffer III (10mM Tris-HCl pH 8.0, 1mM EDTA pH 8.0, 0.25mM 
LiCl, 0.5% Igepal CA, 1% Sodium deoxycholate) 
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- 2 times with TE (10mM Tris-HCl pH 8.0, 1mM EDTA pH 8.0) 
Between each washing, beads were briefly centrifuged and they were rotated on the magnetic 
rack for 5 times. After the final washing, the beads were resuspended in 100 μL of Elution 
Buffer (50mM Tris-HCl pH 7.5, 10 mM EDTA, 1% SDS) and incubated for 10 minutes at 
65°C and occasionally vortexed. Then supernatant (elution) was recovered and transferred to 
a fresh 1.5 mL DNA low binding tube. The elution was performed a second time using the 
same conditions.  
 
2.2.9.5 - De-crosslinking and DNA extraction 
To the input, 150 μL of elution buffer were added and incubated at 65°C overnight to allow 
de-crosslinking. IP sample was de-crosslinked in parallel using the same condition. Next day, 
200 μL of TE buffer was added to the Input and IP, and briefly vortexed. To degrade RNA, 1 
μL of RNase A (10 mg/ml) was added to the Input and to the IP which were subsequently 
incubated at 37 °C for 30 minutes. To remove proteins from the DNA, 10 μL Proteinase K 
(20 mg/ml) was added and samples were incubated at 55 °C for two hours. DNA was then 
extracted using the QIAquick PCR purification kit, as previously described. 
 
2.2.9.6 - Quantitative Real-Time PCR (qRT-PCR) 
After DNA extraction Input and IP were diluted in sterile distilled water:  input was diluted to 
200 pg/ μL; IP was diluted 1:50 in sterile H2O.  qRT-PCR of diluted Input and IP was 
performed using an ABI-Prism 7000 real-time PCR thermocycler. PCR reactions were 
prepared in technical triplicate using a 96 well plate: each reaction contains 10 μL of 2x 
SyGreen Blue Mix Hi-ROX (PCR-biosystems), 4 μL of diluted Input/IP, 3 μL of 0.4 μM of 
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each forward and reverse primer. The qRT-PCR was run using the following setting: 3 
minutes at 95°C, followed by 40 cycles of 15 seconds at 95°C and 30 s at 60°C. 
 
2.2.9.7 - Calculation of Fold enrichment  
ChIP-qPCR enrichments are normalized to the input and expressed as fold enrichment relative 
to a negative locus (intergenic), which is not expressed. The fold enrichment is calculated 
with the following formula;  
 
																															ΔCT1 =Average CT (IP gene) – Average CT (IP intergenic) 
ΔCT2 = Average	CT	(Input	gene) − Average	CT(Input	intergenic) 
ΔΔCT = ΔCT1 − ΔCT2 
                                                     Fold enrichment= 2-^	ΔΔCT 
 
2.2.9.8 - RNase sensitivity  
To check whether a protein is associated with nascent RNA, an RNase sensitivity step was 
introduced before the DNA elution. After two washes in buffer 3, beads were washed three 
times more with 1xTE buffer, to remove excess detergent. Then the beads were resuspended 
in 500 μL of TE buffer and transferred to a fresh 1.5 mL DNA low binding tube. 5 μL of 
RNase A, DNAse and protease-free (10 mg/mL), was added to the mixture, gently 
resuspended and incubated for 30 minutes at room temperature on a rotor. Then the microfuge 
was positioned into the magnetic rack, the supernatant was removed and the beads were 
washed two times more with 1 mL of TE buffer. Elution was performed as previously 
described. 
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2.3 - S. pombe protein analysis techniques 
2.3.1 - Protein extraction from S. pombe cell cultures  
The protein extraction was performed using a rapid method based on NaOH (Matsuo et al., 
2006). A fresh single colony of S. pombe was inoculated in 2 mL of YES or EMM (according 
to the yeast genotype), and grown at 30°C until an OD600=0.5. The 2 mL culture was poured 
in 3 mL of pre-warmed media so that the final volume was 5 mL and grown until an OD600= 
0.5. Cells were harvested by centrifugation at 2700 x g for 5 minutes at room temperature; the 
supernatant was completely removed and cells were washed with 1 mL of sterile H2O. The 
pellet, obtained by centrifugation at the same conditions, was resuspended in 300 μL of sterile 
H2O, to which one volume of 0.6M NaOH (~300 μL) was added so that the final 
concentration of NaOH was 0.3M. The suspension was gently mixed by pipetting and the 
sample was incubated for 10 minutes at room temperature. The cell lysate was pelleted by 
centrifugation at 4000 x g for 5 minutes at 4°C. The NaOH was completely removed and the 
proteins were resuspended in 70 μL of 1X SDS loading buffer (4% SDS, 0.04% bromophenol 
blue, 20% glycerol, 60mM Tris HCl, pH 6.8, 4% mercaptoethanol, 0.01% and 1 mM 
phenylmethanesulfonylfluoride (PMSF)). The samples were boiled for 5 minutes and 
centrifuged at 15700 x g at 4°C. The samples were stored at -20°C, or immediately processed. 
2.3.2 - SDS-PAGE and Western Blotting 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) gels were 
prepared as described in Molecular Cloning 4th edition (Green and Sambrook, 2012). 20 μL of 
the protein extract in 1X SDS loading buffer were loaded in each well. The SDS-PAGE gels 
were run in 1x SDS running buffer (0.025 M Tris-HCl, 0.192 M Glycine, 0.1% (w/v) SDS, 
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pH 8.3), using a Bio-Rad Mini-PROTEAN Tetra Cell electrophoresis chamber, at a constant 
voltage of 100V for 90 minutes. Proteins were transferred onto a nitrocellulose membrane 
(AmershamTM PotranTM, 0.2 μm, GE healthcare), using a Bio-Rad Mini PROTEAN II 
electrophoresis apparatus, at 350 mA for 2 hours in a cold room in 1X transfer buffer (190 
mM glycine, 25 mM Tris-HCl, 20% (v/v) Methanol). The membrane was blocked with 10 mL 
of 1x TBS (25mM Tris-HCl, 137 mM NaCl), containing 5% milk. The primary antibodies 
used in this study (reported in Appendix V), were diluted according to the company, in 2.5% 
skimmed milk in TBST (25mM Tris-HCl, 137 mM NaCl, with 0.1% Tween 20), and 
incubated overnight in a cold room on a shaker. The next day, the membrane was washed 3 
times for 10 minutes, in 30 mL of 1xTBST (25mM Tris-HCl, 137 mM NaCl, with 0.1% 
Tween 20), and incubated for 1 hour at room temperature, with a secondary horseradish 
peroxidase (HRP) conjugated antibody (Sigma), using a standard dilution of 1:10000 in 
TBST. After incubation with the secondary antibody, the membrane was washed 6 times for 5 
minutes in 1xTBST. To develop the signal of the protein of interest, 1 mL of a mix formed by 
Buffer A and Buffer B of the ECL Western Blotting Detection Reagent (GE Healthcare) was 
applied to the membrane: the membrane was wrapped in a cling film and the signal was 
detected using the ChemiDoc imaging system. For the secondary antibody conjugated with 
fluorescent dyes, some protocol modifications were made. Blocking of the membrane was 
performed in 1xTBS containing 2.5% dried milk. The membrane was washed using the 
TBST-high salt (TBS supplemented with NaCl, to the final concentration of 500mM,). 
Additionally, the last washing before the detection of the signal was carried out in 1xTBS to 
eliminate residual Tween-20 that could interfere with the detection. The detection of the 
signal was performed using the Odyssey Imaging Software, LI-COR. 
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2.3.4 - Western Blot quantification analysis 
Quantification of the band of the protein of interest was performed using ImageJ. The western 
blot image was imported in ImageJ. The intensity of the band of interest was quantified by 
selecting the area around the band. Then this value was divided by the intensity derived by the 
quantification of  a-tubulin.  
 
2.3.5 - Bioinformatics analysis  
Primary protein sequences were downloaded from Pombase, FlyBase or Uniprot. Alignment, 
visualization, and editing were performed using Jalview (http://www.jalview.org/). 
Visualization and editing of the 3D structures were performed using UCSF Chimera. 
Homology modelling of 3D protein structures was performed using Swiss-Model  
(https://swissmodel.expasy.org). 
 
2.4 - S. pombe RNA analysis techniques 
2.4.1 - RNA extraction from S. pombe 
To extract RNA from S. pombe, 15 mL of the cell culture was grown in YES or EMM, 
according to the genotype, until OD600=0.5. Cells were harvested at 4000 x g for 5 minutes at 
4°C. The supernatant was removed and the pellet was resuspended in 1mL of cold sterile 
H2O, and transferred into a sterile 1.5 mL Eppendorf tube. Cells were harvested for 10 
seconds at maximum speed at 4°C. The supernatant was removed and the pellet was 
resuspended in 400 μL of AE buffer (50mM NaOAc pH 5.3, 10mM EDTA), 40 μL of 10% 
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SDS and 400 μL of acid phenol. The tube was vortexed for 20 seconds, and incubated at 65°C 
into a heat block, for 10 minutes. After incubation, the sample was frozen at -80°C for 10 
minutes; then it was defrosted on the bench and spun at maximum speed at room temperature 
for 10 minutes. The aqueous upper phase was transferred into a cold 1.5 mL Eppendorf tube 
containing 400 μL of acid phenol: chlorophorm: isoamyl (25:24:1), vortexed for 30 seconds 
and spun at maximum speed for 10 minutes at room temperature. The upper phase was then 
transferred into a cold 1.5 mL Eppendorf tube containing 400 μL chloroform, vortexed for 30 
seconds and spun at maximum speed for 5 minutes at room temperature. Lastly, the upper 
phase was transferred to a fresh Eppendorf tube containing 1 mL of 100% EtOH and 40 μL of 
7.5 M NH4Ac. The tube was inverted for a few times and RNA was precipitated for 2 hours 
at -80°C. The RNA was pelleted at maximum speed for 10 minutes at 4°C; EtOH was 
completely removed and the pellet was washed with 500 μL of 70% EtOH. After 
centrifugation at the same condition, the pellet was air-dried at room temperature for 20 
minutes and resuspended in 20 μL of ddH2O.  The concentration of 1 μL of purified RNA was 
checked via nanodrop (ND-1000 spectrometer), and the remaining RNA was stored at - 20°C 
for downstream applications. 
 
2.4.2 - Agarose gel electrophoresis of RNA 
To check the quality of RNA, 4-5 μg of RNA (approximately 1 μL), were diluted in 10 μL of 
DEPC treated H2O. Then 2 μL of 6x DNA gel Loading Dye (NEB) was added to the sample.  
The RNA samples were loaded in a 1% agarose gel, which was made by using DEPC treated 




2.4.3 - Northern Blot 
All the solutions were made in DEPC-treated dH2O. The samples were run on 1% agarose 




Agarose 1.5 g 
10x MOPS 15 mL 
Formaldehyde (37%) 7.5 mL 
DEPC H2O 127.5 mL 
 
      Table 2 - Agarose formaldehyde gel composition for Northern Blot analysis 
 
 
The RNA samples for Northern Blot analysis were prepared on ice, by mixing 5 μg of RNA, 
1 μL of Ethidium bromide, 5 μL of denaturing buffer and DEPC-dH2O up to 10 μL. Then the 
RNA samples were denatured at 70°C for 5 minutes and quickly placed on ice. The 
electrophoresis chamber was filled with approximately 600 mL of 1xMOPS buffer. 10 μL of 
RNA samples were loaded in each lane in parallel with 5 μL of 6xDNA loading buffer (2.5 
mg/mL bromophenol blue, 2.5 mg/mL xylene cyanol, 39% glycerol, 10mM EDTA pH 8.0), 
used to check the electrophoresis run. The gel was run at 80V until the bromophenol blue 
reached 2/3 of the gel. After the run, the fractionated RNA was blotted overnight into a 
neutral nylon Amersham Hybond-N membrane (GE Healthcare), and UV-cross-linked to 
immobilize the RNA. After the cross-linking, the membrane was placed into a glass 
hybridization tube, to which 13 mL of RNA Hybridization Buffer (PerfectHyb, Sigma) was 
added. The pre-hybridization was performed for 45 minutes at 42°C. The probes were 
prepared by mixing 1 μL of 10 μM of a specific primer, 1 μL of T4 Polynucleotide Kinase 
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(NEB), 1.5 μL of T4 Polynucleotide Kinase reaction buffer, 1 μL of Adenosine triphosphate, 
labeled on the gamma phosphate group with 32P, and DEPC-dH2O to a final volume of 15 μL. 
The reaction was incubated at 37°C for 30 minutes and inactivated at 65°C for 20 minutes. 
The labeled probes were added to the pre-hybridized membrane and incubated for 5 hours at 
42°C. Then the membrane was washed 3x5 minutes with 100 mL of hot 2xSSC containing 
0.1% SDS. After the final washing, the membrane was wrapped in a cling film and the signal 
was visualised using the Quantity One Software. 
 
2.4.4 - Polysome Profiling 
2.4.4.1 - Preparation of sucrose gradients 
All the solutions were prepared in DEPC-treated sterile H2O, and all the steps were carried 
out in ice or at 4°C to avoid RNA degradation. The sucrose gradient used in this study varied 
from 10 to 50 %, and it was prepared using a Biocomp Master Base Unit (Wolf Laboratories), 
by mixing sucrose solutions at 10% and 50% (prepared in 10mM Tris-acetate pH 7.4, 70mM 
ammonium acetate, 4mM magnesium acetate and 100 μg/mL cycloheximide). In brief, using 
a cannula attached to a syringe, the 10% solution was firstly dispensed into an SW41 
centrifuge tube, until the solution level reached almost half of the tube. Then the 50% solution 
was dispensed by inserting a clean cannula at the bottom of the tube and slowly filled until 
half of the tube. Then, the tube was positioned into the rack of the Biocomp Master Base Unit, 
and the gradient was made using the 1-step long 10-50% sucrose program. The gradients were 
kept at 4°C and used just before the loading of the samples.  
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2.4.4.2 - Cell lysis 
An S. pombe cell culture was grown in 50 mL of YES until OD600=0.5. Then the cells were 
treated with 100 μg/mL cycloheximide for 5 minutes at 30°C and the culture was immediately 
poured into a 50 mL centrifuge tube containing ice. The cells were harvested at 1000 x g and 
resuspended in a cold wash buffer (20 mM HEPES pH 7.4, 2 mM magnesium acetate, 2 mM 
magnesium chloride, 100 mM potassium acetate, 100 μg/mL cycloheximide). The cells were 
pelleted at the same condition and resuspended in 600 μL of lysis buffer (wash buffer with 1 
mM dithiothreitol (DTT), 1 mM phenylmethanesulfonyl fluoride (PMSF), 1x cOmpleteTM 
Mini EDTA-free Protease Inhibitor Cocktail (Roche) and either 10 mM Ribonucleoside 
Vanadyl Complex (RVC) (New England Biolabs) or 20 units of RiboLock (Thermo Fisher 
Scientific) as an RNase inhibitor). The cell suspension was then transferred into a clean 2 mL-
screw cap tube, containing approximately 1 mL of either acid-washed glass or Zirconia silica 
beads (0.5 mm diameter, Biospec products, distributed by Cole-Palmer). To break the cells, a 
tissue homogenizer (Precellys 24, Bertin instruments) was used: a cell lysate was obtained by 
applying 3x15s beads shaking pulse at 5500 rpm. Between each pulse, the sample was cooled 
on ice for two minutes. To recover the lysate, the 2 mL screw-cap tube was pierced on the 
bottom using a 25G needle; then the screw cap was positioned into a 5 mL syringe, located 
itself into a 15 mL tube. The 15 mL tube was then centrifuged at 1000 x g for 5 minutes at 
4°C and the lysate was transferred into a clean 1.5 mL Eppendorf tube. The cell debris was 
pelleted by centrifugation at maximum speed for 5 minutes at 4°C; then the supernatant was 
transferred into a new 1.5 mL tube and centrifuged at the same conditions for a second 
clearing.  
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2.4.4.3 - Polysome fractionation  
To evaluate the volume of the cell lysate to load into the sucrose gradient, the absorbance 
abs260 of 1 μL of lysate was measured by the use of a nanodrop (ND-1000 spectrometer). The 
volume corresponding to 20 abs260 was loaded into the gradient, and the tubes were positioned 
into the bucket of a Beckman SW41 rotor. Centrifugation was carried out at 1200 x g at 4°C 
for 150 minutes. After sucrose fractionation, the sample was recovered from the bottom by 
the action of a peristaltic pump (P-1, Pharmacia), attached to a capillary tube. By the use of a 
flow-through UV spectrophotometer (ISCO UA-6 detector), the absorbance at 254 was 
constantly measured and recorded using a chart recorder (PicoLog Data Logger). Each 
fraction within the sucrose gradient was recovered using a fraction collector (FRAC100, 
Pharmacia). Samples were stored at -20°C or processed immediately for downstream 
applications.  
2.4.4.4 Protein extraction from polysomal fractions  
The proteins were extracted from the polysomal fractions using the Methanol/Chloroform 
method. A 150 μL aliquot of polysomal fraction, was mixed with 600 μL of Methanol, 150 
μL of Chloroform and 450 μL of sterile H2O. The sample was centrifuged at maximum speed 
for 5 minutes at room temperature. After centrifugation, a white layer of proteins formed 
between the bottom organic phase and the upper aqueous phase: the aqueous phase was 
removed, and 650 μL of methanol was added to the sample. The sample was centrifuged at 
15700 x g for 5 minutes at RT. The supernatant was completely removed and the pellet was 
air-dried for 5-10 minutes. The precipitated proteins were resuspended in 35 μL of 1X SDS 
loading buffer (4% SDS, 0.04% bromophenol blue, 20% glycerol, 60mM Tris HCl, pH 6.8, 
4% mercaptoethanol, 0.01% and 1 mM phenylmethanesulfonylfluoride (PMSF)), and boiled 
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for 5 minutes. The protein extracts were run on 10-12% SDS polyacrylamide gel and analysed 
by Western Blot.  
 
2.5 - Escherichia coli methods 
2.5.1 - E. coli Strains  
The E. coli strains used to amplify plasmids were DH5 alpha, with genotype: F–
 endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZΔM15Δ(lacZYA-
argF) U169, hsdR17(rK–mK+), λ–. The plasmids used in this project can be found in Appendix 
IV.  
 
2.5.2 - E. coli media and growth condition 
Luria-Bertani (LB) liquid media and LB agar plates were used to grow E. coli. Typically, a 
single colony of E. coli was inoculated in 5 ml and grown at 37°C overnight using a shaking 
incubator at 220 rpm. The subsequent culture was used to scale up to the desired volume. The 
ampicillin was added to LB liquid media to a concentration of 100 μg/mL. For plated cells, 
they were grown overnight on LB agar plates at 37°C overnight. Plates were supplemented 
with ampicillin at the same concentration. 
 
 2.5.3 - Bacterial Transformation  
1 μL (1 ng) of plasmid was added to 50 μL of DH5 alpha competent cells, gently mixed and 
incubated on ice for 30 minutes.  After incubation, cells were heat-shocked at 42°C for 30 
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seconds using a water-bath. Cells were immediately transferred on ice for 2 minutes. To 
recover the cells after the heat-shock, 500 μL of NZY media (details of which is reported in 
Appendix I) was added and cells were incubated at 37 °C for 1 hour in a thermo-shaker at 250 
rpm. 100 μL of cells was spread on LB agar plates containing 100 μg/mL Ampicillin. Cells 
were grown overnight at 37°C.  
 
2.5.4 - Cloning by Gibson assembly  
To clone a fragment of DNA into a vector, the Gibson Assembly Cloning technique was 
adopted in this study. The fragment of DNA was amplified via PCR using primers forward 
and reverse with at least 25 bp of homology to the region of insertion on the plasmid (Figure 
2.2). The plasmid was amplified via PCR, with primer forward and reverse with the same 25 
bp of homology of the fragment. The two products were then purified using the QIAquick 
PCR purification kit (Qiagen) or the PCR and DNA cleanup kit (Monarch). The assembly 
reaction was performed using the NEBuilder HIFI DNA assembly Master Mix (NEB). The 
reaction was set up by combining 3 μL of 2x Gibson Assembly Master Mix, 0.5 pmols of 
each DNA fragment and 6 μL of sterile water. The mix was incubated in a thermocycler at 
50°C for 15 minutes. After incubation 10 µl of the mix was used to transform the DH5 alpha 






Figure 2.2 - Gibson assembly schematic representation. A DNA fragment to insert into 
a plasmid of interest are both amplified by PCR, using hybrid primers having at least 25 
nucleotides of homologous sequence. The PCR amplified products are purified using a 
Monarch PCR Purification Kit (or a QIAquick PCR Purification Kit). The Gibson 
assembly is then performed by combining the purified fragment and the vector backbone 









2.5.5 - Small scale plasmid preparation (Method 1)-Boiling prep 
A single colony of DH5 alpha was inoculated in 2-3 mL of LB liquid media and grown 
overnight at 35.5°C.  After 12 hours, the culture was poured into a 1.5 mL tube and 
centrifuged for 5 minutes at 300 g. The supernatant was discarded and the pellet was 
resuspended in 400 μL of STET buffer (8% sucrose, 0.1% Triton-X 100, 50 mM EDTA pH8, 
50 mM Tris pH 8) and 30 μL of lysozyme (Sigma). The mixture was firstly incubated at room 
temperature for 5 minutes and then boiled for further 3 minutes.  Cells were pelleted at 
maximum speed for 10 minutes and the supernatant was transferred into a sterile 1.5 mL tube, 
to which 60 μL of RNase A (10mg/mL) and 50 μL of NaAc pH 5.2 was added. The sample 
was incubated at room temperature for 5 minutes, after which 1 volume of isopropanol, was 
added and centrifuged at maximum speed for 10 minutes. The supernatant was discarded and 
the pellet was washed with 650 μL of 75% EtOH and air-dried. The DNA was dissolved in 50 
μL of 1xTE buffer and plasmid concentration was evaluated by nanodrop (ND-1000 
spectrometer). 
 
2.5.6 - Small scale plasmid preparation (Method 2) 
A second method was adopted at the beginning of this study, before Boiling Prep (2.5.5) was 
optimized. A single colony of DH5 alpha was inoculated overnight in 2 mL of LB liquid 
media at 37°C using a shaking incubator at 220 rpm. After 12 hours, the culture was poured in 
a 1.5 ml tube and centrifuged for 5 minutes at 300 g. Plasmid DNA was purified using an 
Invitrogen mini-prep kit. The final DNA pellet was resuspended in 50 μL of TE buffer and 
the concentration of the plasmid was evaluated by nanodrop (ND-1000 spectrometer). 
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2.5.8 - Plasmid diagnostic digestion 
Plasmids were cut using restriction enzymes from NEB. The digestion conditions varied 
according to the restriction enzyme: (https://www.neb.com/tools-and-resources/usage-
guidelines/nebuffer-performance-chart-with-restriction-enzymes). Typically, 1 μg of DNA 
plasmid was digested. The reactions were set up as shown in Table 3. The buffer was chosen 
according to the performance chart. After reaction set-up, the mix was incubated at 37°C, for 
an hour, and products were resolved on a 1% agarose gel. 
 
Reagent Quantity 
10x NEBuffer 5μL 
Restriction enzyme 1μL 
Plasmid DNA 1μg 
ddH2O Up to 50 
 


















Chapter 3: Application of the Auxin-Inducible 
Degron (AID) system for the rapid depletion of Fal1 
in S. pombe 
 
3.1 - Introduction  
Numerous methods have been developed to control the expression of ectopic genes in S. 
pombe. The nmt1 (no message in thiamine) gene of S. pombe is typically highly expressed but 
it is subjected to transcription repression when the media is supplemented with thiamine 
(Vitamin B1) (Maundrell, 1990). The promoter of this gene, Pnmt1, can be exploited to 
substitute the regulatory elements of heterologous essential genes, and to evaluate the 
subsequent phenotype upon thiamine repression (Basi et al., 1993). 
 However, the strong activity of the Pnmt1 makes this tool unsuitable to repress genes which 
are already expressed at low levels because even in the presence of thiamine, the original 
Pnmt1 retains a low level of transcription activity (Watson et al., 2013). 
To overcome this issue, two weaker versions of the nmt1 promoter, the Pnmt41 and the 
Pnmt81, derived by nucleotide changes in the TATA box, have been developed, and represent 
the most common systems to “shut-off” an essential gene in S. pombe. However, these 
versions still require a considerable temporal window, from 6 to 21 hours (depending on the 
half-life of the protein), to cause a substantial reduction of the levels of the target protein 
(Basi et al., 1993, Maundrell, 1993). Since the cell cycle is completed within three hours for 
most of the strains that I used in this project, these promoters represent a clear drawback to 
answer advanced questions relative to gene expression (Watt et al., 2008). A truncated form 
of the Pnmt1 has been also characterized; the promoter is repressed in a shorter time, but it 
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requires a temperature shift rather than thiamine repression, thus causing relevant changes in 
the gene expression profile due to stress conditions (Kumar and Singh, 2006, Watt et al., 
2008). A faster alternative to regulate the expression of a target gene at transcriptional levels, 
is represented by the urg1 promoter: Watt and colleagues have shown that upon addition of 
uracil, the promoter is activated in less than 30 minutes, and a similar rapid inactivation is 
observed upon removal of uracil (Watt et al., 2008). However, several studies have argued 
about the utility of the urg1 system, due to a pivotal caveat: despite a substantial reduction in 
the levels of mRNA, the basal level of the protein regulated by the urg1 promoter is still too 
high to determine a null-like phenotype (Watson et al., 2013).  
Another strategy available in S. pombe is to sequester the protein of interest or delocalize it in 
another cellular compartment. For example, the target can be endogenously tagged with the 
hormone-binding domain (HBD) of the estrogen receptor (ER). The tag attracts the Hsp90 
complex, which binds the HBD, rendering the protein inactive: however, upon addition of 
estradiol to the media, the hormone binds the HBD domain, causing a change of 
conformation, with the release of the Hsp90 and subsequent activation of the protein of 
interest (Bøe et al., 2008). Despite the system appearing conceptually attractive, the key 
limitation of this tool is the cytoplasmic localisation of the Hsp90 complex, which might limit 
the application only to those proteins which function in the cytoplasm (Pai et al., 2012). 
Similar to the HBD system, another way to sequester a protein in another cellular 
compartment is represented by the Anchor-Away (AA) system originally developed in S. 
cerevisiae to deplete nuclear proteins (Haruki et al., 2008). The anchor away system is based 
on the use of rapamycin which allows the interaction between two protein domains: the FRB 
domain, of the TOR1 protein, and the FKBP12 domain, present in the FRP1 factor (Otsubo 
and Yamamato, 2008, Weisman, 2004). Therefore, the application of this method requires 
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that the protein of interest is endogenously tagged with the FRB domain, while the FKB12 
domain will be added to a highly expressed protein that rapidly translocates from the nucleus 
to the cytoplasm, such as a ribosomal protein. In the presence of rapamycin, the protein of 
interest will be quickly transported to the cytosol, permitting the analysis of the consequent 
phenotype. Since translocation of the target occurs rapidly, it has been observed that after 30-
60 minutes from addition of rapamycin, the nucleus appears depleted of the protein of 
interest. However, several limitations are associated with the AA system: firstly, since the 
protein sequestration occurs in the cytoplasm, it can be mainly applied to those proteins which 
have a nuclear function. Secondly, the sequestration of the target protein from the nucleus to 
the cytoplasm may cause the translocation of interacting partners, thus impeding the correct 
discrimination of the protein function. Lastly, it appears to be protein-specific, and not 
applicable to all the nuclear proteins (Haruki et al., 2008).  
The Auxin-Inducible Degron (AID) is another tool originating from plants, whose activation 
permits the rapid degradation of a protein of interest upon addition of the plant hormone auxin  
(Nishimura et al., 2009). The correct growth and development of a plant can require a spatio-
temporal regulation of many proteins, regulated as in other organisms, by the release and 
action of different hormones. In the case of auxin, whose name derives from the Greek word 
“auxien”, which means to grow, it specifically targets transcriptional repressors containing a 
typical IAA17 epitope. In brief, auxin binds the pocket of a perceptive F-box protein, the 
Transport Inhibitor Response 1 (TIR1), acting as a molecular glue for the insertion in the 
pocket of an AUX/IAA transcriptional repressor. TIR1 is part of an SCF-type E3 ubiquitin- 
protein ligase complex, which comprises Skp1, Cullin and RBX1. The last two factors, 
transfer the ubiquitin from an E1/E2 enzyme system to the Aux/IAA transcriptional repressor, 
thus causing its polyubiquitination and degradation by the proteasome (Gray et al., 2001, 
 70 
Kepinski and Leyser, 2005). In absence of auxin, the transcriptional repressor is not degraded, 
and its binding to the promoter of target genes prevents the activation of signaling pathways 
required for the growth and development of the plant (Chapman and Estelle, 2009). 
Application of the AID tool in non-plant organisms requires that the gene of interest is tagged 
with the IAA17 epitope, normally referred to as AID, and the transplantation of the TIR1 
element from plant to the desired organism, typically inserted in a silent area of the genome. 
The proteins forming the SCF complex (Skp1, Cul1, and Rbx1) are all highly conserved 
across eukaryotes, therefore they are not required to be transplanted for the engineering of the 
AID system (Figure 3.0) (Natsume et al., 2016). Normally, a successful application of the 
AID system allows the degradation of a target protein after 30 minutes by the addition of 






Figure 3.0 - Chemical structure of the Indole-3-acetic acid (IAA) and the mechanism of 
action of the Auxin-Inducible degron system (AID). (A) The Indole-3-acetic acid is the 
most basic and abundant auxin in plants, which is formed by an aromatic ring (indole) and a 
carboxylic acid group. (B) Schematic representation showing the mechanisms of action of the 
Auxin-Indicuble degron tool: auxin binds TIR1 (present in SCF-TIR1 complex), which 
induces the interaction of TIR1 with the IAA17(AID)-tagged protein. SCF-TIR1 recruits E2, 





Another system that allows the rapid degradation of the target protein is known as degradation 
tag (dTAG) (Nabet et al., 2018). This tool requires the fusion of the protein of interest with 
the FKBP12 protein, which contains a point mutation (F36V), causing a cavity in FKBP12. 
The “hole” is recognized by a bifunctional degrader (dTAG), which also contains a binding 
site for an E3 ligase. The formation of the ternary complex, formed by FKB12F36V, dTAG and 
E3, causes the rapid ubiquitination and degradation of the target protein (Nabet et al., 2018). 
Rapid degradation of the protein of interest can be also achieved using a Heat-Inducible 
Degron system. In S. cerevisiae, it was reported that a Dihydrofolate Reductase (DHFR), 
harboring a destabilizing arginine residue at the N-terminal, is normally expressed at 23°C, 
but it is ubiquitinated and degraded by the proteasome when the temperature is shifted to 
37°C. Thus, the arg-DHFR element can be fused with the target protein to trigger its rapid 
degradation after temperature shift (Dohmen et al., 1994). This system has been further 
modified: Iwamoto and colleagues reported that a DHFR mutant protein from E. coli 
(ecDHFR) can confer instability to a fused protein, which is rapidly degraded. However, 
ecDHFR can be stabilized by a small high-affinity ligand know as Trimethoprim (TMP). As a 
consequence of this mechanism, in absence of TMP, the protein levels of the target are hardly 
detectable (Iwamoto et al., 2010). 
 In this chapter we present the application of a system, which we termed “OFF-AID system”, 
for the rapid depletion of Fal1, the homolog of eIF4AIII in S. pombe, which exploits both the 
nmt81 promoter and the AID system, acting therefore at two levels of regulation: gene 
expression and protein turnover. The final goal is to rapidly deplete Fal1 from fission yeast 
and evaluate whether it has a direct function in transcription and pre-mRNA processing, by 
extracting and sequencing the nascent-RNA (Churchman and Weissman, 2011).  
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Some of the experiments presented in this Chapter were done under the supervision and in 
collaboration with Dr. Kayoko Tanaka, a Principal Investigator at the University of Leicester, 






















3.2 - Results 
3.2.1 - Fal1 is conserved in S. pombe 
Before embarking on the application of the AID system for the rapid depletion of Fal1, I first 
evaluated whether Fal1 is conserved in S. pombe. With this analysis, I aimed to investigate 
whether future prospectives coming from the study of Fal1 might be applied in higher 
eukaryotes. To this aim, the Fal1 protein sequence obtained from PomBase was aligned with 
the protein sequences of eIF4AIII across common model eukaryotes. The alignment was 
performed using Jalview,  software for multiple sequence alignment, editing, visualization 
and analysis (Clamp et al., 1998, Clamp et al., 2004).  
The result of this investigation confirmed that eIF4AIII is conserved across eukaryotes and 
that Fal1 shows high levels of similarity with eIF4AIII of Human (79%), D. melanogaster 
(78%), S. cerevisiae (65%), C. elegans (78%), Arabidopsis (72%) and Xenopus (76%) (Figure 
3.1). Additionally, the domains for the binding/hydrolysis of the ATP and the RNA binding 
appear particularly highly conserved among species, including S. pombe, except for two 
single amino acid substitutions; a phenylalanine which substitutes a threonine in the domain 
Ib, which is important to establish interactions with the sugar-phosphate backbone of the 
RNA, and a threonine which substitutes a lysine in the Motif Q, which regulates the 
hydrolysis of the ATP (Figure 3.2). Despite these two changes, this analysis reveals that Fal1 
might have the same, or at least comparable, ATP and RNA binding properties as in other 






     Figure 3.1 - Fal1 amino acid sequence shows high similarity with the eukaryotic 
counterparts. Fal1 shows a high percentage of identity with its counterparts in Human 
(78%), D. melanogaster (79%), C. cerevisiae (65%), C. elegans (78%), Arabidopsis (72%) 
and Xenopus (76%). Alignment and visualization are performed using Jalview. Identical 
residues are indicated in dark blue; gaps are indicated in white; residues with a positive 
score in the Blosum62 matrix are indicated in light blue. 
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Figure 3.2 - Fal1 protein motifs are highly conserved across eukaryotes. Motifs 
involved in the ATP binding/hydrolysis and interaction with the substrate are aligned using 
Jalview and conservation grade is evaluated using the amino acids substitution matrix 
Blosum62. 
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3.2.2 - Fal1 is required for normal cell growth in S. pombe 
The deletion of eIF4AIII, or reduction of its protein levels, correlates with inviability or 
severe growth defects in all the organisms in which its function has been investigated 
(Choudhury et al., 2016, Favaro et al., 2014, Haremaki et al., 2010, Kittler et al., 2004, 
Kressler et al., 1997, Marayati et al., 2016). 
In S. cerevisiae, tetrad analysis performed after replacing the fal1 ORF with a gene cassette 
conferring resistance for G418 has shown that deletion of fal1 is lethal for budding yeast 
(Kressler et al., 1997).  In D. melanogaster the depletion of eIF4AIII associates with an 
aberrant organization of the cytoskeleton, reduction of nuclei size and disaggregation of the 
follicular epithelium, a clear indication of cell death (Palacios et al., 2004). Choudhury and 
colleagues also reported growth defects in the salivary glands (Choudhury et al., 2016). 
The knock-down of eIF4AIII in the frog Xenopus laevis results in whole body paralysis and 
defects in the neural crest (Haremaki et al., 2010).  
In mice, eIF4AIII haploinsufficiency also causes neural crest defects, and in human, a 
noncoding expansion in the 5’-UTR of the gene leads to acrofacial dysostosis, defined as 
Richieri-Costa Pereira syndrome (RCPS) (Favaro et al., 2014, Miller et al., 2017). Notably, 
the depletion of eIF4AIII in zebrafish causes craniofacial alterations similar to RCPS (Favaro 
et al., 2014). Lastly, the depletion of eIF4AIII in HeLa cells, causes a mitotic arrest and 
alteration of the morphology of the spindle (Kittler et al., 2004). Overall these observations 
suggest that eIF4AIII plays a crucial role in growth and development across eukaryotes.  
Previous attempts to generate a fal1 deletion strain in fission yeast were not successful, 
suggesting that the gene could be essential for S. pombe (Wen and Brogna, 2010). Meanwhile, 
Marayati and colleagues reported that gene deletion results in a severe growth defect but 
nonetheless, the fal1 deletion is not lethal (Marayati et al., 2016). To clarify this situation 
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we performed gene knock-out of fal1 in diploid cells, followed by a tetrad dissection, which 
was done in collaboration with Dr. Kayoko Tanaka. The fal1 gene disruption in heterozygous 
diploids (potentially fal1+/fal1:ClonNAT) was verified by PCR (Figure 3.3A).  
Then, the heterozygous diploid strains were induced to sporulation and asci were dissected 
using a micromanipulator; the four spores derived by its dissection were aligned vertically on 
a YE+adenine (YEA) plate, and after a few days, replica plated on YEA supplemented with 
the selective antibiotic (clonNAT). We found that the spores derived from each ascus were 
able to generate colonies on the YEA plate, suggesting that the fal1 gene was not essential; 
additionally, on the selective plate, just two out of four colonies containing the antibiotic 
resistance survived, supporting the expected fal1+/fal1::ClonNAT phenotype of the parental 
diploid cells (Figure 3.3B). 
Importantly, we also noted that the colonies derived from the fal1 deleted spores, which were 
ClonNAT resistant, were substantially smaller; they emerged from the plates after several 
days of delay compared to the WT, suggesting that fal1 gene deletion greatly reduces cell 
viability (Figure 3.3B). 
To confirm whether the deletion of fal1 affects cell growth, the growth of the haploid fal1 
deletion mutant was compared to the WT strain by growth spot assay. The plates were 
incubated at 30°C and 32°C and survival was evaluated after 72 hours. Interestingly we found 
that the deletion of fal1 associated with a severe growth defect in S. pombe (Figure 3.3 C), 









Figure 3.3 - fal1 knock-out and tetrad dissection.  (A) Verification of the deletion of 
fal1 by PCR in diploid heterozygous yeast cells.  Deletion of fal1 is confirmed by genome 
PCR, using primers Fal-F1 and Fal-1-CHK-R, where the second anneals outside the region 
of recombination. An expected band of 2.3 kb is amplified in all the colonies analyzed. A 
second PCR is also performed using the primer pair pFA6a-FWD and Fal1-CHK-RV, 
where the first anneals in the ClonNAT cassette; an expected band of approximately 1.7 kb 
is amplified for 8 colonies, while no amplification is detected from the WT genomic DNA. 
A schematic representation of the gene deletion is reported in Appendix VIII. 
(B) Diploid heterozygous for fal1+; Δfal1::ClonNAT are analyzed by tetrad dissection. The 
products of each tetrad are aligned vertically (red box) on a YEA plate, and replica plated 
on YEA plates containing the ClonNAT antibiotic. The tetrad dissection analysis shows 
the fal1 deleted spores survive on the YEA+ClonNAT plate, suggesting that the gene is not 
essential.  (C) The growth of the haploid fal1 deletion mutant is compared to the WT 
strain, by spot growth assay on YES plates. Diluted spots contain approximately 105, 104, 
103, 102, 10 cells. Plates are incubated at 30°C and 32°C and the growth is evaluated after 
72 hours.   







3.2.3 - Fal1 is nuclear in S. pombe 
As previously explained, the main goal of this chapter is to generate a system which allows 
the depletion of Fal1 in a rapid and conditional manner. Therefore, it is pivotal to evaluate the 
levels of Fal1 at different times, by fluorescence and/or WB.  
Due to the lack of antibodies against Fal1 in S. pombe, we first generated a yeast strain in 
which Fal1 was endogenously tagged at the C-terminus with a double tag, the GFP-2xFLAG 
epitope, whose integration in the genomic locus was verified by PCR (Figure 3.4A).  
The expression of the endogenous tag was confirmed by WB using an anti-FLAG antibody 
(M2 Sigma): Fal1, GFP and x2 FLAG have a molecular weight of 44.71, 25 and 2.2 kDa 
respectively, therefore a band of approximately 72 kDa was expected and detected by 
immunoblotting (Figure 3.4B). Since fal1 gene knock-out affects cell viability, to assess that 
the protein was still functional after the addition of the tag, we performed a spot growth assay, 
comparing the viability of the Fal1-GFP-2xFLAG strain to the WT (non-tagged). Cells were 
spotted in serial dilution on a YES plate, which was incubated at 30°C for 72 hours. We found 
that the Fal1-GFP-2xFLAG strain had no growth defects, indicating that the tag did not affect 






















Figure 3.4 - Endogenous GFP-2xFLAG tag of Fal1 does not affect cell viability. (A) 
Verification of the GFP-2xFLAG tag of Fal1 by PCR: integration of the tag is confirmed by 
PCR using as template the genomic DNA extracted from eight selected colonies. Using the 
primer pair Fal1-F1 and Fal1-CHK-RV, where the second is designed outside the region of 
recombination, expected bands of approximately 5 kb and 2.3 kb for the tag and the WT 
strains respectively are amplified. A schematic representation of the gene tagging is reported 
in Appendix VIII. 
(B) Expression of the tag is confirmed by WB, using an anti-FLAG antibody (M2, Sigma); a 
band of 72 kDa is detected for four colonies.  
Note that the WB is qualitative and aimed to confirm the presence of the FLAG-tag in the 
positive colonies; therefore, the membrane was not probed with a loading control antibody.  
(C) The growth of the Fal1-GFP-2xFLAG is compared to the WT, by spot growth assay on 
a YES agar plate. Diluted spots contain approximately 105, 104, 103, 102, 10 cells. Plates are 









Having tagged Fal1 with GFP, we exploited this tag to determine its subcellular localisation 
in S. pombe. Previous studies reported that eIF4AIII was predominantly in the nucleus of a 
wide range of organisms from flies to mammals (Ferraiuolo et al., 2004, Palacios et al., 2004). 
In S. cerevisiae, Fal1 is associated but not restricted to the nucleolar region, the site of 
ribosome biogenesis (Kressler et al., 1997). Nucleolar localisation of eIF4AIII was also 
reported in Arabidopsis thaliana (Pendle et al., 2005).  
To evaluate the localisation of Fal1 in S. pombe, the Fal1-GFP-2xFLAG strain was grown 
until mid-log phase and the GFP signal was visualized by confocal microscopy. We found 
that in S. pombe, as in other eukaryotes, Fal1 is predominantly nuclear (Figure 3.5A). 
Additionally, a cell live imaging experiment showed that Fal1 persistently localised to the 
nuclear compartment during nuclear division, indicating that the main function of this protein 






      
 
Figure 3.5 - Fal1 is localised to the nucleus of S. pombe. (A) The Fal1-GFP-2xFLAG 
strain was visualized by confocal Microscopy (Nikon A1R); the signal derived by the GFP 
tag is predominantly nuclear.  (B) Cell live imaging of Fal1-GFP-2xFLAG: images were 
acquired every 60 seconds for 30 minutes using a 2D array scanning laser confocal 
microscopy (Infinity 3, VisiTech). The figures are representative of a time frame of 0-4 
minutes. Two nuclei in fission are indicated with green and magenta arrows. 




3.2.4 - Swapping the Fal1 promoter with the Pnmt81 
Before tagging Fal1 with AID, the physiological promoter of fal1 was substituted with the 
weakest version of the nmt promoters, Pnmt81, which is effectively repressed by thiamine 
(Basi et al., 1993, Maundrell, 1993, Tamm, 2012). Having previously tagged Fal1 with the 
GFP-2xFLAG epitope, we decided to change the promoter in this strain, so that the repression 
of Fal1 could be monitored both by fluorescence and immuno-blotting. The shut-off system 
was made through the “PCR sewing” method, using the N-terminal tag approach and the 
integration in the genomic locus was verified by PCR (Figure 3.6A).  
The functionality of the Pnmt81 promoter was tested via WB using an anti-flag antibody 
(Sigma, M2), detecting an expected band of 72 kDa for two positive colonies (Figure 3.6B). 
Moreover, we also verified that the expression of Fal1 under the Pnmt81 promoter did not 








Figure 3.6 - fal1 promoter swapping with the nmt81 promoter. (A) The physiological 
promoter of fal1 is substituted with the Pnmt81. A DNA fragment containing the hygromycin 
resistant cassette upstream the Pnmt81, and sequence of homology with the 5’-UTR and the 
N-terminal region of fal1, is transformed in the Fal1-GFP-2xFLAG strain and integrated into 
the genome via homologous recombination. The integration of the fragment is verified by 
PCR on the genomic DNA of the select colonies: using primer Fal1-F1, as forward, and Fal1-
CHK-rev as reverse, an expected band of approximately 8 kb is amplified in four colonies. 
The same primer pair amplifies a band of 2.3 from the WT genomic DNA. A schematic 
representation of the promoter swapping is reported in Appendix VIII. 
(B) Western blot analysis and localisation analysis of Fal1 under the nmt81 promoter: WB 
using anti-flag antibody (M2, Sigma) reveals that the Pnmt81 is functional, able to express the 
Fal1-GFP-2xFLAG protein in two positive colonies. The expression of Fal1 under Pnmt81 
does not affect the protein nuclear localisation. 
Note that the WB is qualitative and aimed to confirm the presence of the FLAG-tag in the 













3.2.5 - Pnmt81 “shut-off” causes a depletion of Fal1 within 12 hours 
To evaluate the temporal window required to deplete Fal1 upon repression of the nmt81 
promoter, we performed a time course WB experiment; the Pnmt81:Fal1-GFP-2xFLAG strain 
was grown in EMM liquid media, supplemented with thiamine and aliquots of the cell culture 
were collected at 0, 6, and 12 hours. The protein levels of Fal1 were evaluated by probing 
with an anti-Flag antibody. We found that the protein levels of Fal1 were strongly reduced 
after 12 hours of thiamine treatment suggesting that the Pnmt81 promoter was responsive to 
thiamine repression (Figure 3.7A). We also monitored and compared the GFP signal of the 
Pnmt81:Fal1-GFP-2xFLAG strain to the signal of the parental strain (in which Fal1-GFP-
2xFLAG is expressed by the physiological promoter) during the temporal window 0-12 hours. 
The two strains were grown in EMM with thiamine and a small aliquot of the cell culture was 
used to visualize the GFP fluorescence every three hours. Coherently with the WB analysis, 
we found that the GFP signal was almost undetectable after 12 hours of thiamine repression; 
as expected no effect was observed for GFP levels of the parental strain. Our result indicated 
that the shut-off system specifically depleted cells of Fal1 in response to thiamine addition 












Figure 3.7 - Evaluation of the Fal1 protein levels upon thiamine repression. (A) WB 
analysis of the Pnmt81:Fal1-GFP-2xFLAG, grown in EMM liquid media supplemented with 
thiamine. Cells are collected at 0, 6, 12 hours; the protein levels of Fal1 are evaluated probing 
the membrane with anti-flag antibody. The antibody against a-tubulin is used as a loading 
control. (B) The GFP-signal relative to the Pnmt81:Fal1-GFP-2xFlag strain is compared to 
the signal of the parental strain (no repressible promoter). The two strains are grown in EMM 
liquid media supplemented with thiamine, and images of the GFP fluorescence are taken 
every three hours. The images are acquired using a 2D array scanning laser confocal 
microscope (Infinity 3, VisiTech).  























Since the deletion of Fal1 strongly affected cell viability, we predicted that the repression of 
the Pnmt81 promoter should cause a reduction of cell viability. Therefore, to validate the 
efficiency of the repressible system, we first performed a spot growth assay comparing the 
growth of the conditional mutant, Pnmt81:Fal1-GFP-2xFLAG, to that of the parental strain, 
Fal1-GFP-2xFLAG strain, which was previously shown to grow as WT (Figure 3.8A).  Not 
surprisingly, we found that the addition of thiamine impaired cell growth for the shut-off 
strain, but did not affect the viability of the parental (Figure. 3.8A).  
To evaluate the minimal temporal window required to induce growth defects, we performed a 
growth assay of the shut-off strain, in EMM liquid media. Cells were set at approximately 
OD600=0.03/0.04 in liquid media, with or without thiamine, and the cell densities were 
counted every two hours using a hemocytometer. After eight hours, the cell cultures were 
diluted to fresh media to avoid saturation of the cell culture. It was observed that up to about 8 
hours the two cultures behaved similarly (Figure 3.8B). 
Notably, we found that after 12 hours from the beginning of the time course, cells cultured in 
presence of thiamine started to exhibit growth defects (Figure 3.8B). The time of appearance 
of the growth phenotype, at about 12 hours after addition of thiamine, coincided with almost 
complete disappearance of Fal1 protein, judged by WB and fluorescence microscopy (Figure 








Figure 3.8 - Evaluation of the cell phenotype upon transcriptional repression of fal1.  
(A) Spot growth assay comparing the growth of the strain in which fal1 is under the 
control of the nmt81 promoter, to Fal1-GFP-2xFLAG, which we previously showed to 
grow as WT. Diluted spots contain approximately 105, 104, 103, 102, 10 cells. The addition 
of thiamine to the EMM agar plate affects cell growth of the shut-off strain while no effect 
is observed for the parental.  
(B) Growth assay in EMM liquid media of the Pnmt81:Fal1-GFP-2xFLAG strain, cultured 
with and without thiamine; cells are synchronized at approximately OD=0.03/0.04 and 
counted every two hours using a hemocytometer. After 8 hours, the cell cultures are 
diluted (dilution point; the number of cells counted after the dilution point were multiplied 
by the dilution factor, to keep continuity in the graph). Cell growth is monitored for 14 
hours; growth defects emerge after 12 hours from the beginning of the time course. Error 




3.2.6 - Engineering of the AID system for the rapid depletion of Fal1 
The “shut-off” method described in paragraph 3.2.5, represents a powerful system to 
conditionally regulate the protein levels of Fal1; however, it took 12 hours to deplete the 
target protein and to observe a cellular phenotype. Considering that in fission yeast the cell 
cycle is completed within 2-3 hours, a considerable disadvantage of this tool is represented by 
the inability to discriminate primary effects from the secondary ones, which could emerge as 
a consequence of cell adaptation. 
To overcome this issue, we have applied the AID system to rapidly reduce Fal1 protein levels; 
the AID system was engineered on top of the “shut-off strain, thus allowing the promoter 
repression and the protein degradation by addition of thiamine and auxin respectively.  
The plasmid containing the AID epitope (pAW8ENdeI-cHAIAA7-spo5DSR) was a gift from 
Professor Tony Carr, from the University of Sussex, and the map is reported in Appendix IV. 
Watson and colleagues reported that the AID system poorly functioned in S. pombe, due to 
the inability to completely deplete the target protein (Watson et al., 2013). To improve the 
system, they introduced a DSR element (Determinant of Selective Removal), a sequence 
naturally occurring in the 3’-UTR of the meiotic mRNAs of S. pombe. The DSR allows the 
selective elimination of meiotic mRNAs during the mitotic growth (Harigaya et al., 2006). 
During the vegetative growth, the mRNAs harboring the DSR are recognized and bound by 
the Meiotic mRNA Interception 1 protein (Mmi1), which interacts with components of the 
nuclear exosome causing the degradation of the transcripts (Watson et al., 2013, Yamashita et 
al., 2012). However, during meiosis, Mmi1 interacts with meiRNA, a lncRNA that retains 
Mmi1 on the sme2 locus, thus permitting the translation of the meiotic mRNAs (Ding et al., 
2013) (Figure 3.9A).  
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Based on previous observations from Watson and colleagues, we decided to introduce the 
DSR in our AID system, to cause a reduction in the Fal1 mRNA levels.  
Therefore, we substituted the 3-UTR of Fal1, with the 3-UTR of the meiotic gene spo5 
(SPBC29A10.02). A schematic representation of the engineering of the AID system is 
reported in Figure 3.9B. 
The integration in the genomic locus was verified by PCR (Figure 3.9C). The amplified 
fragment was sent for sequencing to verify that no point mutations occurred in the junction 
between the GFP and the AID epitopes; 100% of homology with the expected sequence was 
obtained for a region of almost 700 bp starting from the GFP-seq2 primer, which annealed in 
the GFP sequence epitope (Appendix VI). Then, the AID tagged strain was crossed with a 
TIR1 expressing strain, bought from the National BioResource Project-Yeast (details in 
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Figure 3.9 - Engineering of the AID system for the rapid depletion of Fal1. (A) Role of 
the DSR element in the selective elimination of the meiotic transcripts. During mitotic 
growth, the meiotic transcripts containing a DSR element, are recognized by Mmi1 and 
degraded by the nuclear exosome. During meiosis, Mmi1 is sequestered at the sme2 locus, by 
interaction with a lncRNA. (B) Schematic representation of the method used to tag Fal1 with 
the AID epitope: a DNA fragment containing the GFP tag, the AID epitope (IAA17), the DSR 
element, the marker conferring resistance for the antibiotic Nourseothricin sulfate 
(ClonNAT), and a sequence of homology with the 3’-UTR of Fal1 is generated using 
overlapping PCRs, transformed in the nmt81:Fal1 strain and integrated in the genomic locus 
via homologous recombination. A detailed schematic representation of the gene tagging with 
the AID, is reported in Appendix VIII. (C) Integration in the genomic locus is verified by 
PCR on the genomic DNA of four selected colonies: using primer Fal1-GFP-F1 as forward, 
which anneals in the Fal1 gene, and Fal1-CHK-RV as reverse, which is designed outside the 











3.2.7 - Characterisation of the AID system 
To evaluate the protein levels of Fal1 upon addition of thiamine and auxin, we first monitored 
the GFP signal of the Pnmt81:Fal1-AID:DSR (strain in which fal1 was under the control of 
the Pnmt81 promoter and contains the AID epitope and the DSR element for transcription 
down-regulation) comparing to the Fal1 parental strain. The two strains were inoculated in 
EMM with thiamine and 1-Naphthaleneacetic acid (NAA), a synthetic analog of auxin, and 
images of the GFP fluorescence were taken at time 0-90 minutes using confocal microscopy. 
We found that the GFP nuclear signal of the Pnmt81: Fal1-AID strain reduced after 90 
minutes from thiamine and auxin treatment, while as expected, the parental strain showed no 
effect (Figure.3.10A). 
 This result suggested that the AID system was working upon addition of thiamine and auxin; 
however, we also noted that the intensity of the GFP signal for the Pnmt81:Fal1-AID strain 
was substantially reduced even before the addition of thiamine and NAA, compared to the 
parental (Figure.3.10A). 
 This effect was probably due to: 
-  destabilization of the protein caused by the AID tag, as reported by Eaton and 
colleagues (Eaton et al., 2018); 
- a protein degradation caused by a basal level of interaction between Fal1-AID and the 
TIR1 (Mendoza‐Ochoa et al., 2019, Morawska and Ulrich, 2013, Natsume et al., 
2016);   
-  or a reduction in the mRNA levels due to the DSR element (Watson et al., 2013). 
To confirm the situation by WB analysis, the Pnmt8:Fal1-AID:DSR strain was grown in 
EMM liquid media, supplemented with thiamine and NAA; cells were collected at times  
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 0, 30, 60, 90 and 120 minutes. The protein levels of Fal1 were evaluated by WB, probing 
with an anti-GFP antibody (AHP975, Bio-rad). The presence of the AID tag increased the 
molecular weight of the Fal1-AID strain so that a band just below 100 kDa was expected 
(Figure 3.10B).  
This experiment confirmed that the intensity of the band of interest was much weaker when 
compared to the parental strain at time zero (Figure 3.10B). Actually, almost double of the 
protein extract typically loaded (30 µL) had to be used to detect the Fal1-GFP-AID protein. 
 We also found that the level of Fal1-AID-GFP was almost undetectable after 60 minutes 





Figure 3.10 - Evaluation of the protein levels of Fal1 upon addition of thiamine and 
auxin. (A) The GFP signal of two degron clones is compared to the signal of the Fal1 
parental strain, upon thiamine and NAA (a synthetic analog of auxin) treatment. Images of the 
GFP fluorescence are taken at time 0-90 minutes using a 2D array scanning laser confocal 
microscope (Infinity 3, VisiTech). Example of nuclear GFP signals are indicated by arrow. 
Compared to the Fal1-GFP-2xFLAG strain, Pnmt81:Fal1-GFP-AID cells produce much 
weaker GFP signals. 
(B)Time-course experiments to detect the protein levels of the degron strain by WB; cells are 
collected at 0, 30, 60, 90, 120 minutes upon addition of thiamine and NAA.  Protein extracts 
from WT and Fal1-GFP-2xFLAG strains are used as negative and positive control 
respectively. The membrane is incubated with anti-GFP antibody. Antibody against a-tubulin 
is used as a loading control. 




















To test the efficiency of the AID system from a phenotypical point of view, and to verify 
whether the reduced protein levels observed in Figure 3.10A and Figure 3.10B affected cell 
viability, we performed an extensive analysis of the cell growth phenotype under different 
conditions.  
Firstly, we performed spot growth assay comparing the TIR1 strain used to generate the 
degron system, to the Fal1-GFP-2xFLAG strain, which we had previously shown to grow as 
WT. We could confirm that the presence of the plant element TIR1 in the yeast background 
did not affect cell viability (Figure 3.11A).  
Then, we compared the growth of the degron strain (Pnmt81:Fal1-GFP-AID, which also 
contains the DSR element) which lacked TIR1, with the parental strain Fal1-GFP-2xFLAG. 
Interestingly, we found that the two strains grew identically, indicating that the AID epitope 
and the DSR element did not affect cell viability (Figure 3.11B).  
Lastly, we compared the growth of the degron strain containing TIR1 (Pnmt81:Fal1-GFP-
AID: DSR + TIR1), to the Fal1-GFP-2xFLAg strain. Cells were spotted on EMM, EMM 
supplemented with thiamine, EMM supplemented with NAA, and EMM supplement with 
thiamine and NAA; surprisingly we found that the presence of TIR1 and the AID-tagged 
protein in the same background strongly affected cell viability even in absence of thiamine 
and NAA. Additionally, the presence of thiamine and NAA to the media only slightly affected 
the cell growth, which was already compromised on EMM only (Figure 3.11C). Overall, the 
results presented in this paragraph indicate that despite the quick decrease in the protein levels 
of Fal1 observed upon treatment with NAA and thiamine, our application of the “OFF-AID 






Figure 3.11 - Characterization of the growth phenotype of the AID system.  (A) 
Evaluation of the growth of the TIR strain on EMM agar plate; the growth of the TIR1 and 
the Fal1-GFP-2xFlag (which grows as WT), is compared by spot growth assay. Diluted spots 
contain approximately 105, 104, 103, 102, 10 cells. 
(B) Evaluation of the growth of the Fal1 degron strain prior conjugation with the TIR1 
element:  Diluted spots contain approximately 105, 104, 103, 102, 10 cells. 
(C) Evaluation of the growth of the Fal1 degron containing the TIR1 element: cells are 
spotted on EMM, EMM supplemented with thiamine, EMM supplemented with auxin, and 
EMM supplemented with both the drugs. Diluted spots contain approximately 105, 104, 103, 





















3.2.8 – Generation of a tool to be used to assess the role of Fal1 on the RNA 
Pol II elongating complex. 
The spot growth assay from Figure 3.11 reveals that growth defects occurred only when TIR1 
was introduced in the Pnmt81:Fal1-AID:DSR tagged strain (Figure 3.11C), indicating that the 
DSR element per se was not responsible for the phenotype (Figure 3.11B). 
Therefore, we predicted that we still could use the Pnmt81-Fal1-AID strain, not containing 
TIR1, where the DSR element would reduce the time required for the depletion of Fal1.  
Since the original aim of this project was to isolate and sequence the nascent-RNA upon rapid 
depletion of Fal1, we decided to use the Pnmt81:Fal1-AID:DSR strain, not containing TIR1, 
for this purpose. The purification of the nascent RNA requires an immunoprecipitation (IP) of 
RNA Pol II elongating complex, consisting of DNA, RNA Pol II, and the nascent RNA still 
attached to it (Churchman and Weissman, 2011). To accomplish this goal, with technical 
expertise of Dr. Kayoko Tanaka, the Pnmt81:Fal1-AID:DSR strain, not containing TIR1, was 
crossed with the strain in which the third subunit of RNA Pol II, Rpb3, is tagged at the N-
terminal with a single FLAG-tag, that could be used to purify the elongating complex (Figure 
3.12A). After crossing, the resultant strains of at least 10 tetrads were analyzed by colony 
PCR, to check the presence of the FLAG-Rpb3. By using primer pair Rpb3-FW (annealing to 
the 5’-UTR of Rpb3) and Rpb3-RV (annealing to the Rpb3 coding sequence), the presence of 
the FLAG epitope, could be detected and we successfully isolated several clones harbouring 
both Pnmt81-Fa1-GFP-AID:DSR and FLAG-Rpb3 (Figure 3.12B). To check the time frame 
required to deplete Fal1, we collected cells at 0, 3, 6, 9 and 12 hours after addition of thiamine 
and we performed WB using anti-GFP antibody. Interestingly we found that the level of Fal1-
AID was lower compared to the parental strain expressing Fal1-GFP-2xFLAG only (Figure 
3.12C). This was probably due to the presence of the DSR element (Watson et al., 2013). 
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However, the level was much higher compared to Fal1-AID containing TIR1 (Figure 3.12C 
and Figure 3.10B), confirming again that the main issue relative to the AID system derived 
from TIR1.  
Moreover, we noted that in only 3 hours of thiamine repression, the levels of Fal1 drastically 
reduced and in 6 hours, the signal was almost undetectable, in agreement with our initial 
prediction (Figure 3.12C).  
To check whether a growth phenotype was associated with the depletion of Fal1, a spot 
growth assay was performed on EMM plates in presence and absence of thiamine, comparing 
the growth of the Fal1-AID;FLAG-Rpb3 strain, with the FLAG-Rpb3 and the Fal1-GFP-
2xFLAG (WT) strains; interestingly we found that the Fal1-AID after crossing with the 
FLAG-Rpb3, was growing slightly less than the WT on EMM, but a severe growth defect was 
observed in presence of thiamine, indicating that the tool could be exploited  for further 












Figure 3.12 - Creation of a tool for isolation of nascent RNA upon depletion of Fal1. 
(A) Schematic representation of the nascent RNA purification: RNA Pol II elongating 
complex is purified via immunoprecipitation (IP), by exploiting an antibody which binds a 
tagged subunit of RNA Pol II. (B) Generation of Pnmt81-Fal1-GFP-AID:DSR strain 
harbouring FLAG-Rpb3 but lacking TIR. The successful introduction of the FLAG-Rbp3 
tag results in an increase in the size of the PCR products. In this instance, colony 2 and 4 
are positive for the FLAG-Rbp3 tagging (indicated by a Magenta asterisk) 
(C) The temporal window to deplete Fal1 in the newly generated strain is assessed by WB: 
cells are collected at time 0, 3, 6, 9, 12 hours and Fal1 is detected using anti-GFP antibody. 
Protein extracts from WT and Fal1-GFP-2xFLAG are used as negative and positive control 
respectively. The membrane is also probed with anti-a-tubulin, as a loading control. 
(D) Spot growth assay comparing the Fal1-AID:Flag-Rpb3 (not containing TIR1) strain to 




3.3 - Discussion  
In the first part of this chapter, we have shown a characterization of Fal1 in terms of sequence 
conservation between divergent organisms, cellular phenotype derived by its deletion, and 
localisation. Our data indicate that Fal1 shares a high percentage of identity with its 
orthologues. Moreover, the domains for the binding/hydrolysis of the ATP and the RNA 
binding appear highly conserved in Fal1, thus suggesting an evolutionarily conserved 
function, which is kept in fission yeast (Figure 3.2). 
Using a gene knock-out approach and subsequent tetrad dissection we have shown that the 
fal1 gene is not essential but it is required for the normal cell growth of S. pombe; severe 
growth defects emerge upon fal1 deletion, implying its role in an essential biological function 
(Figure 3.3B and Figure 3.3C).  
Another important feature which appears conserved is that Fal1/eIF4AIII is found 
predominantly in the nucleus as divergent organisms such as flies, mammalian cells, plants 
and yeast (Ferraiuolo et al., 2004, Koroleva et al., 2009, Kressler et al., 1997, Marayati et al., 
2016, Palacios et al., 2004, Choudhury et al., 2016). By tagging endogenous Fal1 with the 
GFP epitope, we observed that also in S. pombe, Fal1 is distributed in the nucleus, where it 
remains constantly associated during nuclear division, suggesting that the function of Fal1 is 
mainly nuclear (Figure 3.5A and Figure 3.5B).  
The fact that fal1 deletion affects cell viability makes the knock-out strain inappropriate for 
any experiment relative to gene expression, since it does not allow to discriminate direct and 
indirect effects that can arise as a consequence of a cell adaptation. To overcome this issue, 
we have generated an OFF-AID system, in which Fal1 is regulated by transcriptional 
repression (OFF), and protein turn-over (AID). Additionally, the 3’-UTR of the gene has been 
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replaced by an mRNA destabilizing element (DSR), which has been shown to improve the 
efficiency of the AID system in S. pombe (Watson et al., 2013).  
The shut-off system (OFF) which we first created, substituting the physiological promoter 
with a repressible one, the Pnmt81, appears to function both at phenotypical and protein 
levels: upon thiamine repression, the Fal1 protein levels decrease within 12 hours from the 
beginning of the treatment (Figure 3.7A; Figure 3.7B). Accompanying, growth defects also 
emerge around 12 hours (Figure 3.8B). At a glance, therefore, this shut-off tool represents a 
huge step forward to study the function of Fal1. However, cell adaptations could potentially 
still occur during the 12 hours time frame required for Fal1 depletion.  Therefore, to 
overcome this issue, the shut-off strain has been further improved by the addition of the AID 
and the DSR elements. By adding these two components to the previous tool, the depletion of 
Fal1 is accomplished within almost 60 minutes from thiamine and auxin treatment (Figure 
3.10B). However, we observed a substantial reduction of the protein compared to the parental 
strain, which is independent of auxin incubation (Figure 3.10A; Figure 3.10B; Figure 3.11C). 
The reduced levels of Fal1-AID affect cell viability, which is compromised before the 
addition of auxin and thiamine (Figure 3.11C).  
To understand the reason behind this phenotype we have analyzed the cellular phenotypes of 
the strains used to generate the degron system; particularly, the strain containing the AID-
DSR element, but not TIR1, can grow on EMM as the parental, without showing obvious 
growth defect (Figure 3.11B). Moreover, the strain containing only the TIR1 element does not 
exhibit phenotypical defects when compared to the WT (Figure 3.11A). This suggests that 
growth defects arise when TIR1 and the AID-tagged protein coexist in the same background. 
One possibility to explain this phenomenon, is that Fal1 is degraded before the addition of 
auxin, because of an intrinsic basal affinity between TIR1 and AID, characterized by the 
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entrance of the IAA17 epitope in the pocket of TIR1 even in absence of the auxin. This 
explanation appears consistent with numerous recent observations (Mendoza‐Ochoa et al., 
2019, Natsume et al., 2016, Watson et al., 2013, Yesbolatova et al., 2019).  
Overall our work has revealed that a key limitation for the application of the degron system in 
fission yeast is represented by the constitutive expression of the TIR1 element. 
To overcome this problem, Yesbolatova and colleagues have recently developed a TIR1 
antagonist known as auxinole, which binds TIR1 preventing its association with the AID-
fused protein; then when the degradation of the protein of interest is required, the auxinole is 
washed off and cells are resuspended into a fresh media containing auxin (Yesbolatova et al., 
2019). The auxinole, which is commercially available, will be tested in the future to verify 
whether it will be able to abolish the TIR1 leakage effect, which prevents us to use the degron 
tool for further experiments.  
Another approach to test in the future is to change the TIR1 promoter with the urg1 promoter, 
which has been shown to be activated in almost 30 minutes upon addition of uracil; the 
system in this case will be characterized by a “block and release” of TIR1 expression and 
subsequent degradation of Fal1 by addition of auxin (Watt et al., 2008).  
Since we had observed that the growth defects occurred only when the TIR1 element was 
introduced in the AID tagged strain (Figure 3.11C), we decided to cross the Pnmt81:Fal1-
AID-DSR strain, not containing TIR1, with a strain in which the third subunit of the RNA Pol 
II was FLAG-tagged at the N-terminal, to generate a tool for isolation of nascent-mRNA upon 
depletion of Fal1 (Churchman and Weissman, 2011). In fact, we predicted that the presence 
of the DSR, would have reduced the mRNA levels of Fal1, thus causing a faster depletion of 
Fal1, but without affecting cell viability. As we predicted, the protein levels of Fal1 
drastically reduced in almost three hours upon addition of thiamine and the signal is almost 
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undetectable in six hours. The protein levels of Fal1 at time zero appear lower compared to 
the parental strain, probably due to the presence of the DSR (Figure 3.12C). Interestingly we 
found that the newly generated strain harbouring both Fal1-GFP-AID:DSR and FLAG-Rbp3, 
is sensitive to thiamine, but it shows a minimal variation in cell growth, when compared to the 
WT (Figure 3.12D). 
To give an explanation to this phenomenon, we have hypothesized that the presence of a 
double tag for Fal1 and Rbp3, could negatively affect a putative interaction between the two 
factors, which was previously speculated for other organisms,  thus causing a minimal 
reduction in cell viability (Akhtar et al., 2019, Singh et al., 2019, Wang et al., 2014). 
This new tool appears extremely promising since it allows to obtain fast depletion of Fal1 in 
the background of a tagged Pol II subunit. The double tag can be exploited for a co-
immunoprecipitation (co-IP) experiment, to evaluate whether the two proteins interact and 
whether the interaction is RNA sensitive, as observed in D. melanogaster (Singh et al., 2019).  
In case of interaction, since previous studies suggested a role for eIF4AIII in the regulation of 
Pol II elongation and pausing, we will examine the changes in Pol II loading through ChIP-
seq analysis, before and after rapid degradation of Fal1 (Akhtar et al., 2019, Wang et al., 
2014). The change in Pol II density after fast depletion of Fal1, will be further investigated 
using a high-resolution approach, which permits to isolate the nascent RNA via isolation of 
the ternary complex formed by DNA-RNA-Pol II, and to capture the Pol II position at single- 
nucleotide resolution (Churchman and Weissman, 2011). Because we will assess nascent-
RNA upon rapid depletion of eIF4AIII, we should be able to discriminate whether the effect 
on Pol II elongation is direct or indirect. Several studies also report a role of eIF4AIII in the 
regulation of splicing (Akhtar et al., 2019, Ashton-Beaucage and Therrien, 2011, Ashton-
Beaucage et al., 2010, Marayati et al., 2016, Wang et al., 2014). However, we suspect that this 
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effect can be indirect, mainly due to the sick phenotype of the cells observed upon eIF4AIII 
depletion. To clarify this situation, we will purify the newly transcribed RNA with the 4-
thiouridine labeling to examine the role of Fal1 on mRNA processing at high-resolution 




















Chapter 4: Fal1 associates with transcriptionally 
active gene loci regardless of the presence of an 
intron 
 
4.1 - Introduction  
For several years it has been reported that splicing alters the composition of the mRNPs, 
primarily, as discussed in Chapter 1, by deposition of the EJC, typically at 20-24 nucleotides 
upstream of each exon-exon junction, in a sequence-independent fashion (Le Hir et al., 
2001b).  
However a new observation suggests that the EJC factors might associate co-transcriptionally 
also on mRNAs derived from intron-less genes (Akhtar et al., 2019, Choudhury et al., 2016, 
Viphakone et al., 2019)   
The model of deposition of the EJC has been called into question for the first time by 
Choudhury and colleagues, who found that eIF4AIII, MAGO and Y14 are associated on the 
polytene chromosomes of D. melanogaster, both on intron-containing as well as intron-less 
genes. Furthermore, the association was dependent on nascent transcripts, since the signals 
were RNase sensitive (Choudhury et al., 2016). This breakthrough has been recently 
confirmed in mammalian cells and D. melanogaster, by the use of high-throughput 
approaches (Akhtar et al., 2019, Viphakone et al., 2019).  
To date, in light of these new pieces of evidence, the mechanisms underlying  EJC deposition 
appear still controversial since in stark contrast to the traditional model that the EJC is 
deposited only on spliced mRNA (Le Hir et al., 2000, Le Hir et al., 2016). 
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This chapter aims to clarify this by using ChIP, whether the deposition of the core EJC occurs 
regardless the presence of an intron in S. pombe, which appears a suitable model organism 
considering that more than 40% of the genes contain introns.  
 
4.2 - Results  
4.2.1 - Standardization of ChIP in S. pombe 
Chromatin immunoprecipitation (ChIP) is a powerful molecular biology technique used to 
evaluate whether a protein interacts with DNA, either directly or through association with the 
nascent RNA (Abruzzi et al., 2004, Carey et al., 2009). 
To use the ChIP assay in fission yeast, I have optimized all aspects of the technique, starting 
from the sonication. The quality and reproducibility of the ChIP assay depends on the size of 
the sonicated DNA (Carey et al., 2009, Pillai and Chellappan, 2009). I have optimised the 
sonication procedure to generate DNA fragments which mainly accumulate between 800 to 
200 bp (Figure 4.0A and Materials and Methods). 
The IP step was initially optimized using a strain in which the third subunit of the RNA Pol II, 
Rpb3, was tagged at the N-terminal with a single FLAG-tag, confirmed by PCR on genomic 
DNA (Appendix VI). The occupancy of Rpb3 was evaluated by qPCR, on two specific target 
genes; the intron-less gene fba1 (1077 nt) encodes for fructose-bisphosphate aldolase, a 
highly transcribed gene that generates an average of 520 molecules of RNA per cell during 
the vegetative growth (Marguerat et al., 2012). The intron-containing gene, gpd3, encodes for 
glyceraldehyde-3-phosphate dehydrogenase, which generates an average of 110 molecules of 
RNA per cell during the vegetative growth phase (Marguerat et al., 2012). For these genes, 
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several primer pairs were designed to evaluate the level of enrichment and the pattern of Rpb3 
along the coding sequence (Figure 4.0B). The occupancy of Rpb3 along the CDS of these 
genes was normalized to the input and expressed as fold enrichment relative to a negative 
locus (intergenic), as described in Material and Methods (2.2.9.7) 
I found that on fba1, Rpb3 showed an enrichment of almost 20-fold relative to the intergenic; 
the pattern of Rpb3 along the CDS of fba1, appeared to be even along the gene (Figure 4.0B) 
and similar to that reported by Larochelle and colleagues, suggesting that the ChIP assay was 
functioning appropriately (Larochelle et al., 2018).  
On gpd3, Rpb3 showed enrichment of almost 15-fold relative to the intergenic, in the middle 
of the CDS, therefore slightly lower when compared to the enrichment observed on fba1, 
which might reflect the difference in terms of gene expression between the two genes. 
Interestingly, on the first part of gpd3, the enrichment of Rpb3 was particularly modest, 
varying from 1.02 to 1.43-fold; from the melting curve analysis, no apparent issues were 
revealed, therefore we hypothesized that the poor signal could be due to the conformation of 
the chromatin in that particular region which might reduce the accessibility of the FLAG-
antibody (Figure 4.0B). 
To further evaluate the robustness of our ChIP protocol, we also performed the ChIP assay 
using an anti-phospho-Ser2 antibody (ab5095), which binds the phosphorylated form of the 
Ser2 of the CTD. As described in Chapter 1, the phosphorylation level of Ser2 is low at the 
beginning of the CDS and it increases constantly throughout the gene body (Buratowski, 
2003, Buratowski, 2009). 
I found that for fba1, the phospho-Ser2 signal was modest at the beginning of the gene (20- 
fold enrichment relative to the intergenic) and firmly increased in the downstream regions 
(90, and 120-fold enrichment relative to the intergenic) (Figure 4.0C). Notably, the pattern of 
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phospho-Ser2 on fba1 was in line with the profile reported by Larochelle and colleagues for 
the same gene in S. pombe (Larochelle et al., 2018).  
Additionally, I also tested the phospho-Ser2 signal on a gene expressed at low levels during 
the vegetative growth, arg11 (2658 nt), which encodes for the N-acetyl-gamma-glutamyl-
phosphate reductase. I confirmed not only the expected pattern of phospho-Ser2 along the 
coding sequence, but I also noted a correlation between the occupancy of the RNA Pol II and 
the level of expression; differently from fba1, whose level of expression is 520 molecules of 
RNA per cell during the the vegetative growth, the RNA levels for arg11 is only 8.5, and the 
subsequent phospho-Ser2 signal varied from 2-fold, at the beginning of the gene, to 5-fold at 
the end of the CDS. Lastly, on gpd3, the phospho-Ser2 signal was varying from 2.44 to 30- 
fold enrichment relative to the intergenic region (Figure 4.0C). Due to the presence of a small 
enrichment detected in the first region of gpd3, I decided to exclude it from further analysis. 
Overall, considering the expected patterns of Rpb3 and phospho-Ser2, I concluded that the 
ChIP protocol was working in my hands and could be used to further examine whether Fal1 












Figure 4.0 - Standardization of ChIP assay in S. pombe. (A) The fragmentation of the 
chromatin is performed using the Diagenode Bioruptor sonicator as described in more details 
in the Material and Methods; 15 cycles of sonication, of 20 seconds each, allow to generate a 
pattern of digested fragments accumulated between 200 and 800 bp.  
(B) ChIP-qPCR of the Rpb3 subunit of the RNA Pol II, FLAG-tagged at the N-terminal. The 
occupancy of the Rpb3 subunit is evaluated on two highly expressed genes, fba1 (1077 nt) 
and gpd3 (1008 nt); the numbers  reported on the top of the genes correspond to the position 
of each primer pair, and the red segment in the gpd3 gene represents an intron located in the 
5’-UTR. The signal derived by the qPCR-ChIP analysis is normalized to the input and 
expressed as fold change relative to a negative locus (intergenic) of S. pombe. The error bars 
represent mean ± SEM (n=2). (C) ChIP-qPCR using the anti-phopsho Ser2 antibody (ab5095) 
against the phosphorylated form of the Ser2 of the Rpb1 subunit; occupancy is evaluated on a 
low expressed gene (arg11) and two highly expressed ones (fba1 and gpd3), and expressed as 
fold change relative to a negative locus. Figure in C derives from a single experiment. 
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4.2.2 - Fal1 associates at transcriptionally active sites regardless of the 
presence of an intron 
 
To assess the association of Fal1 at transcriptionally active sites, I performed the ChIP assay 
with a strain in which Fal1 was tagged at the C-terminal with a GFP-2xFLAG epitope, which 
as discussed earlier, does not affect the functionality of the protein (Chapter 3, Figure 3.4C). 
The IP step was performed using an anti-FLAG antibody (Sigma, M2), which is highly 
specific for the FLAG-tag strain as demonstrated by immunoblotting (Figure 4.1A).  
The occupancy of Fal1 was evaluated along two RNA Pol II transcribed genes: fba1 (intron-
less) and gpd3 (intron-containing). Interestingly, I found that Fal1 is associated with gpd3, 
giving a 5 to 6-fold enrichment relative to the intergenic region, hence indicating that Fal1 
associates with transcriptionally active sites also in S. pombe (Figure 4.1B).   
Notably, I also found an association of Fal1 along the CDS of the intron-less gene fba1; the 
enrichment varied from an average of 4-fold in the first region of the gene to almost 6-fold at 
the end of the CDS (Figure 4.1B). The Fal1 ChIP signal appears to be specific as there is little 
enrichment in the WT (untagged) strain, which was around 2-fold or below compared to the 
intergenic region; the enrichment in the untagged strain was set background for the next ChIP 
assays (Figure 4.1B). 
Additionally, the occupancy on gpd3, appears to be similar to that on fba1, suggesting that in 
fission yeast, Fal1 does not bind preferentially to intron-containing genes.  
The association of Fal1 was also tested on a second intron-less locus, pma1, confirming that 
the binding of Fal1 can occur regardless of an intron (Appendix VI). Overall the experiments 
demonstrated that Fal1 is specifically associated with transcriptionally active Pol II 
transcribed genes in S. pombe, and the recruitment is intron independent. To evaluate the 
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global binding profile of Fal1 in S. pombe, we collected IP chromatin for ChIP-seq analysis, 





Figure 4.1 - Fal1 associates with RNA Pol II transcribed loci regardless of the presence 
of an intron. (A) The specificity of the FLAG antibody (Sigma, M2) used for the ChIP assay, 
is verified by immunoblotting of Fal1-GFP-2xFLAG, detecting a unique band of 
approximately 72 kDa. Note that the WB is qualitative and aimed to evaluate the specificity 
of the FLAG antibody; therefore, the membrane was not probed with a loading control 
antibody.  
(B) ChIP-qPCR of Fal1-GFP-2xFLAG and WT (untagged) strain. The occupancy is evaluated 
on fba1 (intron-less gene) and gpd3 (intron-containing gene); the signals are normalized to the 
input and expressed as fold enrichment relative to a negative locus (not expressed). Error bars 
























4.2.3 - The binding of Fal1 at gene loci is partially sensitive to RNase  
Since Fal1 is an ATP dependent-RNA helicase, we tested whether its association with the 
chromatin was mediated by interaction with the nascent-RNA. To this aim, an RNase step 
was introduced in the ChIP assay (details in Materials and Methods). The principle behind the 
RNase treatment is conceptually straightforward; if the target protein is bound to the nascent 
RNA, the corresponding DNA sequences will be lost during the RNase digestion and the 
derived signal detected by ChIP-qPCR will be lower compared to the non-treated control. An 
illustration of the RNase treatment is reported in Figure 4.2A.  
I found that the RNase treatment caused a significant reduction (p-value < 0.05) of the Fal1 
occupancy on gpd3 in three independent experiments, of approximately 24%, 47% and 59%, 
suggesting that Fal1 might be co-transcriptionally recruited to intron-containing transcripts 
(Figure 4.2B). However, the only partial sensitivity to RNase could also mean that Fal1 can 
establish additional contacts with the chromatin or with the transcription machinery. 
On fba1, I found a reduction in the first region of the gene only in two experiments out of 
three performed (almost 31% and 75% reduction). Conversely, in the last region of the fba1 
gene, I found a reduction in the three experiments performed, of almost 58%, 70% and 30%, 
but not significant from a statistical point of view (Figure 4.2B). However, also for the second 
region of fba1, the signal of the RNase treated sample appeared partially reduced compared to 














Figure 4.2 – The association of Fal1 with gene loci is partially sensitive to RNase (A) 
Illustration of the ChIP-RNase treatment: RNase A treatment is performed to evaluate 
whether Fal1 associates with the nascent-RNA. If the protein is bound to the nascent-RNA, 
the DNA sequences in its proximity are lost during the treatment, causing a reduction in the 
ChIP signal compared to the not-treated control. (B) The enrichment of Fal1 is evaluated on 
gpd3 and fba1, with or without RNase treatment in the ChIP assay. The Fal1 occupancy is 
normalized to the input and expressed as fold enrichment relative to a negative locus. The 
average reduction of the Fal1 signal after the RNase treatment is reported in the graph. 
The error bars represent the mean ± SD of independent experiments (n=3).  
Statistical analysis was performed using unpaired Student t-test: NS (not significant); *p < 























Since the interaction of the EJC components with the transcription machinery has been 
recently observed in two different studies in D. melanogaster and the profile of eIF4AIII on 
the polytene chromosomes of the same organism, remarkably overlaps with that of RNA Pol 
II, I predicted that the partial sensitivity to RNase treatment, could be due to an interaction 
with the polymerase (Akhtar et al., 2019, Choudhury et al., 2016, Singh et al., 2019). 
To test this hypothesis, the binding profile of Fal1 was compared to that of Rpb3, along the 
CDS of the fba1 gene. Notably, I found that the pattern of Fal1 and Rpb3 were similar 
throughout the CDS of the gene (Figure 4.3).  For both Fal1 and Rpb3, the enrichment was 
lower at the beginning of the gene, then it peaked in the middle of the CDS, and lastly 
decreased in the proximity of the end of the gene (Figure 4.3).  
Overall, the data reported in this paragraph indicate that Fal1 is partially sensitive to the 
RNase treatment and it might interact with the transcription machinery. 
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Figure 4.3 – The binding pattern of Fal1 is similar to that of Rpb3. Evaluation of the 
binding profile of Fal1 and Rpb3 along the CDS of the fba1 gene (1077 nt). The enrichment 
of Fal1 and Rpb3 is normalized to the input and expressed as fold enrichment relative to a 












4.2.4 - Y14 and MAGO are mostly found in the nucleus of S. pombe 
According to the EJC model, Fal1 together with MAGO and Y14, makes a stable grip with 
the RNA (Le Hir et al., 2016). Having found that Fal1 is recruited at active gene loci in an 
intron-independent fashion, I also investigated whether other members of the EJC exhibited a 
similar binding mode. To test this hypothesis, I generated yeast strains in which Y14 and 
MAGO were endogenously tagged at the C-terminal with the GFP-2xFLAG epitope (Figure 
4.4A). The expression of the endogenous GFP-2xFLAG tagged Y14 and MAGO was 
evaluated by western blot using an anti-FLAG antibody; expected bands of approximately 
43.2 kDa and 46.5 were detected for Y14 and MAGO respectively (Figure 4.4B). Since the 
localisation of MAGO and Y14 has never been reported in S. pombe, I exploited the GFP-tag 
to determinate their subcellular distribution. Using confocal microscopy, I found that in S. 
pombe, as in other eukaryotes, the two factors mainly localise in the nucleus, which suggests 
that their function is predominantly nuclear in fission yeast (Figure 4.4C) (Choudhury et al., 
2016, Kataoka et al., 2011, Koroleva et al., 2009, Le Hir et al., 2001a, Pendle et al., 2005). 
The images were acquired with technical assistance of Dr. Alessandro di Maio, microscopy 













     
 
   Figure 4.4 - MAGO and Y14 are mostly found in the nucleus of S. pombe. (A) The 
integration of the GFP-2xFLAG tag is verified by PCR as illustrated.  
(B) The expression of Y14 and MAGO, endogenously tagged with the GFP-2xFLAG 
epitope, is detected by WB, using anti-FLAG antibody (M2, Sigma); expected bands of 
approximately 43.2 kDa and 46.5 are detected for Y14 and MAGO respectively. Note that 
the WB is qualitative and aimed to confirm the presence of the FLAG-tag in the positive 
colonies; therefore, the membrane was not probed with a loading control antibody.  
(C) The GFP signal of MAGO and Y14 was visualized by confocal microscopy (Nikon 
A1R). 
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4.2.5 - Y14 might not stably associate with transcription active sites   
To test whether Y14 exhibited the same binding pattern of Fal1 on the target genes, a ChIP 
assay was performed using the newly created strain. Surprisingly, I found a modest 
enrichment on gpd3 (almost 2-fold relative to the intergenic), only in one experiment out of 
three performed; in the other two experiments, the enrichment (varying from 1 to 1.5-fold) 
was similar to the ChIP signal derived from previous experiments with a WT-untagged strain 
(Figure 4.5). Also, for fba1 a modest signal (almost 3-fold relative to the intergenic), was 
observed in one experiment out of three performed (Figure 4.5). The occupancy of Y14 was 
also tested on a second highly expressed intron-less gene, pma1, observing similar results 
(Appendix VI). These data suggest that Y14 might not be associated or at least not stably, 
along the CDS of fba1 and gpd3. 
I also performed preliminary ChIP of MAGO, whose occupancy was tested on fba1, and 
gpd3, but, I did not observe an obvious enrichment above the intergenic, in agreement with 




Figure 4.5 - Y14 may not associates or at least not stably with transcription active sites. 
ChIP-qPCR of Y14 on fba1 (intron-less gene) and gpd3 (intron-containing gene); the Y14 
signal is normalized to the input and expressed as fold enrichment relative to a negative 
locus (not expressed). The blue dashed line indicates a level of background previous 
reported for an untagged-WT strain. Error bars represent mean ± SD of independent 
experiments (n=3). 
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4.3 - Discussion  
According to the EJC model, eIF4AIII is deposited 20-24 nucleotides upstream of each exon-
exon junction, in a sequence-independent fashion (Le Hir et al., 2000, Le Hir et al., 2016). In 
mammalian cells a non-canonical deposition of eIF4AIII was revealed using CLIP-seq 
experiments; eIF4AIII appears prevalently associated with the canonical position, but it also 
marks different exonic regions of spliced mRNAs. However, its binding seems to occur only 
on the mRNAs derived from intron-containing genes (Saulière et al., 2012, Singh et al., 
2012).  
Contrary to this common view, Choudhury and colleagues have reported that in D. 
melanogaster eIF4AIII, and other EJC components, are recruited on the nascent RNA 
regardless of the presence of an intron (Choudhury et al., 2016). This binding fashion has 
been recently confirmed in mammalian cells and D. melanogaster (Akhtar et al., 2019, 
Viphakone et al., 2019).  
With this project, I aimed to investigate whether eIF4AIII associates with transcriptionally 
active sites and whether the association depends on the presence of an intron in S. pombe. To 
this end I have performed ChIP of Fal1, the homolog of eIF4AIII in S. pombe; its occupancy 
has been evaluated on two RNA Pol II transcribed genes; fba1, which is intron-less, and gpd3, 
which contains an intron in the 5’-UTR. The data indicate that Fal1 is associated along the 
CDS of fba1 and gpd3, without showing a preferential association for the latter (Figure 4.1). 
The association on these genes is probably mediated via nascent RNA since when an RNase 
treatment is introduced in the ChIP assay, it causes a partial reduction of the Fal1 occupancy 
on gpd3 (an average of 43%) and fba1 (an average of 52%, despite the decrease appears 
reproducible only in the last region of the gene) (Figure 4.2). However, on fba1 the reduction 
of Fal1 occupancy is not statistically significant. This can be either due to technical 
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considerations such as the low number of replicates (N=3) used for the statistical analysis or 
to a biological mechanism which suggests that Fal1 might associate with RNA Pol II but its 
deposition of Fal1 occurs only on the mRNA derived by intron-containing genes. It is also 
important to note that in the ChIP assay, the fixation of protein-chromatin interactions with 
formaldehyde, could reduce the accessibility of the RNase to the nascent-mRNAs, thus 
causing a substantial inter-experimental variability  (Abruzzi et al., 2004, De et al., 2011). 
Due to this limitation, it could be interesting to clarify whether Fal1 binds single-exon 
transcripts using a more direct approach such as Cross-Linking Immunoprecipitation (CLIP) 
(Ule et al., 2003). 
The partial sensitivity to RNase could also reflect a putative interaction of Fal1 with the 
transcription machinery. For example, in D. melanogaster eIF4AIII interacts with RNA Pol 
II, and the interaction is sensitive to RNase; a similar feature is also shared by MAGO 
(Akhtar et al., 2019, Singh et al., 2019). Additionally, in D. melanogaster, the signal of 
eIF4AIII, but not that of MAGO and Y14,  remarkably overlaps with that of RNA Pol II 
(Choudhury et al., 2016). From this evidence, Choudhury and colleagues conjectured that 
eIF4AIII might have a global role in gene expression, and Akthar and collegues concluded 
that it may affect the elongation of RNA Pol II, as previously anticipated in mammalian cells 
(Akhtar et al., 2019, Choudhury et al., 2016, Wang et al., 2014). In support of this hypothesis, 
I found that Fal1 and the Rpb3, exhibit a similar binding pattern along the fba1 gene (Figure 
4.3). Whether Fal1 has a direct role in the elongation of RNA Pol II needs to be evaluated in 
the future, possibly following rapid depletion of Fal1 (as discussed in Chapter 3). 
To test whether other EJC proteins exhibit a Fal1-like binding profile, Y14 and MAGO have 
been endogenously tagged  with the same GFP-2xFLAG epitope, which has revealed that the 
two factors accumulate mainly in the nuclear compartment (Figure 5.4), a subcellular 
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distribution that is in agreement with that observed in other eukaryotes (Choudhury et al., 
2016, Kataoka et al., 2011, Koroleva et al., 2009, Le Hir et al., 2001a, Pendle et al., 2005).  
However, ChIP experiments of Y14 indicate that the protein might not be or at least not stably 
associated on the tested genes, since the enrichment was modest and similar to the signal 
derived from the WT-untagged strain (Figure 5.5). Some preliminary ChIP of MAGO suggest 
a similar behavior (Appendix VI). This data indicates that eIF4AIII might be associated at 
some gene loci independently of the heterodimer MAGO and Y14, which is consistent with 
what has been recently observed in D. melanogaster (Choudhury et al., 2016). It is also 
possible that the association of Y14 on these gene loci is transitory and not stable enough to 
be captured using the time of fixation of our ChIP protocol. Therefore, it will be crucial in the 
future to extend the fixation time, and to evaluate the occupancy of Y14 on more gene loci.  
Overall the main conclusion of this study is that Fal1 associates with transcriptionally active 
loci regardless the presence of an intron, in agreement with recent findings reported in D. 












Chapter 5: The main function of Fal1 is independent 
of MAGO and Y14 in S. pombe 
 
5. 1 - Introduction  
The current EJC model predicts that the tight association of eIF4AIII with a splice junction 
depends on the interactions eIF4AIII makes with the MAGO-Y14 heterodimer (Bono et al., 
2006). The observation that Y14 is not, or at least not stably associated on spliced mRNA, as 
discussed in Chapter 4, led me to better explore whether a mammalian-like EJC is formed in 
S. pombe. Here I describe some evidence which argue against the formation of a mammalian-
like EJC in fission yeast. Despite MAGO and Y14 being conserved and likely to form a 
heterodimer in S. pombe, their deletion does not affect eIF4AIII stability, nuclear localisation 










5.2 - Results 
5.2.1 - MAGO and Y14 are conserved in S. pombe 
Previous studies concluded that a mammalian-like EJC is unlikely to be formed in S. pombe 
(Marayati et al., 2016, Wen and Brogna, 2010). One possibility to explain this phenomenon is 
that in S. pombe, MAGO and Y14 have diverged too much from higher eukaryotes, and hence 
structural differences might prevent an interaction with Fal1/eIF4AIII, and therefore also the 
formation of an EJC. 
To explore this hypothesis, I have aligned the protein sequence of MAGO from S. pombe, 
with its orthologs across different model organisms. I found that the sequence of MAGO is 
highly conserved, having 63% of homology with its counterpart in Human, 61% with D. 
melanogaster, 62% with C. elegans, 63 % with Arabidopsis Thaliana and 62% with Xenopus 
(Figure 5.0A). Since the primary sequence of MAGO appeared conserved in S. pombe, I next 
investigated whether the predicted secondary structures showed the same level of similarity 
across the examined organisms. Using the primary amino acid sequence, the secondary 
structure of MAGO has been predicted based on the similarity with known secondary 
structures deposited in the   database (Cuff et al., 1998). Then each prediction is visualized in 
Jalview (Clamp et al., 1998, Clamp et al., 2004). 
From this analysis it emerged that the MAGO local segments exhibited similar conformations 
across eukaryotes, presenting almost identical patterns of a-helices (green arrows) and b-
sheets (red tubes) in the same positions (Figure 5.0B). Lastly, the 3D modeling from the 
primary amino acid sequence, using SWISS-MODEL, a protein homology-modeling server, 
predicted that the tertiary structure of MAGO deriving from S. pombe, had a high degree of 





Figure - 5.0 MAGO is conserved across eukaryotes. (A) The MAGO amino-acid sequence 
from S. pombe shows a high percentage of identity with its counterparts from Human (63%), 
in D. melanogaster (61%), in C. elegans (62%), in Arabidopsis (62%) and in Xenopus (63%). 
Alignment and visualization are performed using Jalview. Identical residues are indicated in 
dark blue; gaps are indicated in white; residues with a positive score in the Blosum62 matrix 
are indicated in light blue. (B) Secondary structure prediction, alignment and visualization of 
the MAGO sequences across eukaryotes. The prediction of the secondary structure is 
performed using Jpred and it is visualized in Jalview; beta-sheets and alpha-helices are 
represented by green arrows and red tubes respectively. The local conformations show a high 
degree of similarity across the analyzed sequences. (C) The prediction of the tertiary 
structures of MAGO from Human, D. melanogaster, and S. pombe is performed using 




















I also evaluated the conservation grade of Y14 across eukaryotes; the protein sequences from 
the same organisms were aligned as previously described and visualized in Jalview. I found 
that Y14 showed 55% of homology with its counterpart in Human, 47% in D. melanogaster, 
48% in C. elegans, 57% in Arabidopsis and 51% in Xenopus (Figure 5.1A). However, despite 
the high level of similarity, I also noted that in fission yeast, Y14 lacked the N-terminal 
domain, which in higher eukaryotes seems to be fundamental to establish interactions with 
MAGO (Fribourg et al., 2003). As expected, the predicted secondary structures of Y14 
exhibited high variability at the N-terminal domain and became progressively more conserved 
in the central region where identical patterns of a-helices and b-sheets were observed (Figure. 
5.1B). The 3D modeling predicted that the tertiary structure of Y14 deriving from S. pombe, 
had a high degree of structural similarity with its Human and D. melanogaster orthologs, 
despite a shorter N-terminal portion (Figure 5.0C). Overall the data presented in this 
paragraph reveal that MAGO and Y14 are conserved in S. pombe; however, the lack of the N-
terminal region of Y14, lead us to better explore its relationship with MAGO, whose results 








Figure 5.1 - Y14 is conserved across eukaryotes. (A) Y14 amino-acid sequence from S. 
pombe shows a high percentage of identity with its counterparts in Human (55%), in D. 
melanogaster (47%), in C. elegans (48%), in Arabidopsis (57%) and in Xenopus (51%). 
Alignment and visualization are performed using Jalview. Identical residues are indicated in 
dark blue; gaps are indicated in white; residues with a positive score in the Blosum62 matrix 
are indicated in light blue. (B) Secondary structure prediction, alignment and visualization of 
the Y14 sequences across eukaryotes. The prediction of the secondary structure is performed 
using Jpred and it is visualized in Jalview; beta-sheets and alpha-helices are represented by 
green arrows and red tubes respectively. (C) The prediction of the tertiary structures of Y14 
from Human, D. melanogaster, and S. pombe is performed using SWISS-MODEL (Schwede 








5.2.2 – Deletion of mago and y14 do not affect cell viability of S. pombe 
In higher eukaryotes eIF4AIII associates with MAGO and Y14, forming a stable complex 
which is tightly locked on the mRNA (Bono et al., 2006). Due to the nature of the complex, it 
is also possible that mago and y14 deletion mutants could exhibit a severe growth defect as 
that described for Fal1 in Chapter 3. Previous studies reported that the deletion of mago and 
y14 in S. pombe did not affect cell viability (Marayati et al., 2016). To test whether this is the 
case, I decided to generate my own strains and evaluate whether the deletion of mago and y14 
affected cell viability in S. pombe. I firstly generated deletion strains of mago and y14 (Figure 
5.2A); then I performed a spot growth assay on YES plates, comparing the growth of the 
mutants to the WT. As expected, I confirmed that the deletion of mago and y14 did not affect 
cell viability; this result suggests that the sick phenotype deriving from the deletion of fal1 
does not depend by the disruption of a putative EJC in S. pombe (Figure 5.2B). To exclude the 
presence of MAGO and Y14 paralogs that might potentially rescue growth defects in S. 
pombe, the amino acid sequence of the two factors was aligned with the Basic Local 
Alignment Search Toll (BLAST), searching for putative homologs within the same organism. 
The sequence of MAGO did not align with any protein in the S. pombe database (data not 
shown). For Y14, my search reported 11 hits, which were characterized by a low percentage 
of identity (Appendix VI). This analysis confirms that mago and y14 might be unique within 
the S. pombe genome, and their deletion, does not impair cell viability. Moreover, the severe 
growth defect derived by the deletion of fal1 indicates that it could play an essential function 




Figure 5.2 – The deletion of mago and y14 do not affect cell viability. (A) Confirmation of 
the deletion of mago and y14  by PCR: deletion of y14 is verified by PCR on the DNA 
extracted from selected colonies, using the primer pair Y14-del-CHK and Y14-R1, with the 
first anneals outside the region of recombination, amplifying expected bands of approximately 
2.3 kb and 1.5 kb for the KO and the WT respectively. Deletion of mago is verified via PCR 
on the DNA extracted from selected colonies, using the primer pair Mago-F1 and Mago-
CHK, where the latter anneals outside the region of recombination, amplifying expected 
bands of approximately 2.4 kb and 2 kb for the KO and the WT respectively. (B) The growth 
of mago and y14 deletion mutants is compared to the fal1 deletion and WT strains, by growth 
spot assay. Dilute spots contain approximately 105, 104, 103, 102, 10 cells. The YES plates are 
incubated at 30°C and 32°C and survival is evaluated after 72 hours.  
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5.2.3 - MAGO and Y14 fractionate separately from Fal1 on a sucrose 
gradient  
According to the EJC model, the EJC factors remain associated with spliced mRNAs until 
they are removed by the ribosome during the first round of translation. Key evidence 
supporting this view is that in mammalian cells, Y14 is present in the monosomal, but not in 
the polysomal fractions (Dostie and Dreyfuss, 2002). 
To gain further insight into the nature of the EJC in S. pombe, I have analyzed with the 
technical help of Dr. Marija Petric, a fellow PhD student in the group, the distribution of the 
EJC proteins in polysomal fractions of fission yeast cytoplasmic extracts. A schematic 
representation of the procedure is reported in figure 5.3A. 
However, to avoid possible issues relative to the functionality of MAGO and Y14, which 
were previously tagged with a GFP-2xFLAG epitope, we decided to perform the polysome 
profiling with new strains in which MAGO and Y14 were endogenously tagged at the C-
terminal with a 5xFLAG, that being smaller should have no impact on the protein 
functionality (creation of the strains, validation and WB analysis is reported in additional 
results of Appendix VI). Notably, we found that Y14 and MAGO did not sediment with Fal1 
by sucrose gradient fractionation of fission yeast cytoplasmic extracts (Figure 5.3B). In fact, 
while MAGO and Y14 stayed on the light fraction (lane 11 and 12), corresponding to free 
proteins or small molecular weight complexes, Fal1 was detected both in the monosomal and 
polysomal fractions, suggesting that it is not removed by the translating ribosome. The 
sedimentation profile of Y14 and MAGO also suggests that they are not bound to mRNAs in 
the cytoplasm, contrary to what the EJC model predicts for mammalian cells, but in 
agreement to more recent observation in D. melanogaster (Choudhury et al., 2016). 
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Additionally, the different pattern of sedimentation of the EJC factors, suggests that it is not 









Figure 5.3 –MAGO and Y14 fractionate separately from Fal1 on sucrose gradient. 
Polysome profiling and western blotting analysis of the sucrose gradient fractions, show the 
distribution of eIF4AIII, Y14 and MAGO.  
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5.2.4 - MAGO and Y14 are required for the stability of each other in S. 
pombe 
Next, I examined whether MAGO and Y14 can form a heterodimer in S. pombe. The two 
components form an obligatory heterodimer in almost 12 species in which the interaction has 
been studied (Gong et al., 2014); according to previous studies they not only interact, but they 
are also required for the stability of each other. (Boisramé et al., 2019, Choudhury et al., 
2016, Le Hir et al., 2001a, Miller, 2017). However, in fission yeast the interaction and 
interdependency between MAGO and Y14 have not yet been investigated.  
To gain further insight into this aspect, I firstly inspected whether the residues of interaction 
between MAGO and Y14, known from previous studies in mammalian cells, were conserved 
in S. pombe. Based on the crystal structure of the mammalian EJC, Bono and colleagues 
reported the conserved residues of MAGO which were required for its interaction with Y14 
(Bono et al., 2006). By aligning and visualizing the MAGO sequences from S. pombe, D. 
melanogaster and Human, I found that most of these residues were highly conserved (Figure 
5.4A); however, in S. pombe, a conserved histidine in position 53 (HIS53), is replaced with a 
serine.  In order to investigate whether this amino acid substitution can be accommodated in 
the mammalian 3D structure of the EJC (PDB accession number: 2J0S), without major 
rearrangements of the protein, I have used USCF Chimera, a package for molecular 
visualisation, which provides several tools for exploring and editing 3D structures (Pettersen 
et al., 2004). Interestingly, the substitution of HIS53 in the mammalian 3D structure of the 
EJC, with the serine rotamer (the conformation of the side-chain of an amino acid) having the 
highest probability (40% of probability according to the Dunbrack rotamers library of 2010; 
Table in Appendix VI) does not appear to cause clashes or unfavorable interactions in the 
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structure (Figure 5.4B). Overall the strong conservation of these amino acids and the apparent 















Figure 5.4 - Residues of interaction of MAGO with Y14 are conserved in S. pombe. (A) 
Alignment and visualization of the MAGO amino acid sequences from S. pombe, D. 
melanogaster and Human. The amino acid residues of MAGO, required for the interaction 
with Y14 (derived from (Bono et al., 2006)), are grouped and visualized in Jalview. Identical 
residues are indicated in dark blue; gaps are indicated in white; residues with a positive score 
in the Blosum62 matrix are indicated in light blue. (B) Most of the residues are conserved 
except for a histidine in position 53 (HIS53) of S. pombe, which is replaced by a serine. The 
substitution of the HIS53 with the most likely serine rotamer (40% of probability according to 
Dunbrack rotamers library of 2010) using USCF Chimera, does not cause clashes or 
















Contrary to the highly conserved features of MAGO, the protein sequence of Y14 in S. pombe 
lacks an extensive N-terminal region where seven residues of interaction with MAGO were 
previously identified in mammalian cells (Fribourg et al., 2003) (Figure 5.5A); however the 
lack of the N-terminal region seems to be not critical for a putative interaction between 
MAGO and Y14, since also Y14 from the budding yeast Yarrowia lipolytica lacks a 50 
amino-acid N-terminal extension present in the human orthologue, it can still interact and 
stabilize MAGO (Boisramé et al., 2019). 
The central domain of Y14 is characterized by 13 amino acids involved in the interaction with 
MAGO, which are highly conserved, except for phenylalanine in position 76 (PHE 76), which 
is replaced with an isoleucine. Interestingly, the substitution of the PHE 76, in the mammalian 
3D structure of the EJC, with the most likely isoleucine rotamer (68% of probability 
according to the Dunbrack rotamers library of 2010; table in Appendix VI), seems to cause a 
clash with the valine in position 56 of MAGO (VAL56), and the cysteine in position 149 












Figure 5.5 - Residues of interaction of Y14 with MAGO are not fully conserved in S. 
pombe. (A) Alignment and visualization of the Y14 sequences from S. pombe, D. 
melanogaster and Human. The amino acid residues of Y14, required for the interaction with 
MAGO (derived from(Bono et al., 2006, Fribourg et al., 2003)), are grouped and visualized in 
Jalview. Identical residues are indicated in dark blue; gaps are indicated in white; residues 
with a positive score in the Blosum62 matrix are indicated in light blue. In S. pombe, Y14 
lacks an N-terminal portion, containing 7 conserved residues involved in the interaction with 
MAGO. In the central domain, all the residues are conserved except for phenylalanine in 
position 76 (PHE76) of S. pombe, which is substituted with an isoleucine. (B) The 
substitution of the PHE76 with the most likely isoleucine rotamer (68% of probability 
according to Dunbrack rotamers library of 2010) using USCF Chimera, causes unfavorable 




















To further investigate whether MAGO and Y14 could form a stable complex in S. pombe I 
decided to explore experimentally the nature of the interaction, asking whether MAGO and 
Y14 are interdependent in S. pombe, as in other eukaryotes (Gong et al., 2014). In fact, it has 
been reported that the stability of MAGO and Y14 depends on their heterodimerisation; 
therefore evaluating the protein levels of a component in absence of its partner, could be an 
indirect approach to evaluate whether the two factors form a stable complex (Choudhury et 
al., 2016). 
To this aim, I firstly generated deletion of mago in a strain in which Y14 was previously 
tagged with a 5xFLAG epitope at the C-terminal (Figure 5.6B). Next, I performed western 
blot analysis using an anti-FLAG antibody, comparing the protein levels of Y14-5xFLAG 
with those in which mago was deleted. Interestingly, I found that the deletion of mago caused 
a reduction of the protein levels of Y14, in agreement with previous observation in 
mammalian cells and D. melanogaster (Choudhury et al., 2016, Miller, 2017) (Figure 5.6B). 
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Figure - 5.6 MAGO is required for the stability of Y14. (A) Confirmation of the deletion 
of mago in a strain in which Y14 is tagged at the C-terminal with a 5xFLAG epitope: deletion 
of mago  is verified by PCR on DNA extracted from three colonies, using the primer pair 
Mago-F1 and Mago-CHK-R, where the second anneals outside the region of recombination, 
amplifying expected bands of approximately 2.4 kb and 2 kb for the KO and the WT 
respectively. (B) WB analysis that compares the protein levels of Y14-5xLAG with Y14-
5xFLAG:Δmago. Quantification of the bands of interest is normalized to the loading control 
(a-tubulin), and expressed as % of protein relative to the Y14-5xFLAG strain, which is set at 
100%. Error bars are mean ± SEM (n=2). Quantification was performed using ImageJ. 
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To evaluate whether the two factors were interdependent, I also generated a deletion of y14 in 
a strain in which MAGO was previously tagged with a 5xFLAG epitope at the C-terminal 
(Figure 5.7A). The WB experiment confirmed that deletion of y14 caused a reduction of the 
protein levels of MAGO of approximately the same magnitude (Figure 5.7B). Overall the 
results reported in this paragraph indicate that MAGO and Y14 are required for their 
reciprocal stability in S. pombe; therefore they likely form a stable complex as in other 
organisms (Gong et al., 2014). Furthermore, the few variations in the amino acids which 
participate in the interactions between MAGO and Y14, could be interpreted as a strategy of 
fission yeast, to preserve the heterodimerisation as suggested by Gong and colleagues (Gong 
et al., 2014). Additionally, the lack of the N-terminal portion of Y14, containing some amino 
acids which are fundamental for its interaction with MAGO in mammalian cells, might be not 
crucial in yeast as recently observed also by Boisrame and colleagues (Boisramé et al., 2019). 
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Figure 5.7 Y14 is required for the stability of MAGO. (A) Confirmation of the deletion of 
y14 in a strain in which MAGO is tagged at the C-terminal with a 5xFLAG epitope: deletion 
of y14 is verified by PCR on the DNA extracted from three colonies, using the primer pair 
Y14-del-CHK and Y14-R1, with the first annealing outside the region of recombination, 
amplifying expected bands of approximately 2.3 kb and 1.5 kb for the KO and the WT 
respectively. (B) Western blot analysis comparing the protein levels of MAGO-5xFLAG with 
MAGO-5xFLAG:ΔY14. Quantification of the bands of interest is normalized to the loading 
control (a-tubulin), and expressed as % of protein, relative to the MAGO-5xFLAG strain, 
which is set at 100%. Error bars are mean ± SEM (n=2). Quantification has been performed 
using ImageJ. 
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5.2.5 - y14 deletion causes a depletion of MAGO nuclear signal and vice-
versa 
As shown in the previous paragraph, the deletion of mago reduces the levels of Y14 and vice-
versa, suggesting that also in S. pombe, the two proteins are required for the stability of each 
other. To confirm this aspect from a qualitative point of view, I also evaluated the GFP signal 
of MAGO upon deletion of y14, and the GFP signal of Y14 upon deletion of mago. 
To accomplish this goal, I deleted y14 and mago in the strains in which their respective 
partners were tagged at the C-terminal with a GFP-2xFLAG epitope.  
Then I visualized the GFP signal of MAGO, with and without the deletion of y14 by confocal 
microscopy. As previously shown in Chapter 4, MAGO mainly localised in the nuclear 
compartment of S. pombe; interestingly, upon deletion of y14, the GFP signal decreased, and 
the remaining appeared fragmented (Figure 5.8). 
To evaluate the inter-dependency of the mechanism, I visualized the GFP signal of Y14, with 
and without the deletion of mago by confocal microscopy; in agreement with the previous 





Figure 5.8 – y14 deletion causes a depletion of MAGO nuclear signal.  Y14 deletion is 
performed in a strain in which MAGO was tagged at the C-terminal with a GFP-2xFLAG 
epitope. The GFP signal of MAGO with and without deletion of y14 was visualized by 







Figure 5.9 - mago deletion causes a depletion of Y14 nuclear signal.  mago deletion is 
performed in a strain in which Y14 was tagged at the C-terminal with a GFP-2xFLAG 
epitope. The GFP signal of Y14 with and without deletion of mago was visualized by 






5.2.6 - Fal1 exists independently of MAGO-Y14 in S. pombe 
As shown in the previous paragraphs, the deletion of fal1 but not mago and y14, severelly 
affected cell viability, indicating that the Fal1 main function is independent of MAGO and 
Y14 in S. pombe. To investigate whether there is an inter-dependency between Fal1 and 
MAGO/Y14, I studied whether protein level, nuclear localisation and the functionality of Fal1 
were affected upon deletion of mago and y14.  
To this aim, I deleted mago and y14 in a strain in which Fal1 was tagged at the C-terminal 
with the GFP-2xFLAG epitope (Figure 5.10). Next, I evaluated by confocal microscopy, 
whether the nuclear localisation of Fal1 was affected upon deletion of mago and y14; not 
surprisingly, I found that the deletions of mago and y14 did not affect the nuclear localisation 
of Fal1 (Figure 5.11).  
To evaluate whether mago and y14 deletions affected the protein levels of Fal1, I performed 
WB analysis comparing the protein levels of Fal1-GFP-2xFLAG with those in which mago 
and y14 were deleted. I found that their deletion did not cause a significant reduction of the 
protein levels of Fal1 (Figure 5.12A). Moreover, the deletions of mago and y14 did not alter 
the functionality of Fal1, since the tagged strain did not show any growth defect (Figure 
5.12B). Overall, the results reported in this paragraph indicate that Fal1 exists in S. pombe 







Figure 5.10 - Deletion of mago and y14 from Fal1-GFP-2xFLAG tagged strain. 
Confirmation by PCR of the deletion of mago and y14 in a strain in which Fal1 was tagged at 
the C-terminal with a GFP-2xFLAG epitope is performed with the primer pairs annotated in 
the schematic representation. Positive colonies for the deletion are indicated with a Magenta 
asterisk. Note that the WB is qualitative and aimed to confirm the presence of the FLAG-tag 






Figure 5.11 - Deletion of mago and y14 do not affect Fal1 nuclear localisation. The GFP 
signal of Fal1, with and without deletion of mago and y14, was visualized by confocal 





Figure 5.12 - Deletion of mago and y14 do not affect Fal1 protein stability and 
functionality. (A) WB analysis of the protein levels of Fal1-GFP-2xFLAG, Fal1-GFP-
2xFLAG:Δmago and Fal1-GFP-2xFLAG:Δy14. The quantification of the bands of interest is 
normalized to the loading control (a-tubulin), and expressed as % of protein relative to the 
Fal1-GFP-2xFLAG strain, which is set at 100%. Error bars represent mean ± SD (n=3). 
Quantification has been performed using ImageJ. 
(B) Spot growth assay comparing the growth of Fal1-GFP-2xFLAG, Fal1-GFP-2xFLAG: 
Δmago and Fal1-GFP-2xFLAG:Δy14. Diluted spots contain approximately 105, 104, 103, 102, 
10 cells. Plates are incubated at 30°C and survival is evaluated after 72 hours.  
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5.2.7 - Depletion of Fal1 might be associated with abnormalities in rRNA 
processing 
 
The observation that the deletion of fal1, but not mago and y14, affected cell viability, lead 
me to hypothesize that the protein could play a critical biological function independently of 
MAGO and Y14. In S. cerevisiae, Fal1 localises also in the nucleolus and its depletion leads 
to a reduction of the steady-state 18S rRNA levels, and as a consequence a decrease of the 
40S ribosomal subunit (Kressler et al., 1997). The function appears evolutionarily conserved, 
since the Human and D. melanogaster orthologs of eIF4AIII, can complement the phenotype 
of the Fal1 deletion in S. cerevisiae  (Alexandrov et al., 2011). Moreover, the knock-down of 
eIF4AIII correlates with defects in ribosomal biogenesis also in mammalian cells 
(Alexandrov et al., 2011, Badertscher et al., 2015, Mao, 2016, Tafforeau et al., 2013, Wild et 
al., 2010, Zhang et al., 2011) 
To evaluate whether the role of Fal1 in the biogenesis of the 18S rRNA is conserved in S. 
pombe, I performed, with help of Dr. Pawel Grzechnik, Principal Investigator at the 
University of Birmingham, a preliminary Northern Blot analysis, upon Fal1 thiamine-
repression using the strain previously characterized in Chapter 3; interestingly, I found that 
Fal1 down-regulation associated with a reduction of the steady-state 18S rRNA levels in 
fission yeast (Figure 5.13). However, the molecular mechanism behind this reduction needs to 








Figure 5.13 - Depletion of Fal1 is associated with the reduction of the steady-state 18S 
rRNA levels. (A) Ethidium bromide-stained 1% non-denaturing agarose gel of total RNA (5 
μg) isolated from yeast cells in which Fal1 was repressed by thiamine for 13 hours, or not 
repressed (t=0) (B) Northern blot analysis of the 18S rRNA levels, upon depletion of Fal1. 







5.2 - Discussion 
The results reported in this chapter are in agreement with previous studies that have argued 
against the formation of a mammalian-like EJC complex in fission yeast (Marayati et al., 
2016, Wen and Brogna, 2010). 
To study whether an EJC is formed in S. pombe, I firstly reasoned in terms of conservation 
asking whether MAGO and Y14 are conserved in fission yeast. For instance, it is possible that 
differences in the protein structures compared to other eukaryotic counterparts may affect the 
formation of a putative EJC in fission yeast. Instead, I found that MAGO is highly conserved 
across eukaryotes in terms of primary, secondary and tertiary structure (Figure 5.0). Also Y14 
appears conserved, despite lacking a long N-terminal segment in S. pombe, which in the 
mammalian counterpart contains numerous residues of interaction with MAGO (Figure 5.1) 
(Fribourg et al., 2003). However, despite the absence of the N-terminal segment, my data 
suggest that it is likely that MAGO and Y14 form a stable heterodimer in S. pombe; in 
support of it, I found that the deletion of y14 reduced the protein levels of MAGO and vice-
versa, suggesting that in fission yeast the two factors are required for the stability of each 
other (Figure 5.6 and Figure 5.7). MAGO and Y14 are mainly localised in the nucleus of S. 
pombe as reported in Chapter 4; however, the deletion of mago or y14, causes a reduction of 
the nuclear signals of the respective partners. In mammalian cells and  D. melanogaster the 
inter-dependency of MAGO and Y14 is the result of a change in the protein stability of the 
two factors, rather than a variation in the mRNA levels (Choudhury et al., 2016, Miller, 
2017). Therefore, it will be essential in the future to verify the molecular mechanism of this 
phenomenon in fission yeast. 
Despite the fact that MAGO and Y14 are conserved and might form a stable complex in S. 
pombe, an observation which argues against the formation of an EJC in fission yeast, is that 
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the deletion of mago and y14 does not impair cell viability, contrary to fal1 whose deletion is 
associated with severe growth defects. However, despite appearing reasonable that the main 
function of Fal1 is independent of MAGO and Y14, we cannot fully rule out that an EJC is 
formed in S. pombe.  
However, another piece of evidence which argues against the formation of an EJC, is that 
MAGO and Y14 fractionate separately from Fal1 on sucrose gradient fractionation. The EJC 
model conjectures that the EJC components remain associated with spliced mRNAs until they 
are displaced by the ribosome during the first round of translation (Dostie and Dreyfuss, 
2002). Contrarily, I found not only that MAGO and Y14 remain on top of the gradient, 
corresponding to free proteins or small molecular weight complexes, but also that Fal1 
associated both with monosomal and polysomal fractions, as previously reported in D. 
melanogaster (Choudhury et al., 2016). This distribution indicates that MAGO and Y14 
might dissociate from the mRNA before the translation initiation and it is not likely that they 
form a stable complex with Fal1 on translating mRNA in fission yeast. The lack of 
association with translating ribosomes also suggests that MAGO and Y14 are not involved in 
translation as in mammalian cells (Nott et al., 2004). Moreover, since MAGO and Y14 are 
found only in the light fraction, it is likely that they disengage from the transcripts either in 
the nucleus or as soon as they pass through the nuclear pore complexes, before the mRNA is 
bound by the ribosome. This mode of  binding suggests that the two proteins might escort the 
transcript to the cytoplasm, perhaps to determine its cytoplasmic localisation, as previously 
reported in D. melanogaster (Hachet and Ephrussi, 2004, Palacios, 2002). This hypothesis 
will be tested through a poly(A) RNAs in situ hybridization, to verify whether the deletion of 
MAGO and Y14 triggers the accumulation of mature transcripts in the nucleus.  
 171 
The fact that the deletion of fal1 affects cell viability, unlike mago and y14 (Figure 5.2), 
indicates that Fal1 is not inter-dependent with MAGO and Y14. My data indicate that 
deletions of mago and y14 do not affect neither the protein levels nor the nuclear distribution 
(Figure 5.11 and Figure 5.12) indicating that Fal1 exists in S. pombe independently of other 
EJC components, as reported in mammals and D. melanogaster (Alexandrov et al., 2011, 
Choudhury et al., 2016, Miller, 2017). Moreover, a preliminary analysis it also suggests that 
the severe growth defect derived by the deletion of fal1 is not due to the EJC disassembly, but 
perhaps to a reduction in the steady-state levels of the 18S rRNA (Figure 5.13), which is a 
phenotype observed in other organisms (Alexandrov et al., 2011, Badertscher et al., 2015, 
Kressler et al., 1997, Mao, 2016, Tafforeau et al., 2013, Wild et al., 2010, Zhang et al., 2011). 
However, the molecular mechanism by which this defect occurs needs to be explored in the 
future. In conclusion, my observations argue against the formation of an EJC. This is in 
agreement with previous studies in S. pombe (Marayati et al., 2016, Wen and Brogna, 2010), 












Chapter 6: Conclusions and Discussion 
6.1 - Summary of this project 
Although a widely held consensus is that the EJC components are deposited on spliced 
mRNAs, 20-24 nucleotides upstream of the exon-exon junctions, new compelling evidence 
suggests that the EJC factors might bind mRNAs regardless of the presence of an intron in the 
corresponding genes, as discussed in the introduction. The following have driven the work of 
this PhD project: (I) evaluating whether eIF4AIII and other members of the EJC are 
associated at transcriptional active loci independently of splicing; (II) understanding the direct 
function of eIF4AIII at this transcriptionally active site by engineering of the Auxin-inducible 
Degron (AID) system for the rapid depletion of eIF4AIII;  (III) clarifying whether a 
mammalian-like EJC is formed in fission yeast.  
6.2 - Fal1 is associated with active gene loci regardless of the presence of an 
intron  
Recent observations show that the EJC factors might be associated co-transcriptionally on the 
mRNA independently of introns, both in mammalian cells and D. melanogaster (Akhtar et al., 
2019, Choe et al., 2014, Choudhury et al., 2016, Viphakone et al., 2019). Therefore, the 
question at the start of this project was whether in S. pombe the EJC factors also associate at 
active gene loci transcribed by RNA Pol II, and if so, whether the association is splicing 
independent. This question has partly been answered by ChIP assay using two genes carrying 
either an intron or intronless as targets. The main conclusion of this work is that Fal1 is 
recruited on both the intron-containing and intron-less gene, and interestingly without 
showing a preferential association for the latter. My data indicate that the binding of Fal1 to 
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chromatin is partially sensitive to the RNase treatment thus in part this reflects association 
with the nascent transcript. This observation is consistent with eIF4AIII being found 
associated with RNA Pol II transcription sites in Drosophila polytene chromosomes 
(Choudhury et al., 2016). It is possible that Fal1 might interact with the transcription 
machinery, a hypothesis that seems supported by the fact that in D. melanogaster eIF4AIII 
co-precipitates with RNA Pol II and the interaction is sensitive to RNAse (Singh et al., 2019). 
It could be essential in the future to evaluate whether Fal1 interacts with RNA Pol II in S. 
pombe, and if so, whether the interaction is RNA dependent. This hypothesis will be tested by 
Co-IP using an available tool in which Fal1 and Rpb3 are both tagged endogenously in the 
same background.  
According to the EJC model, eIF4AIII acts as an anchor point for the binding of MAGO and 
Y14 (Bono et al., 2006, Fribourg et al., 2003). Therefore, I decided to assess whether these 
components exhibited a binding pattern similar to Fal1. Despite a strong nuclear 
accumulation, my data suggest that Y14 might not associate or at least not stably on the 
regions in which Fal1 is reproducibly precipitated. Preliminary results indicate a similar 
behavior for MAGO. This observation suggests either that Fal1 can associate on the 
chromatin independently of Y14 and MAGO, meaning that an EJC is not constitutively 
assembled in fission yeast, or that the interaction between the EJC components is transitory 
and therefore not stable enough to be captured during the fixation time of our ChIP protocol 
(Choudhury et al., 2016).  
6.3 - is there an EJC in S. pombe ?  
The EJC model predicts that eIF4AIII, MAGO and Y14 are engaged in a stable grip on the 
RNA (Bono et al., 2006). Since I have shown that the deletion of fal1 severely affects cell 
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viability, I have also evaluated whether the deletion of its partners correlated with a similar 
phenotype. My results indicate instead, that the deletion of mago and y14 does not cause any 
obvious growth defect, in agreement with previous findings (Marayati et al., 2016). This 
observation suggests that an EJC may not be formed in fission yeast (Marayati et al., 2016, 
Wen and Brogna, 2010). Notably, the silent phenotype deriving from the deletion of mago 
and y14 in fission yeast, is divergent from that observed in other eukaryotes, which instead 
might depend on that disruption of an EJC; for example, in D. melanogaster, the depletion of 
MAGO and Y14 is accompanied by abnormalities in the dorsal-ventral region, and in C. 
elegans a single point mutation of MAGO causes a prominent masculinization during the sex 
determination (Gong et al., 2014). Also, in Arabidopsis thaliana, the knock-down of MAGO 
and Y14 is associated with a lethal phenotype (Gong et al., 2014, Park et al., 2009) and in 
mouse haploinsufficiency for MAGO or Y14 cause abnormalities in the cortical development 
and microcephaly (Mao et al., 2016).  
According to the consensus, the EJC components remain associated with spliced mRNAs 
until they are displaced by the ribosome during the first round of translation. The piece of 
evidence which supports this view is that Y14 sediments in the monosomal fractions, but not 
in the polysomal ones in mammalian cells (Dostie and Dreyfuss, 2002). Contrarily, I have 
found that MAGO and Y14 remain on top of the sucrose gradient, corresponding to free 
proteins or small molecular weight complexes, a pattern that has been also observed in D. 
melanogaster (Choudhury et al., 2016). This distribution indicates that MAGO and Y14 
might dissociate from the mRNA before the translation initiation and that it is not likely that 
they form a stable complex with Fal1, which instead persists on translating mRNA.  
The fact that mago and y14 deletion mutants grow similarly to the WT strain, also suggests 
that Fal1 is not inter-dependent from MAGO and Y14. In fact, my data indicate that the 
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deletion of mago and y14 do not affect its protein levels and the nuclear localisation. A 
conserved function of eIF4AIII, from human to yeast, is the ability to regulate the biogenesis 
of the 18S rRNA (Alexandrov et al., 2011, Badertscher et al., 2015, Kressler et al., 1997, 
Mao, 2016, Mao et al., 2016, Tafforeau et al., 2013, Wild et al., 2010, Zhang et al., 2011). My 
preliminary results suggest that the function is conserved in S. pombe, since depletion of Fal1 
correlates with a reduction in the steady-state levels of the 18S rRNA. However, the 
mechanisms behind this process have not been yet investigated. Mechanistically, one 
possibility is that Fal1, as in S. cerevisiae and Human, could exploit its helicase activity to 
favor some of the endonucleolytic cleavage required for the maturation of the 18S rRNA 
(Alexandrov et al., 2011, Kressler et al., 1997). However, It may possible that the reduction of 
the 18S rRNA is an indirect effect; for example, Fal1 might regulate the expression of other 
genes which are required for the metabolism of the rRNAs or the expression of ribosomal 
proteins, as recently observed by Mao and colleagues (Mao et al., 2016). Therefore, this 
mechanism requires to be confirmed in the future. 
Since Fal1 is not dependent on MAGO and Y14, I also evaluated whether there is an inter-
dependency between the latter in S. pombe. Both quantitative and qualitative experiments 
indicate that the two proteins are required for the stability of each other in fission yeast.  Since 
it has been demonstrated that the stability of the two components depends on their 
heterodimerisation, it is likely that they form an obligatory interaction in S. pombe as in other 
eukaryotes (Boisramé et al., 2019, Choudhury et al., 2016, Gong et al., 2014, Le Hir et al., 
2001a, Miller, 2017). However, it is crucial to evaluate whether this inter-dependency is a 
result of a change in the stability of the proteins, as observed in other organisms, or due to a 
change in the mRNA levels, caused for example by a negative feedback on gene expression 
(Choudhury et al., 2016, Miller, 2017). 
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6.4 - The AID system causes a decrease in the Fal1 protein levels before the 
addition of auxin 
 
My PhD research aimed to implement the AID degron system to rapidly deplete eIF4AIII so 
to allow discrimination between direct and indirect functions of this protein in gene 
expression as detailed earlier. I have applied an OFF-AID-DSR system for the rapid depletion 
of Fal1, the homolog of eIF4AIII in fission yeast, which is characterized by the presence of 
repressible promoter (OFF), the degron system (AID), and an mRNA destabilizing element 
(DSR). However, my results indicate a substantial reduction of the protein at basal levels, 
which reflects unfortunately on cell viability, already compromised before the addition of 
auxin and thiamine. 
Although the AID system did not work as expected, since a cellular phenotype is observed 
even in absence of auxin and thiamine, my data are still relevant because they indicate that 
TIR1 could be the limiting factor for the application of the AID system in fission yeast. Based 
on genetic evidence this investigation concludes that growth defects arise only when the AID 
tagged protein and TIR1 coexist in the same background. Supporting my observation, recent 
studies pinpointed that an important caveat for the application of the AID system in budding 
yeast and mammalian cells, is represented by the constitutive expression of TIR1 under the 
control of a strong promoter: high-levels of expression of TIR1 cause an auxin-independent 
degradation of the target (Mendoza‐Ochoa et al., 2019, Natsume et al., 2016, Yesbolatova et 
al., 2019). To overcome this issue in view of future applications, two strategies can be 
adopted; the first is represented by the use of a commercially available TIR1 inhibitor, 
auxinole, which blocks the association between TIR1 and the AID domain of the target 
protein, thus suppressing basal degradation (Yesbolatova et al., 2019). A second possibility is 
to conditionally regulate the expression of TIR1; for instance, the actual promoter of TIR1, 
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the adh1 promoter, can be substituted with the rapid uracil-regulatable promoter, which is 
repressed or activated in almost 30 minutes (Watt et al., 2008).   
 
6.5 - Conclusion and future directions  
My data demonstrate that Fal1 can associate at both an intron-containing and an intron-less 
gene in S. pombe. To evaluate the global binding profile of Fal1, ChIP-seq will need to be 
performed in the future. My experimental evidences also indicate that the binding of Fal1 on 
the gene loci is partially sensitive to RNase, suggesting that Fal1 can establish interactions 
with the nascent-RNA or the transcription machinery. However, it could be interesting to 
clarify whether Fal1 binds the single-exon transcripts using a more direct approach such as 
Cross-Linking Immunoprecipitation combined with high-throughput sequencing (CLIP-seq) 
(Ule et al., 2003).  
To assess the role of Fal1 on transcription and pre-mRNA processing, a strain that allows its 
rapid depletion, in a background with tagged RNA Pol II has been generated. Using this tool, 
we will purify and sequence the newly transcribed RNA with the 4-thiouridine labeling, to 
evaluate whether Fal1 depletion can affect directly the RNA synthesis and splicing  (Mata and 
Wise, 2017, Rutkowski and Dölken, 2017). Moreover, to investigate whether the effects on 
transcription are depedent from changes in the RNA Pol II loading or rate, we will isolate the 
nascent-RNA via purification of the ternary complex formed by DNA-RNA-RNA Pol II, and 
the position of the polymerase will be captured at single-nucleotide resolution (Churchman 
and Weissman, 2011). Using this approach, we will evaluate the effect of Fal1 rapid depletion 
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2.2 g 15.5 mM 
L-glutamic 
acid 
3.38 g 2.3 mM 
Adenine 225 mg 1.31 mM 
uracil 225 mg 2.01 mM 
L-hystine 225 mg 1.45 mM 
L-leucine 225 mg 1.71 mM 
L-lysine 225 mg 1.23 mM 
Arginine 225 mg 1.3 mM 
50x salt stock 20 mL 1x 
1000x vitamin 
stock 
1 mL 1x 
10000x 
mineral stock 








Reagent Quantity (for 1 L) Final 
Concentration 
Glucose 30 g 3% 
Yeast extract 50 g 0.5% 
Adenine 225 mg 1.31 mM 
Uracile 225 mg 2.01 mM 
L-histidine 225 mg 1.45 mM 
L-leucine 225 mg 1.71 mM 
L-lysine 225 mg 1.23 mM 
Arginine 225 mg 1.3 mM 
Agar (for solid 
media) 
20 g 2% 
ddH2O To 1 L  
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1 g 81.2 mM 
Nicotinic acid 10 g 81.2 mM 
Inositol 10 g 4.2 mM 














Boric acid 5 g 80.9 mM 
Magnesium 
sulphate 
4 g 33.2 mM 
Zinc sulphate 
heptahydrate 
4 g 13.9 mM 
Ferric chloride  
hexahydrate 
2 g 7.4 mM 
Molybdic acid 0.4 mg 0.32 mM 
Potassium 
iodide 
1 mg 6.02 mM 
Cupric sulfate 
pentahydrate 
0.4 mg 1.6 mM 
Citric acid 10 mg 47.6 mM 
 
 











Yeast Extract 5 g 0.5% 
Bacto-tryptone 10 g 1% 
NaCl 10 g 1% 
Agar (for solid 
media) 
15 g 1.5% 


















Yeast Extract 5 g 0.5% 
Sodium 
chloride 




2 g 10 mM 
NZ amine 10 g 1% 





Appendix II - S. pombe strains 










A4 ΔFal1 Otr1R(Sph1)::ura4+, 
pFal1-deletion:kanMX 
 
Marayati et al., 
2016 










A19 Y14-GFP-2xFlag h- leu1-32,uraD4-D18, 
Y14-GFP-2xFLAG 
This study 




A20 TIR1 strain 







A24 Fal1-degron  
(crossed with TIR1) 
h- ade6-M216 leu1.32, 
Pnmt81:hygr: Fal1-GFP-
AID:clonat-TIR                      
This study 






A36 Y14-5xFlag h-  leu1-32 uraD4-D18, 
Y14-5xFlag 
This study 













kanMX, ΔMago: clonat  
This study 
A45 WT h-  leu1-32 uraD4-D18 Lab stock 















kanMX, ΔY14 :clonat 
This study 
A55 ΔFal1  H90/h90, ade6-
M216/ade6-M210 
leu1/leu1: ΔFal1:clonat  
This study 















A71 nmt81:Fal1 with  
Rpb3-flag 











Appendix III - List of primers 
List of primers used to create S. pombe strains  
 
Code Primer Name Primer sequence 
 











A7 4A3.FW CGAATATTGGTCAAGCGCGA 
A8 4A3.RV GCATCTCACCGTGCATACTG 
A9 kanmx.FW CGGTTGCATTCGATTCCTGT 









A14 Fal1-R1 TTCGTGATGAAGTTTTCTGGTGGTCCAAGC 
A15 Fal1-R1_nest GCAAAGAAAGCCAATTCCTCA 
A16 Fal1-seq1 GTGGAATCTATGCGTATGGCTATGAGACTC 
A17 Fal1-F1 GTGGTGGGCAATTCTGGTTAGGAAACATTAA
TTG 
A18 Fal1-nmt-R1 GATGTGCCGCCTATACAAGCATGACATTG 
A19 Fal1-nmt-F2 GTTTAAACGAGCTCGAATTCAATGGAAGTTG
TAGTAGTTATGTTATGTCAGCCCAAC 





















A28 Fal1-GFP-F1 CGAATATTGGTCAAGCGCGATGAACTTACTC 
A29 GFP-seq3 GTCCACACAATCTGCCCTTT 
A30 AID CTAAAGATCCAGCCAAACCTCC 
A31 Gar2-F1 CCCAGCCAACCCTCAACCATATGC 



















A39 Y14-R1 GGCAGAAATTTGGGGCATAAATCATATAC 
A40 Y14_CHK CTCGTTGGAAAGCAGTCACA 
A41 CBC20-FW CCTTTAGGATCTTCTCTAGAAC 







A45 Mago-GFP-F1 GGAGATGTTCGTCAGTGAGC 




A48 Mago-R1 TCCTTCATCGACTGCATCCA 
A49 RV-marker-km GGTATTCTGGGCCTCCATGTC 




A52 Mago R2-del GTTTAAACGAGCTCGAATTCATGCATTCCATT
TTCTTAT 
ATATTAGG 






A56 Y14 R2 GTTTAAACGAGCTCGAATTCATGGGCTTCTG
AAAATACACAAAACTTATTTATGTTAG 







A61 Y14-F1 GTGAAGATAGCGAATGTTGTTACCAGGAG 
A62 Y14-del-CHk AGGCACGAACAATACGATTCC 
A63 AID CTAAAGATCCAGCCAAACCTCC 
A64 rbp3-rv CCTACTGGAGGCGGTTCATC 
A65 rpb3-fw AGACCAAACGACACATTCTCA 
 
 
List of primers used for ChIP-qRT-PCR analysis 
 
 
Gene name & primer 
stock reference 
Primer pair Primer Sequence 
Intergenic region (T67- 
T68) 






From Sandip De stocks 




























gpd3 (JM80-JM83)  
From Jianming Wang  
G1 F 
G1 R 





















Details of gene loci analysed by CHIP-qPRC 
 
 























































List of primers used as probe for Northern-Blot 
 
Primer Sequence 
18S - annealing in 18 rRNA (Reverse 
primer) 
TGCACCACCACCCATAGAAT 




































Appendix IV - Maps of plasmids 
 





pFA6a-KanMX6 - Map of the pFA6a-KanMX6 plasmid: variant of this plasmid, containing 












pFA6a-GFP-2xFLAG-KanMX6 – a variant of pFA6a-KanMX6 plasmid: variant of this 
plasmid, containing GFP-2xFLAG upstream the KanMX6  gene cassette has been used to tag 
Fal1, MAGO and Y14. The nucleotide sequence shows the GFP sequence (in green), the 
2xFLAG (in magenta), the stop codon (red). The remaning nucleotides represent the 

























































































pAW8ENdeI-cHAIAA7-spo5DSR - Map of the pAW8ENdel-cHIAA7-spo5DSR plasmid: 
this plasmid has been used to tag Fal1 with the AID (IAA17) epitope. 
The plasmid was a gift from Professor Anthony Carr, University of Sussex. The plasmid is 
















Brief description of the pAW8ENdeI-cHAIAA7-spo5DSR (Watson et al., 2013): it contains 
the AID sequence epitope in frame with the DSR element of spo5 (S. pombe gene: 
SPBC29A10.02). The nucleotide sequence of the AID (in cyan), the spo5-DSR element (in 
magenta) and the stop codon (in red) is showed below. 





























pFA6a-hphMx6-P81nmt1-3xFLAG - Map of the pFA6a-hphMx6-P81nmt1-3xFLAG 
plamisd: a gene cassette containing the Pnmt81 promoter dowstream the Hygromycin 
resistence gene, deriving from this plasmid, has been used to generate the Fal1 conditional 









pFA6a-natMX6 - Map of the pFA6a-natMX plasmid: a gene cassette deriving from a 










pFA6a-5xFlag-KanMX6 - Map of the pFA6a-5xFLAG-KanMX6 plasmid: this plasmid has 












Appendix V - List of antibodies 
 
List of primary antibodies used for WB 
 
Antibody Reference Dilution 
anti-FLAG (mouse) M2, monoclonal, Sigma 1:5000 





List of antibodies used for ChIP  
 
Antibody Reference 
anti-Flag (mouse) M2, monoclonal, Sigma 






















Appendix VI - Additional Results 
 
 
Additional ChIP experiments. ChIP of MAGO-GFP-2xFLAG on fba1 and gpd3. ChIP of 






Verification of the correct integration of the AID tag in frame with the GFP epitope. The 
sequence of the AID fragment shows 100% of homology with the expected sequence and the 













Creation and Validation of Y14-5xFLAG and MAGO-5xFLAG strains.  (A)MAGO and 
Y14 are tagged at the C-terminal with a short 5xFLAG epitope. The integration of the tag is 
verified by PCR: for Y14, using the primer Y14-GFP-F1, as forward, and Y14-CHK as 
reverse (annealing outside the region of recombination), an expected band of almost 3 kb is 
successfully amplified in all the colonies analyzed. For MAGO, using the primer Mago-GFP-
F1, as forward, and Mago-CHK, as reverse (annealing outside the region of recombination), 
an expected band of almost 3 kb was amplified in four colonies. (B) The expression of the 
5xFLAG tagged Y14 and MAGO is verified by WB analysis using an anti-FLAG antibody 
(Sigma M2); bands of approximately 25 kDa and 28 kDa were detected for Y14 and MAGO 
respectively. A background line signal, also present in the WT-untagged strain is highlighted 





(A) Percentage of identity of Y14 amino acid sequence of S. pombe, with putative 
paralogs. The Y14 amino acid sequence of S. pombe is aligned with putative paralogs using 
Protein Blast (https://blast.ncbi.nlm.nih.gov/Blast.cgi?PAGE=Proteins). (B) Rotamers of 
isoleucine and Serine according to the Dunbrack 2010 rotamers library. Table of 
rotamers of Isoleucine and Serine. Chi1 and Chi2 represent the side chain torsion angles. 
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Appendix VII - Point by Point protocols 
 
1. ChIP 
1) A fresh patch of S. pombe strain is inoculated in 10 mL of YES media and grown 
overnight at 30°C. Next day, the cell culture is poured in 90 mL of YES and grown 
until OD595=0.5 (1x 107 cells/ml) (Wait at least 2-3 division). 
2) Cells are fixed for 5 minutes at RT by adding 2.7 mL of 37% Formaldehyde (Sigma).  
3) To stop the reaction, 20 mL of 2.5 M glycine is added to the cells suspension and 
incubated for 10 minutes at RT on a rotor.  
4) The cell culture is poured in two 50 mL Falcon tubes and centrifuged at 5000 rpm for 
3 minutes at 4°C.  
5) Pellet is resuspended in 40 mL of cold 1XPBS. Cells are centrifuged at 5000 rpm for 3 
minutes at 4°C; other two washings with cold 1X PBS are perfoemd at the same 
condition. 
6) Pellet is resuspend in 750 μL  ice-cold FA Lysis Buffer (100 mM HEPES-KOH, 
pH.7.5, 300 mM NaCl, 2mM EDTA, 2% Triton X-100, 0.2% Na Deoxycholate) 
containing an EDTA-free protease inhibitors cocktail tablet  (Roche, 1 tablet for 10 
mL of FA Lysis Buffer); cell suspension is transferred in a 2 mL microfuge tube. 
7) Cells are pelleted at 6000 rpm for 2 minutes at 4°C. to the pellet 750 μL FA lysis 
Buffer with EDTA-free protease inhibitor cocktail tablet and 400 μL of Zirconia 
beads, 0.7mm of diameter (Biospec), are added.  
8) Cells are broken using a cell homogenizer (Bertin Technologies, Precellys 24) in 10 
cycles: 30 seconds at 5500 rpm and 2 minutes in ice. The bottom of each screw cap 
tube is pierced two times with a red-hot 25 G needle and each tube is immediately 
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transferred in the barrel of a syringe and adapted in a 15 mL falcon tube. Lysate is 
collected at 1000 rpm for 1 minute at 4°C; remaining lysate is collected adding 500 μL 
of FA lysis Buffer with mini EDTA-free protease inhibitor cocktail tablet and 
centrifuging at the same conditions. 
9) The cell lysate is transferred in a 1.5 ml microfuge tube and harvested at 13000 rpm 
for 25 minutes at 4°C. Pellet was resuspended in 600 μL of FA lysis Buffer with mini 
EDTA-free protease inhibitor cocktail tablet.  
10)  750 μL of cell lysate transferred in a 15 mL tube (Sumitomo or in alternative a typical 
a 15mL tube): 250 μL of FA lysis Buffer with mini EDTA-free protease inhibitor 
cocktail tablet was added to reach the final volume of 1 mL. To allow the sonication is 
essential to add 20 μL of 10% SDS (without SDS the chromatin is not sonicated) and 
20 μL of 100 mM PMSF is added to the mixture and gently resuspended. Samples are 
sonicated for 15 cycles, using Bioruptor (Diagenode). 
11) After sonication the sample is transferred into a 1.5 mL tube and centrifuged 13000 
rpm for 25 minutes at 4°C. The aqueous phase (containing the sonicated chromatin), is 
transferred into a 15 mL tube (in ice) and diluted with the same volume of FA lysis 
Buffer with mini EDTA-free protease inhibitor cocktail tablet, to reduce the 
concentration of SDS used in the sonication procedure. Keep the sampe in ice, during 
beads preparation. 
12) From this sample, 50 μL of sonicated chromatin are collected as Input and stored at -
20°C. 
13) 50 μL of Dynabeads (Thermofisher), are transferred in a 1.5 mL DNA low binding 
tube (Eppendorf) and washed three times with 1 mL of cold 1xPBS containing 5% 
BSA. Typically, 10 μg of antibody (this depends about the target and the antibody) 
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was added and gently resuspended. The mixture is incubated on a rotor for 1 hour at 
room temperature. To remove unbound antibody, beads are washed three times with 1 
mL 1xPBS containing 5% BSA.  
14) After the final washing, supernatant is removed and beads are mixed with the 
appropriate amount of sonicated chromatin and transferred in a fresh 1.5 mL DNA 
Low- binding tube. Ab coated beads and the chromatin were then incubated overnight 
at 4 °C on a rotor. Note: To determine the amount of sonicated chromatin for each IP, 
1μL of sonicated chromatin is measured by the nanodrop; usually 300 μL of sonicated 
chromatin with a concentration of 1 μg/μL are used for each IP. In case of multple 
reactions, the amount of chromatin is calculated proportionally. 
15) Next day, the tube containing the IP reaction is positioned into a magnetic rack and it 
is rotated 10 times. The supernatant is removed and beads are washed for 5 minutes at 
room temperature on a rotor using the following buffer: 
 
o 2 times with Wash Buffer I (50mM HEPES-KOH pH 7.5, 150 mM NaCl, 
1mM EDTA pH 8.0, 1% Triton X-100, 0.1% Sodium deoxycholate, 0.1% 
SDS) 
o 2 times with Wash Buffer II (50mM HEPES-KOH pH 7.5, 500 mM NaCl, 
1mM EDTA pH 8.0, 1% Triton X-100, 0.1% Sodium deoxycholate, 0.1% 
SDS) 
o 2 times with Wash Buffer III (10mM Tris-HCl pH 8.0, 1mM EDTA pH 8.0, 
0.25mM LiCl, 0.5% Igepal CA, 1% Sodium deoxycholate) 
o 2 times with TE (10mM Tris-HCl pH 8.0, 1mM EDTA pH 8.0) 
Note: between each washing, beads are briefly (not more than 3 seconds) 
centrifuged to avoid the attachment to the lid, and they are rotated on the 
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magnetic rack for 10 times. Every two washing the beads are also transferred 
into a clean 1.5 mL DNA Low-binding tube. 
 
16)  After the final washing, the beads are resuspended in 100 μL of Elution Buffer-EB 
(50mM Tris-HCl pH 7.5, 10mM EDTA, 1% SDS) and incubated for 10 minutes at 
65°C and occasionally vortexed. 
17) The supernatant (elution) is recovered by putting the tube on the magnetic rack, and it 
is transferred in a fresh 1.5 mL DNA low binding tube. Elution is performed a second 
time using same conditions. 
18) To the input 150 μL of EB is added and incubated at 65°C overnight to allow de-
crosslinking. IP sample is de-crosslinked in parallel using the same condition. 
19) After de-crosslinling 5 μL Proteinase K (20 mg/mL) are added to the IP and Input and 
samples are incubated at 50 °C for two hours.  
20) To remove RNA, 1 μL of RNase A (10 mg/mL) is added and the sample is incubated 
for 30 minutes at 37°C. 
21) DNA is extracted using the QIAquick PCR purification kit, and eluted in 40 μL of 














2. Mini-prep boiling methods 
 
1) A single colony of E.coli, is inoculated in 2-3 mL of LB with Ampicillin (or other 
antibiotics according to the resistence) and grown for 13-14 hours at 35.5°C. (Note: it 
is essential to use this temperature). The culture is poured into a 1.5 mL Eppendorf 
tube and bacteria are harvested by centrifugation for 5 minutes at low speed (300g). 
2) The supernatant is completely removed.  
3) Add 400 µL STET buffer (8% sucrose, 5% Triton-x 100, 50 mM EDTA pH 8-8.5, 50 
mM Tris pH 8-8.5. Note: do not autoclave STET buffer), 30 µL Lysozyme (Sigma, 10 
mg/mL (w/v) in 10mM Tris pH 7.5, flash freeze aliquots in liquid nitrogen). 
4) Vigorously vortex to mix and let sit for 5 seconds. 
5) Boil the tube for 1-3 minutes. 
6) Centrifuge for 10 minutes at maximum speed. 
7) Prepare the following mix according to the number of preps: 10 µL RNseA (Roche, 
2mg/ml (w/v) in 10mM Tris ph 7.5, 15 mM NaCl, flash freeze aliquots in liquid 
nitrogen) and 50 µL of 3M NaAc (pH5.2). 
8) The pellet after centrifugation (step 6) will have a gluey texture. Remove with a 
toothpick and add 60 µL RNase/NaAc mix (prepared in step 7) and mix by inverting 
the tube. Wait 5 minutes. 
9) Add 500 µL Isopropanol (or 1 Vol) and mix by inverting the tubes. Spin at maximum 
speed for 10 minutes. 
10) Discard the supernatant, and wash pellet with 650 µLof 75% (v/v) EtOH. 
11) Spin for 8 minutes, discard the supernatant, air dry the pellet. 
12) Dissolve the pellet in 50µL of TE. 
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3. S. pombe transformation  
 
 
1) Inoculate a fresh single colony into 5 mL of YES or EMM liquid media (according 
to the yeast genotype), and grown overnight until OD600=0.5.  
2)  Harvest the cells by pelleting at 3000 rpm for 1 minute at room temperature. 
3)  Wash the pellet with 1 mL of 0.1 M Lithium Acetate and harvest again at 3000 
rpm for 1 minute.  
4) Resuspend the pellet in a solution consisting of:  120 μL of PEG (50% w/v), 18 μL 
of 1M Lithium Acetate, 10 μL of 10 mg/mL salmon sperm DNA, the DNA 
fragment/plasmid to transform (typically 1 μg of DNA) and sterile H2O until a 
final volume of 180 μL. 
5) Incubate the cells for 1 hour at room temperature followed by a heat shock at 42°C 
for 15 minutes.  
6) Harvest the cells at 3000 rpm for 30 seconds at room temperature, and resuspend 
the pellet in 150 μL of sterile H2O.  
7) Plate on a YES or EMM agar plate (according to the yeast genotype).  
8) Incubate the plate at 30°C for 24 hours.  
9) Replica plate on a fresh plate containing the desired antibiotic. The selective plate 







Appendix VIII - Schematic diagrams to generate yeast strains 




Schematic diagram explaining how to tag a gene with the AID system 



















Schematic diagram explaining how to generate gene deletion. This plan can be used to             
generate gene deletion both in haploid and diploid S. pombe strains 






















Schematic diagram explaining how to change the fal1 promoter with the nmt versions (nmt1, 
nmt81, nmt41) 




























Schematic diagram explaining how to tag a gene with the GFP-2xFLAG epitope 





NB. The same plan can be used to tag a gene with any of the versions of the pFA6a plasmids 
(see 5xFLAG or 3xHA), without modifying the sequence of homology with the plasmid in the 
hybrid primers. 
 
The same approach was used to tag MAGO and Y14 with the GFP-2xFLAG epitope and the 
5xFLAG epitope. 
 
 
 
 
